EQT
EQT is a global private markets investment manager that originated in Sweden, with businesses spanning private capital, infrastructure, real estate, and secondaries. It was founded in 1994 by Conni Jonsson with the support of Investor AB, AEA Investors, and SEB, and listed in Stockholm in 2019; it has since expanded by integrating Exeter, LSP, Baring Private Equity Asia, and Coller Capital.
Contents67 sections
Key facts
1994–1995Founding and First Fund
EQT was founded in 1994 by Conni Jonsson with the support of Investor AB, AEA Investors, and SEB. In 1995, its first fund was launched, investing in industrial companies in Sweden and neighboring countries.[1]
2008Infrastructure Business
In 2008, EQT formally launched its infrastructure business and opened an office in New York. This expansion was part of its development from a traditional private equity business into a multi-strategy platform.[1]
2019Listing in Stockholm
On September 24, 2019, EQT AB listed on Nasdaq Stockholm. The listed entity is EQT AB, not the individual investment funds it manages.[1]
2021Acquiring Exeter and Expanding Real Estate Investment
In January 2021, EQT announced an agreement to combine with Exeter Property Group for total consideration of $1.87 billion, including $800 million in new shares and $1.07 billion in cash, with the cash portion including the refinancing of $300 million of existing debt. The 2021 half-year report confirmed that the transaction had been completed, and Exeter’s logistics and other real estate investment businesses were integrated into EQT.[2][3]
2022Integrating LSP and Establishing a Life Sciences Investment Business
On February 28, 2022, EQT completed its acquisition of Life Sciences Partners (LSP) and established EQT Life Sciences. Total consideration was EUR 475 million, including an additional EUR 25 million paid upon achievement of a near-term fundraising target; René Kuijten, formerly managing partner of LSP, leads the business.[4]
2022Combination with Baring Private Equity Asia
On October 18, 2022, EQT completed its combination with Baring Private Equity Asia (BPEA), combining BPEA with EQT’s Asian private equity team and bringing BPEA’s real estate business into its global real estate platform. The combination expanded the firm’s investment network in Asia; investments made by BPEA before the combination also became part of the history of EQT’s Asian business.[5]
2025Per Franzén Becomes Chief Executive Officer
Per Franzén became chief executive officer and managing partner of EQT effective May 27, 2025, having previously been responsible for the private capital business in Europe and North America. His predecessor, Christian Sinding, became a firm partner, chairs the EQT Council, and continues to participate in some investment committees.[6][7]
2026Changes in Chair and Finance Leadership
Jean Eric Salata became chair of EQT effective May 12, 2026. Gustav Segerberg became chief financial officer from July 18, and Kim Henriksson became a senior advisor.[7]
2026Assets Under Management and Operating Data
The figures below correspond to June 30, 2026, and the first half of 2026, respectively, with the combined basis listed separately.
| Metric | Amount | Scope |
|---|---|---|
| Assets under management (AUM) | EUR 291 billion | June 30, excluding Coller |
| Fee-generating assets under management (FAUM) | EUR 155 billion | June 30, excluding Coller |
| IFRS revenue | EUR 1.610 billion | First half of 2026 |
| IFRS net income | EUR 663 million | First half of 2026 |
| Adjusted revenue | EUR 1.407 billion | First half of 2026, adjusted basis |
| Pro forma AUM including Coller | EUR 341 billion | Pro forma value calculated with June 30 data |
| Pro forma FAUM including Coller | EUR 186 billion | Pro forma value calculated with June 30 data |
The pro forma figures reflect the effect of including Coller in the calculation at the same point in time.
2026Completing the Coller Capital Transaction
On August 31, 2026, EQT completed its acquisition of Coller Capital’s management company and general partner businesses, adding secondaries as a business segment. The base price of the transaction was $3.2 billion, paid with 80,360,882 EQT shares and about $65 million of base cash consideration, with additional deferred contingent consideration of up to $500 million agreed. EQT also obtained a 10% carried interest entitlement in Coller’s ninth fund and may, in line with its existing policy, invest in 35% carried interest entitlements in its future closed-end funds. Jeremy Coller continues to lead the business and joined EQT’s executive committee.[8]
2026Fundraising and Evergreen Strategies
In the first half of 2026, BPEA’s ninth fund completed fundraising at $15.6 billion. EQT set a EUR 21 billion target for its seventh infrastructure fund; the Scaleup Europe Fund has a target of EUR 5 billion. On September 9, EQT launched an evergreen private markets strategy for the Asia-Pacific region, expanding its products for individual investors. Evergreen funds use an ongoing structure and run in parallel with traditional closed-end funds that have fixed fundraising and life cycles.[7][9]
September 2026Participating in the ElevenLabs Secondary Share Transaction
On September 30, 2026, ElevenLabsElevenLabsElevenLabs is an artificial intelligence audio company founded in 2022 by Mati Staniszewski and Piotr Dąbkowski. Starting from voice generation, voice cloning, and dubbing tools, it has built ElevenCreative for creators, the enterprise conversational agent platform ElevenAgents, and the developer interface ElevenAPI, and also operates music generation and voice licensing businesses.Open the full entry announced a $300 million employee tender offer, corresponding to a company valuation of $22 billion. EQT was listed among the firms investing in ElevenLabs for the first time; Wellington Management and T. Rowe Price led the transaction. The company said such arrangements are meant to give employees regular opportunities for liquidity. The announcement did not separately disclose EQT’s purchase amount, ownership stake, or specific investment fund.[10]
International Expansion and Formation of Investment Strategies
EQT started out investing in Nordic industrial companies, opened a Munich office in 1999, and entered the Hong Kong market in 2006. Its strategies subsequently expanded into infrastructure, real estate, and venture capital; it entered real estate investment in 2014 and launched EQT Ventures in 2016.[1]
Business Model and Investment Scope
EQT manages private markets capital for institutional and individual investors, with businesses spanning private capital, infrastructure, real estate, and secondaries. Private capital covers corporate buyouts, growth investment, venture capital, and life sciences; infrastructure investment involves energy, digital networks, transportation, and social services; real estate strategies focus on logistics, residential, and other specialized properties. The firm participates in the development of portfolio companies through its investment teams, industry advisors, and operational support.[11][7][8]
Portfolio Companies and Assets: 1X–Airkit
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29]
{
"rows": [
[
"1X",
"Humanoid robot developer.",
"Norway",
"EQT Ventures III: 2024"
],
[
"3Shape",
"Dental intraoral scanners and digital design software.",
"Denmark",
"EQT IX: 2022"
],
[
"AcadeMedia",
"Nordic education group covering preschool, school, and adult education.",
"Sweden",
"EQT VI: 2010"
],
[
"Acerta Analytics",
"Software for analyzing manufacturing processes and product quality.",
"Canada",
"EQT Ventures I: 2018"
],
[
"Aceve",
"Management software for construction, installation, and field service companies.",
"Sweden",
"EQT X: 2024"
],
[
"ActoGeniX (Intrexon)",
"Biotechnology for oral delivery of therapeutic proteins.",
"Belgium",
"LSP 3: 2006"
],
[
"Acumatica",
"Cloud enterprise resource planning software.",
"United States",
"EQT VII: 2019"
],
[
"Acuon Capital",
"South Korean consumer finance, leasing, and corporate finance services.",
"South Korea",
"BPEA Private Equity Fund VII: 2019"
],
[
"Adamo",
"Spanish fiber broadband and fixed communications services.",
"Spain",
"EQT Mid Market Europe: 2016"
],
[
"ADR-Haanpää",
"Transport services for special cargo such as liquid chemicals.",
"Finland",
"EQT Finland: 1999"
],
[
"Adven",
"Industrial and district energy supply services.",
"Finland",
"EQT Infrastructure I: 2012"
],
[
"Aelin Therapeutics",
"Drug development aimed at inhibiting target protein function.",
"Belgium",
"LSP 5: 2017"
],
[
"Aerska",
"Development of RNA medicines and delivery technology for brain diseases.",
"Ireland",
"LSP Dementia Fund: 2025"
],
[
"Affimed",
"Biopharmaceutical developer.",
"Germany",
"LSP 3: 2007"
],
[
"Agomab Therapeutics",
"Drug development targeting fibrosis, tissue repair, and organ function.",
"Belgium",
"LSP 7: 2023"
],
[
"AGS Health",
"Healthcare billing, coding, and revenue cycle management services.",
"United States",
"BPEA Private Equity Fund VII: 2019"
],
[
"AIG Hospitals",
"Integrated medical and hospital services in Hyderabad, India.",
"India",
"BPEA Private Equity Fund VII: 2022"
],
[
"Airkit",
"Enterprise customer service and digital engagement software.",
"United States",
"EQT Ventures II: 2021"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: Aldevron–Arium Networks
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48][49]
{
"rows": [
[
"Aldevron",
"Production of plasmid DNA, proteins, and biologics used in fields such as gene therapy.",
"United States",
"EQT VIII: 2019"
],
[
"Aleris",
"Nordic private healthcare and care services.",
"Sweden",
"EQT III, EQT Exp Capital I"
],
[
"Altus Intervention",
"Oil and gas well intervention, stimulation, and downhole technology services, formerly Qinterra.",
"Norway",
"EQT VI: 2014"
],
[
"Am-Pharma",
"Biopharmaceutical development for diseases such as acute kidney injury.",
"Netherlands",
"LSP 6: 2019"
],
[
"Ambow Education",
"Education services and blended online-offline technology, with products including HybriU.",
"—",
"BPEA Private Equity Fund V: 2011"
],
[
"AMCS",
"Operations management software for waste, recycling, and resource-intensive industries.",
"Ireland",
"EQT X: 2024"
],
[
"Amolyt Pharma",
"Drug development for rare endocrine diseases.",
"France",
"LSP 6: 2019"
],
[
"Anticimex",
"Pest monitoring and prevention services.",
"Sweden",
"EQT Future: 2021; EQT VI: 2012"
],
[
"AnyDesk",
"Remote desktop and device access software.",
"Germany",
"EQT Ventures I: 2018"
],
[
"Anyfin",
"Consumer loan refinancing and repayment management app.",
"Sweden",
"EQT Ventures II: 2020"
],
[
"APAC HR Tech",
"Employee health and benefits platform for companies in the Asia-Pacific region.",
"Australia",
"BPEA Private Equity Fund VIII: 2024"
],
[
"Apleona",
"Integrated facility management and real estate technical services in Europe.",
"Germany",
"EQT VII: 2016"
],
[
"Arcwood Environmental",
"Industrial waste treatment and resource recovery.",
"United States",
"EQT Infrastructure VI: 2023"
],
[
"Ardoq",
"Software for analyzing enterprise architecture, digital systems, and business relationships.",
"Norway",
"EQT Growth: 2022"
],
[
"Argenx",
"Antibody drug development for autoimmune diseases.",
"Netherlands",
"LSP 4: 2009"
],
[
"Argil",
"Artificial intelligence tools for video, digital humans, and content production.",
"France",
"EQT Ventures III: 2024"
],
[
"Ariceum Therapeutics",
"Cancer diagnostics and targeted radiopharmaceutical development.",
"Germany",
"LSP 7: 2021"
],
[
"Arium Networks",
"Outdoor small cell communications infrastructure in North America.",
"United States",
"EQT Active Core Infrastructure I: 2026"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: Arlanda Express–Azelis
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[50][51][52][53][54][55][56][57][58][59][60][61][62][63][64][65][66][67][68]
{
"rows": [
[
"Arlanda Express",
"High-speed rail operation at Stockholm Arlanda Airport.",
"Sweden",
"EQT Active Core Infrastructure I: 2026"
],
[
"Artios Pharma",
"Oncology drug development focused on DNA damage repair.",
"United Kingdom",
"LSP 6: 2018"
],
[
"Arvelle Therapeutics",
"Epilepsy drug development and commercialization company.",
"Netherlands",
"LSP 6: 2019"
],
[
"Asceneuron",
"Small-molecule drug development for neurodegenerative diseases.",
"Switzerland",
"LSP Dementia Fund: 2024"
],
[
"AstronauTx",
"Drug development for neurodegenerative diseases.",
"United Kingdom",
"LSP Dementia Fund: 2023"
],
[
"Atain (formely IGT Solutions)",
"Atain, formerly IGT Solutions; digital customer experience and business process services.",
"India",
"BPEA Private Equity Fund VIII: 2022"
],
[
"Atalanta Therapeutics",
"RNA interference therapy development for brain and spinal cord diseases.",
"United States",
"LSP Dementia Fund: 2024"
],
[
"ATB Therapeutics",
"Development of antibody therapy technology for hematologic cancers and solid tumors.",
"Belgium",
"LSP 7: 2024"
],
[
"Atlantic Therapeutics",
"Medical devices for pelvic floor muscle training and urinary incontinence.",
"Ireland",
"LSP HEF 2: 2018"
],
[
"Atos Medical",
"Medical devices for voice and pulmonary rehabilitation after laryngectomy.",
"Sweden",
"EQT VI: 2011"
],
[
"Atricom and Le Büro",
"Two office building assets in the Frankfurt area.",
"Germany",
"2017"
],
[
"Automic",
"Enterprise business process and IT infrastructure automation software.",
"Austria",
"EQT VI: 2012"
],
[
"AutoStore",
"Robotic systems for warehouse storage and retrieval.",
"Norway",
"EQT VII"
],
[
"Avenso",
"Production and retail of photographic art, with brands including LUMAS and WhiteWall.",
"Germany",
"EQT Mid Market: 2013"
],
[
"Avetta",
"Cloud supply chain and supplier risk management software.",
"United States",
"EQT X: 2024"
],
[
"AviadoBio",
"Gene therapy development for neurological diseases such as frontotemporal dementia.",
"United Kingdom",
"LSP Dementia Fund: 2021"
],
[
"Avidicure",
"Multifunctional antibody development for cancer and autoimmune diseases.",
"Netherlands",
"LSP 7: 2024"
],
[
"Azelis",
"Specialty chemicals and food ingredients distribution and technical services.",
"Belgium",
"EQT VIII: 2018"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: BackWerk–BioArctic
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[69][70][71][72][73][74][75][76][77][78][79][80][81][82][83][84][85][86]
{
"rows": [
[
"BackWerk",
"Bakery and convenience food franchising.",
"Germany",
"EQT Mid Market: 2014"
],
[
"Baffin Bay Networks",
"Cloud-based network threat protection services.",
"Sweden",
"EQT Ventures I: 2018"
],
[
"Baller League",
"Football league and sports entertainment operations.",
"Germany",
"EQT Ventures III: 2024"
],
[
"Ballingslöv",
"Kitchen furniture manufacturing and sales.",
"Sweden",
"EQT I: 1998"
],
[
"Banking Circle",
"Payments and banking infrastructure for financial institutions.",
"Luxembourg",
"EQT VIII, EQT Ventures I: 2018"
],
[
"BBS Automation",
"Industrial automated assembly and testing equipment.",
"Germany",
"EQT Mid Market Europe: 2018; EQT Mid Market Asia III: 2018"
],
[
"Beamery",
"Enterprise talent management software.",
"United Kingdom",
"EQT Ventures I: 2018"
],
[
"Beat81",
"Fitness training services combined with data monitoring.",
"Germany",
"EQT Ventures II: 2019"
],
[
"Beijer Ref",
"Wholesale distribution of refrigeration, HVAC, and air conditioning products.",
"Sweden",
"EQT IX: 2020"
],
[
"Believe",
"Digital distribution and marketing services for independent artists and labels.",
"France",
"EQT X: 2024"
],
[
"Benesse",
"Japanese education and elderly care services group.",
"Japan",
"BPEA Private Equity Fund VIII: 2024"
],
[
"Beside",
"Artificial intelligence tools for small business phone, text, and customer communications.",
"France",
"EQT Ventures III: 2024"
],
[
"Bespak",
"Contract development and manufacturing of inhaled drug delivery products.",
"United Kingdom",
"EQT IX: 2021"
],
[
"Bewator",
"Access control and security systems.",
"Sweden",
"EQT Finland: 2002"
],
[
"BHS",
"High-speed gear units for equipment such as turbines and compressors.",
"Germany",
"EQT Exp Capital I: 2005"
],
[
"Billtrust",
"Enterprise accounts receivable automation and payments software.",
"United States",
"EQT X: 2022"
],
[
"Binx Health",
"Point-of-care diagnostic testing devices for infectious diseases.",
"United Kingdom",
"LSP 4, LSP 6: 2021"
],
[
"BioArctic",
"Biopharmaceutical development for neurodegenerative diseases such as Alzheimer’s disease.",
"Sweden",
"LSP Dementia Fund: 2025"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: Biographica–Calldesk
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[87][88][89][90][91][92][93][94][95][96][97][98][99][100][101][102][103][104][105][106]
{
"rows": [
[
"Biographica",
"AI-assisted crop gene editing and trait research.",
"United Kingdom",
"EQT Foundation Fund: 2024"
],
[
"Biolevate",
"Artificial intelligence platform supporting medical research, regulatory work, and knowledge management.",
"France",
"EQT Ventures III: 2024"
],
[
"Biovian",
"Biopharmaceutical contract development and manufacturing services.",
"Finland",
"EQT Mid-Market Credit, EQT Mid-Market Credit II: 2018"
],
[
"Blizoo",
"Cable television and broadband operations in Bulgaria and North Macedonia.",
"Bulgaria",
"EQT V: 2009"
],
[
"BLOOM FRESH International",
"Breeding of fruit varieties such as grapes, cherries, and blueberries.",
"United Kingdom",
"EQT Future: 2023"
],
[
"Bluebook",
"AI research, documentation, and automation tools for accounting firms.",
"Sweden",
"EQT Ventures: investment announced in 2025"
],
[
"BluumBio",
"Microbial technology for treating soil and water pollution.",
"United States",
"EQT Foundation Fund: 2025"
],
[
"BMEye",
"Medical devices for noninvasive hemodynamic monitoring.",
"Netherlands",
"LSP 3: 2006"
],
[
"Bodilsen",
"Danish flat-pack furniture manufacturer that filed for bankruptcy and ceased operations in June 2009.",
"Denmark",
"EQT Opportunity: 2006"
],
[
"Broadnet",
"Norwegian enterprise fiber communications and data network services.",
"Norway",
"EQT V, EQT VI: 2012"
],
[
"Brukens Thermotreat",
"Metal heat treatment and surface coating services.",
"Sweden",
"EQT I: 1995"
],
[
"BSN medical",
"Medical supplies for wound care, compression therapy, and noninvasive orthopedics.",
"Germany",
"EQT VI: 2012"
],
[
"BTX Group",
"Apparel brand operation and wholesale.",
"Denmark",
"2005"
],
[
"Buena",
"Residential property management and rental management services in Germany.",
"Germany",
"EQT Ventures I: 2017"
],
[
"Bureau van Dijk",
"Private company information databases and business analytics software.",
"Netherlands",
"EQT VI: 2014"
],
[
"Bushu Pharmaceuticals",
"Japanese contract manufacturing services for pharmaceuticals and medical devices.",
"Japan",
"BPEA Private Equity Fund V: 2014"
],
[
"Calisen",
"Smart meter installation, ownership, and management services in the United Kingdom.",
"United Kingdom",
"EQT Active Core Infrastructure I: 2025"
],
[
"Calldesk",
"Artificial intelligence voice customer service agents.",
"France",
"EQT Ventures I: 2017"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: Camion–Charleston
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[107][108][109][110][111][112][113][114][115][116][117][118][119][120][121][122][123][124]
{
"rows": [
[
"Camion",
"AI analytics and workflow tools for real estate energy matters.",
"United Kingdom",
"EQT Ventures III: 2023"
],
[
"Candela",
"Electric boat development and manufacturing.",
"Sweden",
"EQT Ventures III: 2021"
],
[
"Candyking",
"Bulk retail services for candy, chocolate, and snacks.",
"Sweden",
"EQT Exp Capital I: 2008"
],
[
"Cardiac Dimensions",
"Medical devices related to heart valve repair.",
"United States",
"LSP HEF 1: 2015"
],
[
"Cardior",
"RNA therapy development for cardiovascular diseases.",
"Germany",
"LSP 5: 2017"
],
[
"CareNet",
"Japanese pharmaceutical information, physician education, and digital promotion platform.",
"Japan",
"BPEA EQT Mid-Market Growth: 2025"
],
[
"CaridianBCT",
"Blood collection, separation, and processing equipment.",
"United States",
"EQT IV: 2006"
],
[
"Carl Zeiss Vision",
"Eyeglass lens design, manufacturing, and sales.",
"Germany",
"EQT III: 2005"
],
[
"Cast & Crew",
"Payroll, HR, accounting, and workflow software for the entertainment production industry.",
"United States",
"EQT VIII: 2018"
],
[
"Cath Kidston",
"British fashion and home lifestyle brand.",
"—",
"BPEA Private Equity Fund V: 2014"
],
[
"CBR",
"Womenswear brand group, with brands including Street One and CECIL.",
"Germany",
"EQT V: 2007"
],
[
"Celladon",
"Gene therapy developer for cardiovascular diseases.",
"United States",
"LSP 4: 2012"
],
[
"Cemvision",
"Development of low-carbon cement using industrial by-products and electrified processes.",
"Sweden",
"EQT Foundation Fund: 2022"
],
[
"Cerba Healthcare",
"Medical testing, specialty testing, and clinical research laboratory services.",
"France",
"EQT IX: 2021"
],
[
"Certara",
"Drug development modeling, regulatory science, and submission software and services.",
"United States",
"EQT VII: 2017"
],
[
"CFB Group",
"Restaurant chain operations in China, running brands such as DQ and Papa John’s.",
"Greater China",
"2013"
],
[
"CFC",
"Specialty insurance products and risk services, including cybersecurity insurance.",
"United Kingdom",
"EQT IX: 2022"
],
[
"Charleston",
"Nursing home and care services operations in Germany.",
"Germany",
"EQT Infrastructure II: 2014"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: Charly–Coforge
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[125][126][127][128][129][130][131][132][133][134][135][136][137][138][139][140][141][142][143]
{
"rows": [
[
"Charly",
"Household finance tool addressing childcare division and pension gaps.",
"Sweden",
"EQT Foundation Fund: 2022"
],
[
"China Shine",
"Cleaning, building maintenance, security, and facility management services in China.",
"Greater China",
"2019"
],
[
"Cimbria",
"Grain drying, sorting, conveying, and related processing equipment.",
"Denmark",
"EQT Opportunity: 2007"
],
[
"Cinterion",
"Machine-to-machine wireless communication modules.",
"—",
"EQT Expansion Capital II: 2008"
],
[
"Cirba Solutions",
"Battery recycling and material reuse.",
"United States",
"EQT Infrastructure V"
],
[
"Citius Tech",
"Consulting and digital technology services for the healthcare and life sciences industries.",
"United States",
"BPEA Private Equity Fund VII: 2019"
],
[
"Clarifeye",
"Data and knowledge platform for building enterprise AI agents.",
"France",
"EQT Ventures III: 2025"
],
[
"Clarivate Analytics",
"Research, intellectual property, and innovation information analytics services.",
"—",
"BPEA Private Equity Fund VI: 2016"
],
[
"Classic Fine Foods",
"Premium food ingredient distribution and foodservice customer services.",
"Singapore",
"EQT Greater China II: 2011"
],
[
"Cleo",
"AI personal finance assistant.",
"United Kingdom",
"EQT Ventures II: 2020"
],
[
"ClexBio",
"Tissue engineering and regenerative medicine technology for chronic diseases.",
"Switzerland",
"EQT Foundation Fund: 2024"
],
[
"Clinical Innovations",
"Obstetric and neonatal intensive care medical devices.",
"United States",
"EQT Mid Market US: 2017"
],
[
"CluePoints",
"Clinical trial risk management and data quality analytics software.",
"Belgium",
"EQT Growth: 2024"
],
[
"CMS Info Systems",
"Cash logistics, ATM management, and related financial infrastructure services in India.",
"India",
"BPEA Private Equity Fund VI: 2015"
],
[
"Coches.net",
"Spanish automotive classifieds and transaction matching platform.",
"Spain",
"EQT X: 2026"
],
[
"Codacy",
"Code quality review and automated analysis tools.",
"Portugal",
"EQT Ventures I: 2017"
],
[
"Codemao",
"Programming education platform for children.",
"Greater China",
"BPEA Private Equity Fund VII: 2020"
],
[
"Coforge",
"Enterprise digital and IT technology services.",
"India",
"BPEA Private Equity Fund VII: 2019"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: Colisee–DAKO
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[144][145][146][147][148][149][150][151][152][153][154][155][156][157][158][159][160][161][162][163][164]
{
"rows": [
[
"Colisee",
"Nursing homes, assisted living, and home care services in Europe.",
"France",
"EQT Infrastructure V: 2020"
],
[
"Com Hem",
"Swedish cable television, broadband, and communications services.",
"Sweden",
"EQT III: 2003"
],
[
"Compass Education",
"School attendance, payments, assessment, and administrative management software.",
"Australia",
"BPEA EQT Mid-Market Growth: 2025"
],
[
"Concert Bio",
"Beneficial microbial technology for greenhouse and hydroponic agriculture.",
"United Kingdom",
"EQT Foundation Fund: 2024"
],
[
"Constellation Cold Logistics",
"Food cold storage and cold chain logistics services in Europe.",
"United Kingdom",
"EQT Infrastructure VI: 2024"
],
[
"Contanda",
"Bulk liquid storage and logistics services in North America, formerly Westway Group.",
"United States",
"EQT Infrastructure II: 2013"
],
[
"Contex Holding",
"Wide-format scanners and 2D and 3D imaging equipment.",
"Denmark",
"EQT Danmark: 1999"
],
[
"Coromatic",
"Power, communications, and operations services for critical facilities such as data centers.",
"—",
"EQT Expansion Capital II: 2011"
],
[
"Credila Financial Services",
"Domestic and overseas higher education loan services for students in India.",
"India",
"BPEA Private Equity Fund VIII: 2023"
],
[
"Cue",
"Enterprise digital marketing, data analytics, and technology services.",
"Greater China",
"BPEA Private Equity Fund VII: 2021"
],
[
"Curaeos",
"Network of dental clinics and shared management services in Europe.",
"Netherlands",
"EQT VII: 2017"
],
[
"Curetis",
"Molecular diagnostic devices for pathogens and antibiotic resistance.",
"Germany",
"LSP 4, LSP HEF 1: 2009"
],
[
"CYE",
"Cybersecurity risk assessment, attack simulation, and defense optimization services.",
"Israel",
"EQT Mid Market Europe: 2021"
],
[
"Cypress Creek Energy",
"Development and operation of power generation and energy storage assets in the United States.",
"United States",
"EQT Infrastructure V: 2021"
],
[
"Cyted Health",
"Molecular diagnostic technology for early detection of esophageal diseases.",
"United Kingdom",
"EQT HE 3: 2025"
],
[
"Cytora",
"Insurance digitization and AI risk processing software.",
"United Kingdom",
"EQT Ventures I: 2019"
],
[
"Dahl International",
"Wholesale of HVAC, bathroom, drainage, and piping products.",
"Sweden",
"EQT II: 1999"
],
[
"DAKO",
"Cancer pathology diagnostic reagents, instruments, and software.",
"Denmark",
"EQT V: 2007"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: Data Intensity–Dwelly
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[165][166][167][168][169][170][171][172][173][174][175][176][177][178][179][180][181][182][183][184]
{
"rows": [
[
"Data Intensity",
"Managed services for enterprise applications, databases, and cloud environments.",
"United States",
"EQT Mid Market US: 2017"
],
[
"DataFlow",
"Verification of professionals’ educational credentials, experience, and professional qualifications.",
"United Arab Emirates",
"EQT Mid Market: 2014"
],
[
"Dechra Pharmaceuticals",
"Veterinary pharmaceutical development and manufacturing.",
"United Kingdom",
"EQT X: 2024"
],
[
"Dellner Couplers",
"Railway vehicle coupling, buffering, and safety systems.",
"Sweden",
"EQT VIII: 2019"
],
[
"DELTA Fiber",
"Dutch fiber broadband, television, and fixed telephony infrastructure.",
"Netherlands",
"EQT Infrastructure III: 2022"
],
[
"Depict.AI",
"E-commerce product merchandising, search, and recommendation software.",
"Sweden",
"EQT Ventures II: 2021"
],
[
"Desotec",
"Mobile activated carbon industrial filtration and regeneration services.",
"Belgium",
"EQT VII: 2017; EQT Mid Market Europe: 2021; EQT Future: 2026"
],
[
"Deutsche Glasfaser",
"Residential and business fiber broadband networks in Germany.",
"Germany",
"EQT Infrastructure IV, EQT Infrastructure V: 2020"
],
[
"Direct ChassisLink",
"Container chassis leasing and intermodal equipment management in North America.",
"United States",
"EQT Infrastructure II, EQT Infrastructure III: 2018"
],
[
"DNA Script",
"Enzymatic DNA synthesis technology and equipment.",
"France",
"LSP 6: 2019"
],
[
"Dometic",
"Refrigeration, air conditioning, and living equipment for RVs, boats, and outdoor use.",
"Sweden",
"EQT V: 2011; EQT III: 2001"
],
[
"Dorner",
"Precision conveyor systems for manufacturing process automation.",
"United States",
"EQT Mid Market US: 2017"
],
[
"DOTS Technology",
"Detection technology and equipment for substances such as food allergens.",
"United States",
"LSP HEF 2: 2021"
],
[
"dottxt",
"Structured output and application development tools for large language models.",
"France",
"EQT Ventures III: 2024"
],
[
"Ducky",
"Carbon emissions data analytics and environmental behavior management tool.",
"Norway",
"EQT Foundation Fund: 2022"
],
[
"Duni",
"Napkins, tablecloths, and table-setting products for foodservice.",
"Sweden",
"EQT III: 2001"
],
[
"Dunlop",
"Protective boots for industrial, agricultural, and mining use.",
"Netherlands",
"EQT Mid Market Europe: 2018"
],
[
"Dwelly",
"UK property management platform combining AI with residential letting agency operations.",
"United Kingdom",
"EQT Growth: 2025"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: E.I.S. Aircraft–Endotronix
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[185][186][187][188][189][190][191][192][193][194][195][196][197][198][199][200][201][202][203]
{
"rows": [
[
"E.I.S. Aircraft",
"Aircraft cabin components, maintenance, and training services company.",
"Germany",
"EQT Mid Market: 2015"
],
[
"Eagle Railcar Services",
"Railcar repair and maintenance services in the United States.",
"United States",
"EQT Infrastructure IV, EQT Infrastructure VI: 2025"
],
[
"EC-Council",
"Cybersecurity training and professional certification.",
"Singapore",
"2021"
],
[
"Econ Healthcare",
"Elderly care and healthcare services in Singapore and Malaysia.",
"—",
"EQT Greater China II: 2012"
],
[
"ecoplanet",
"Software for corporate energy supply, energy use analytics, and dispatch.",
"Germany",
"EQT Ventures III: 2024"
],
[
"EdgeConneX",
"Development and operation of edge and large-scale data centers.",
"United States",
"EQT Infrastructure IV, EQT Infrastructure V: 2020"
],
[
"Educo Platform",
"Spanish social infrastructure project; EQT Infrastructure VI invested in 2024.",
"Spain",
"EQT Infrastructure VI: 2024"
],
[
"EEW Energy from Waste",
"Waste-to-energy treatment and heat and power generation in Europe.",
"Germany",
"EQT Infrastructure II: 2013"
],
[
"Egle Therapeutics",
"Immunotherapy development centered on regulatory T cells.",
"France",
"LSP 7: 2021"
],
[
"Einride",
"Electric and autonomous freight technology.",
"Sweden",
"EQT Ventures II: 2019"
],
[
"Eldon Holding",
"Metal enclosures for industrial, electrical, and communications equipment.",
"Sweden",
"EQT II: 2001"
],
[
"Electra Therapeutics",
"Antibody therapy development for immune diseases and cancer.",
"United States",
"LSP 7: 2025"
],
[
"ELEVATE",
"Supply chain social responsibility, environmental, and compliance assessment services.",
"Hong Kong",
"EQT Mid Market: 2016"
],
[
"Ellab",
"Validation, monitoring, and calibration services for life sciences production environments.",
"Denmark",
"EQT Mid Market Europe: 2019"
],
[
"Eloxx Pharma",
"Drug development for genetic diseases.",
"United States",
"LSP 5: 2017"
],
[
"Encyclis",
"Energy-from-waste facilities in the United Kingdom and Ireland, formerly Covanta Europe.",
"United Kingdom",
"EQT Infrastructure V: 2021"
],
[
"Endgame",
"Customer data, AI analytics, and workflow software for sales teams.",
"United States",
"EQT Ventures III: 2022"
],
[
"Endotronix",
"Remote heart failure monitoring and patient management technology.",
"United States",
"LSP HEF 2: 2018"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: Enity Group–Fiberklaar
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[204][205][206][207][208][209][210][211][212][213][214][215][216][217][218][219][220][221]
{
"rows": [
[
"Enity Group",
"Nordic specialist residential mortgage bank.",
"Sweden",
"EQT VII: 2017"
],
[
"Envirotainer",
"Temperature-controlled containers and cold chain services for air transport of biopharmaceuticals.",
"Sweden",
"EQT X: 2022"
],
[
"Epidemic Sound",
"Music and sound effects licensing platform for creators and businesses.",
"Sweden",
"EQT Growth: 2021"
],
[
"eTheRNA",
"mRNA technology development for oncology and infectious diseases.",
"Belgium",
"LSP 5: 2016"
],
[
"Eton",
"Men’s shirt and accessories brand.",
"Sweden",
"EQT VII: 2016"
],
[
"Euclid Vision",
"Myopia management and orthokeratology lens products.",
"United States",
"BPEA Private Equity Fund VII: 2022"
],
[
"Europa Biosite",
"Distribution of life sciences research reagents and consumables.",
"Sweden",
"EQT Healthcare Growth: 2025"
],
[
"Evidia",
"Diagnostic radiology, nuclear medicine, and radiotherapy services in Europe.",
"Germany, Scandinavia",
"EQT Infrastructure V: 2021"
],
[
"Evommune",
"Drug development for chronic inflammatory diseases.",
"United States",
"LSP 7: 2021"
],
[
"evroc",
"European cloud computing and data infrastructure.",
"Sweden",
"EQT Ventures III: 2023"
],
[
"EX-Fusion",
"Laser fusion and related energy technology development.",
"Japan",
"EQT Foundation Fund: 2023"
],
[
"Exciva",
"Drug development for agitation symptoms associated with Alzheimer’s disease.",
"Germany",
"LSP Dementia Fund: 2025"
],
[
"Eyesense",
"Continuous glucose monitoring device development.",
"Switzerland",
"LSP 3: 2006"
],
[
"Facile",
"Italian comparison platform for insurance, energy, telecommunications, and personal finance products.",
"Italy",
"EQT VIII: 2018"
],
[
"Fenix Marine Services",
"Container terminal operations at the Port of Los Angeles.",
"United States",
"EQT Infrastructure III: 2017"
],
[
"Fertifa",
"Employer-provided fertility and reproductive health benefits services.",
"United Kingdom",
"EQT Foundation Fund: 2023"
],
[
"Fertin Pharma",
"Contract development and manufacturing of oral and intraoral drug delivery products.",
"Denmark",
"EQT Mid Market Europe: 2017"
],
[
"Fiberklaar",
"Fiber-to-the-home network in the Flanders region of Belgium.",
"Belgium",
"EQT Infrastructure V: 2021"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: Filament–Fundamental VR
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[222][223][224][225][226][227][228][229][230][231][232][233][234][235][236][237][238][239]
{
"rows": [
[
"Filament",
"AI-integrated team collaboration, communications, and professional social network.",
"United States",
"V3: 2025"
],
[
"Findus",
"Food businesses including frozen vegetables, ready meals, and seafood.",
"Sweden",
"EQT II: 2000"
],
[
"Finn-Power",
"Sheet metal processing equipment and automated production systems.",
"Finland",
"EQT III: 2002"
],
[
"First Student",
"School bus and student transportation services in North America.",
"United States",
"EQT Infrastructure V: 2021"
],
[
"First Transit",
"Public transit operations and management services company in North America, merged into Transdev in March 2023.",
"United States",
"EQT Infrastructure V: invested in 2021; sold in 2023"
],
[
"FlexLink",
"Automated conveyor systems for the assembly and manufacturing industries.",
"Sweden",
"EQT I: 1997"
],
[
"Flix",
"Long-distance intercity bus network operations.",
"Germany",
"EQT Future: 2024"
],
[
"Flow Engineering",
"Hardware engineering design collaboration tools.",
"United Kingdom",
"EQT Ventures II: 2022"
],
[
"Flowcardia",
"Medical devices for cardiovascular and peripheral arterial interventions.",
"United States",
"LSP 3: 2007"
],
[
"Fly.io",
"Distributed application deployment and cloud computing services.",
"United States",
"EQT Ventures III: 2023"
],
[
"Flying Tiger",
"Retail of household goods, stationery, toys, and other lifestyle products.",
"Denmark",
"EQT VI: 2013"
],
[
"Formo",
"Development of alternative dairy products using technologies such as cellular agriculture.",
"Germany",
"EQT Ventures III: 2021"
],
[
"Forsta",
"Market research, customer experience, and data analytics software.",
"United States",
"EQT Mid Market US: 2015"
],
[
"Fortnox",
"Accounting, payroll, invoicing, and financial services software for Swedish small and medium-sized businesses.",
"Sweden",
"EQT X: 2025"
],
[
"FoRx Therapeutics",
"Drug development focused on DNA replication stress.",
"Switzerland",
"LSP 6: 2019"
],
[
"Frontify",
"Brand asset and visual guideline management platform.",
"Switzerland",
"EQT Ventures II: 2020"
],
[
"Fujitec",
"Manufacturing and maintenance of elevators, escalators, and moving walkways.",
"—",
"BPEA Private Equity Fund IX: 2025"
],
[
"Fundamental VR",
"Virtual reality surgical training with haptic feedback.",
"United Kingdom",
"LSP HEF 2: 2022"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: Færch Plast–Handshake
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[240][241][242][243][244][245][246][247][248][249][250][251][252][253][254][255][256][257]
{
"rows": [
[
"Færch Plast",
"Development and manufacturing of plastic food packaging.",
"Denmark",
"EQT VI: 2014"
],
[
"Gala TV",
"Taiwanese cable television channels and program content operations.",
"Taiwan",
"EQT Greater China II: 2011"
],
[
"Galderma",
"Development and sales of dermatological treatments, aesthetics, and skincare products.",
"Switzerland",
"EQT VIII: 2019"
],
[
"Gambro",
"Dialysis, blood processing, and related medical services group.",
"Sweden",
"EQT IV: 2006"
],
[
"GeBBS Healthcare Solutions",
"Healthcare revenue cycle and back-office management services.",
"United States",
"BPEA Private Equity Fund VIII: 2024"
],
[
"Generative Engineering",
"Computational software platform supporting engineering design and development.",
"United Kingdom",
"EQT Ventures III: 2023"
],
[
"GETEC",
"Heating, power, and energy services for industrial and real estate customers.",
"Germany",
"EQT Infrastructure III: 2017"
],
[
"Giant Interactive",
"Online game development and operations in China.",
"—",
"BPEA Private Equity Fund V: 2013"
],
[
"Ginko",
"Manufacturing and sales of contact lenses and care products.",
"Greater China",
"BPEA Private Equity Fund VII: 2022"
],
[
"Global Indian Schools",
"International school network and education services.",
"—",
"BPEA Private Equity Fund V: 2011"
],
[
"GlobalConnect",
"Nordic fiber communications, data center, and network infrastructure services.",
"Sweden",
"EQT Infrastructure III, EQT Infrastructure IV: 2017"
],
[
"GotPhoto",
"Photo management, editing, marketing, and sales software for photographers.",
"Germany",
"EQT Growth: 2023"
],
[
"GPA Global",
"Design, manufacturing, and distribution of packaging and display solutions for products such as cosmetics and consumer electronics.",
"Hong Kong",
"2017"
],
[
"Granngården",
"Swedish retail of gardening, pet, farm, and outdoor products.",
"Sweden",
"EQT Opportunity: 2008"
],
[
"Griffin",
"Banking technology platform providing companies with bank accounts, payments, and other services.",
"United Kingdom",
"EQT Ventures II: 2020"
],
[
"Guardian Shanghai Hygiene Service Ltd.",
"Pest control and environmental hygiene services for commercial premises in China.",
"Greater China",
"2022"
],
[
"HackerOne",
"Bug bounty, penetration testing, and security research services platform.",
"United States",
"EQT Ventures I: 2017"
],
[
"Handshake",
"Recruiting platform connecting students, graduates, and employers.",
"United States",
"EQT Ventures I: 2018"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: Harvey–HyTest
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[258][259][260][261][262][263][264][265][266][267][268][269][270][271][272][273][274][275][276]
{
"rows": [
[
"Harvey",
"Legal AI software for law firms and professional services organizations.",
"United States",
"EQT Growth: 2025"
],
[
"HCP Global",
"Design and manufacturing of packaging containers for makeup, skincare, fragrance, and personal care products.",
"Greater China",
"BPEA Private Equity Fund VI: 2016"
],
[
"Headspin",
"Software for testing the performance of mobile apps, websites, and streaming on real devices and networks.",
"United States",
"EQT Ventures I: 2018"
],
[
"Heart Aerospace",
"Electric aircraft development.",
"Sweden",
"EQT Ventures I: 2019"
],
[
"Hector Rail",
"Rail freight traction and related transport services in Europe.",
"Sweden",
"EQT Infrastructure II: 2014"
],
[
"HemoCue",
"Point-of-care diagnostic testing devices for measures such as hemoglobin.",
"Sweden",
"EQT II: 1999"
],
[
"Hexaware",
"Enterprise IT, digital transformation, and business process services.",
"India",
"BPEA Private Equity Fund VII: 2020; BPEA Private Equity Fund V: 2013"
],
[
"HMI Group",
"Hospital, outpatient, and healthcare services in Singapore, Malaysia, and elsewhere.",
"Singapore",
"2019"
],
[
"Holidu",
"Vacation rental search, booking, and property management platform.",
"Germany",
"EQT Ventures I: 2015"
],
[
"Horizon Robotics",
"Assisted and autonomous driving computing solutions for passenger vehicles.",
"Greater China",
"2021"
],
[
"HotSpot Therapeutics",
"Allosteric small-molecule drug development targeting protein regulatory sites.",
"United States",
"LSP 7: 2021"
],
[
"HRBrain",
"Employee performance, talent management, labor management, and organizational assessment software.",
"Japan",
"BPEA EQT Mid-Market Growth: 2023"
],
[
"HTL-Strefa",
"Disposable medical devices such as lancets, safety blood collection devices, and pen needles.",
"Poland",
"EQT V: 2009"
],
[
"Hubs",
"On-demand platform for CNC machining, 3D printing, and sheet metal parts manufacturing.",
"Netherlands",
"EQT Ventures I: 2016"
],
[
"Hume.AI",
"Artificial intelligence for emotional expression and voice interaction.",
"United States",
"EQT Ventures III: 2024"
],
[
"HusCompagniet",
"Design and construction of detached houses in Nordic markets such as Denmark and Sweden.",
"Denmark",
"EQT VI: 2015"
],
[
"Hutchmed",
"Research, development, and commercialization of targeted drugs for cancer and immune diseases.",
"Hong Kong",
"BPEA Private Equity Fund VII: 2021"
],
[
"HyTest",
"Antibodies and antigens for diagnostic reagent makers and research institutions; EQT Credit previously provided acquisition financing.",
"Finland",
"EQT Mid-Market Credit, EQT Mid-Market Credit II: 2018"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: I-MED–Ineffable Intelligence
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[277][278][279][280][281][282][283][284][285][286][287][288][289][290][291][292][293][294]
{
"rows": [
[
"I-MED",
"Medical imaging diagnostic services in Australia.",
"Australia",
"EQT Mid Market: 2014"
],
[
"Icon Group",
"Cancer radiotherapy, drug treatment, pharmaceutical compounding, and pharmacy services.",
"Australia",
"EQT Infrastructure V: 2022"
],
[
"IDEA",
"German medical technology company.",
"Germany",
"LSP 3: 2005"
],
[
"Idealista",
"Real estate listing platform in Spain, Portugal, and Italy.",
"Spain",
"EQT IX: 2020"
],
[
"IFS",
"Enterprise resource planning, asset management, and field service software for industrial companies.",
"Sweden",
"EQT IX, EQT VIII: 2020"
],
[
"Igenomix",
"Genetic testing services related to assisted reproduction and women’s health.",
"Spain",
"EQT VIIII: 2019"
],
[
"ILA Vietnam",
"English training, teacher training, and study abroad consulting in Vietnam.",
"Vietnam",
"2017"
],
[
"Illuminoss",
"Fracture fixation medical devices using light-cured polymer implant technology.",
"United States",
"LSP HEF 1: 2012"
],
[
"ImCheck",
"Immunotherapy antibody development targeting BTN and BTNL molecules.",
"France",
"LSP 5: 2017"
],
[
"Imcyse",
"Antigen-specific immunotherapy development for chronic diseases.",
"Belgium",
"LSP 6: 2019"
],
[
"IMG Academy",
"Sports boarding education, training camps, online coaching, and student-athlete recruiting services.",
"United States",
"BPEA Private Equity Fund VIII: 2023"
],
[
"Immunic",
"Drug development for autoimmune and immune-related diseases.",
"Germany",
"LSP 5: 2016"
],
[
"Impro Precision",
"High-precision castings, machined components, and surface treatment services.",
"Greater China",
"BPEA Private Equity Fund V: 2011"
],
[
"In.Corp Global",
"Company incorporation, corporate secretarial, accounting, tax, and payroll services.",
"Singapore",
"EQT Mid Market: 2016"
],
[
"Indesso",
"Natural flavor and fragrance ingredients and food, nutrition, and health ingredients.",
"Indonesia",
"2021"
],
[
"Indira IVF",
"Network of assisted reproduction and fertility treatment clinics in India.",
"—",
"BPEA Private Equity Fund VIII: 2023"
],
[
"Indium",
"Product engineering, data engineering, AI, software testing, and gaming technology services.",
"United States",
"BPEA EQT Mid-Market Growth: 2024"
],
[
"Ineffable Intelligence",
"AI research focused on reinforcement learning and autonomous learning from experience.",
"United Kingdom",
"2026"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: Infinit–Jakarta Eye Center
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[295][296][297][298][299][300][301][302][303][304][305][306][307][308][309][310][311][312][313]
{
"rows": [
[
"Infinit",
"Financial services and business management platform for small and medium-sized businesses.",
"France",
"EQT Ventures III: 2022"
],
[
"InfoJobs",
"Spanish online recruiting and job listing platform.",
"Spain",
"EQT X: 2026"
],
[
"Innovative Molecules",
"Drug development for herpesvirus infections.",
"Germany",
"LSP 6: 2021"
],
[
"Innovyze",
"Modeling, simulation, and asset management software for water supply, drainage, flood control, and water infrastructure.",
"United States",
"EQT Mid Market US: 2017"
],
[
"Insempra",
"Production of bio-based ingredients for food, personal care, and other industries through precision fermentation.",
"Germany",
"EQT Ventures II: 2021"
],
[
"Instabee",
"E-commerce last-mile delivery and parcel delivery services.",
"Sweden",
"EQT Ventures II: 2021"
],
[
"InstaVolt",
"Public electric vehicle charging infrastructure.",
"United Kingdom",
"EQT Infrastructure V: 2022"
],
[
"IntegrityNext",
"Supply chain sustainability risk assessment, monitoring, and compliance software.",
"Germany",
"EQT Growth: 2023"
],
[
"International Health Insurance",
"Private health insurance for cross-border clients.",
"Denmark",
"EQT II: 2001"
],
[
"internetstores",
"Online retail of bicycles and outdoor products.",
"—",
"EQT Expansion Capital II: 2012"
],
[
"IP-Only",
"Swedish fiber network, data communications, and data center services, later merged into GlobalConnect.",
"Sweden",
"EQT Mid Market, EQT Mid Market Europe: 2013"
],
[
"IslaLink",
"Submarine cables and bandwidth services for telecom operators.",
"Spain",
"EQT Infrastructure II: 2014"
],
[
"ISS",
"Cleaning, catering, property, security, and integrated facility management services.",
"Denmark",
"EQT III, EQT IV: 2005"
],
[
"iStar Medical",
"Development of ophthalmic implant devices for glaucoma treatment.",
"Belgium",
"LSP HEF 2: 2019"
],
[
"itslearning",
"Cloud learning management system for schools and educational institutions.",
"—",
"EQT Expansion Capital II: 2013"
],
[
"IVC Evidensia",
"Animal hospitals, veterinary clinics, and pet pharmacy services in Europe, North America, and elsewhere.",
"United Kingdom",
"EQT VII, EQT IX: 2017"
],
[
"Iver",
"Nordic managed IT, cloud services, and application management.",
"Sweden",
"EQT Mid Market Europe: 2018"
],
[
"Jakarta Eye Center",
"Ophthalmic hospitals and eye care services in Indonesia.",
"—",
"BPEA Private Equity Fund V: 2015"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: Japan Home Centre–Kota
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[314][315][316][317][318][319][320][321][322][323][324][325][326][327][328][329][330][331][332][333]
{
"rows": [
[
"Japan Home Centre",
"Mass-market household goods retail in Hong Kong and other Asian markets.",
"Greater China",
"EQT Greater China II: 2010"
],
[
"JD Health",
"JD.com’s pharmaceutical and health products retail, supply chain, and online healthcare platform.",
"Greater China",
"BPEA Private Equity Fund VII: 2019"
],
[
"Jerini",
"German biopharmaceutical research and development company.",
"Germany",
"LSP 3: 2005"
],
[
"Ju:niz Energy",
"Development, construction, and operation of large-scale battery energy storage systems in Germany.",
"—",
"EQT Transition Infrastructure: 2025"
],
[
"Juni",
"Financial services and financial management platform for e-commerce businesses.",
"Sweden",
"EQT Ventures III: 2021"
],
[
"Kabel Baden-Württemberg",
"Cable television, broadband, and telephone networks in Baden-Württemberg, Germany.",
"Germany",
"EQT IV, EQT V"
],
[
"Kaiber",
"Artificial intelligence tools for image and video creation.",
"United States",
"EQT Ventures III: 2024"
],
[
"Kangda Holdings",
"Water treatment investment related to Kangda Environmental, with business covering construction and operation of sewage treatment facilities.",
"—",
"BPEA Private Equity Fund V: 2012"
],
[
"Karo Healthcare",
"Skin, foot, digestive health, and other everyday consumer health products.",
"Sweden",
"EQT VIII: 2019"
],
[
"Keywords Studios",
"Development, art, testing, localization, and technical services for video games and entertainment content.",
"Southeast Asia",
"BPEA Private Equity Fund VIII: 2024"
],
[
"kfzteile24",
"Retail of auto parts and accessories in Germany.",
"Germany",
"EQT Mid Market: 2015"
],
[
"Kinaset",
"Development of inhaled drugs for respiratory diseases.",
"United States",
"LSP 7: 2026"
],
[
"Kive",
"Media asset management platform for creative teams.",
"Sweden",
"EQT Ventures II: 2020"
],
[
"KMD",
"IT software and services for the Danish public sector and businesses.",
"Denmark",
"EQT V: 2009"
],
[
"Knoetic",
"Software for employee data, organizational structure, attrition, and HR analytics.",
"United States",
"EQT Ventures III: 2022"
],
[
"Kodiak Gas Services",
"Natural gas compression equipment and contract compression services in the United States.",
"United States",
"EQT Infrastructure III: 2019; EQT Infrastructure IV: 2019"
],
[
"Koole Terminals",
"Liquid bulk storage tanks, terminals, and related logistics services.",
"Netherlands",
"EQT Infrastructure I: 2011"
],
[
"Kota",
"Benefits management platform for employee insurance, pensions, and other benefits.",
"Ireland",
"EQT Ventures III: 2023"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: Kuros–Lumenis
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[334][335][336][337][338][339][340][341][342][343][344][345][346][347][348][349][350][351][352][353]
{
"rows": [
[
"Kuros",
"Biomaterials for bone tissue repair and fracture treatment.",
"Switzerland",
"LSP 5: 2015"
],
[
"Kyobo Life Insurance",
"South Korean life, health, retirement, and accident insurance.",
"—",
"BPEA Private Equity Fund V: 2012"
],
[
"Kühnle, Kopp & Kausch",
"Industrial turbines, blowers, compressors, and fans; EQT previously provided mezzanine acquisition financing.",
"Germany",
"EQT Exp Capital I: 2005"
],
[
"Lafarge",
"Lafarge India’s cement and ready-mix concrete business.",
"India",
"BPEA Private Equity Fund V: 2013"
],
[
"Lazer Logistics",
"Logistics yard management, trailer dispatch, and short-haul shuttle services in North America.",
"United States",
"EQT Infrastructure VI: 2023"
],
[
"LBX Pharmacy",
"Pharmaceutical retail chain of LBX Pharmacy in China.",
"Greater China",
"EQT Greater China II: 2008"
],
[
"Lenus",
"Digital business management platform for health and fitness professionals.",
"Denmark",
"EQT Ventures II: 2021"
],
[
"Let's Do This",
"Discovery and registration platform for endurance events such as running and triathlon.",
"United Kingdom",
"EQT Ventures II: 2019"
],
[
"Levande",
"Retirement communities and senior living support services in Australia.",
"Australia",
"EQT Infrastructure V: 2022"
],
[
"Leybold Optics",
"Vacuum thin-film coating equipment for fields such as optics, architectural glass, and solar energy.",
"Germany",
"EQT III: 2001"
],
[
"LimaCorporate",
"Orthopedic implants and joint reconstruction products using additive manufacturing.",
"Italy",
"EQT VII: 2016"
],
[
"Linearity",
"Vector illustration and graphic design software.",
"Germany",
"EQT Ventures II: 2021"
],
[
"Living Carbon",
"Research on carbon storage through tree biotechnology and afforestation projects.",
"United States",
"EQT Foundation Fund: 2021"
],
[
"Logen",
"Domestic e-commerce parcel delivery in South Korea.",
"—",
"BPEA Private Equity Fund V: 2013"
],
[
"Long-spring Education Group",
"Changshui Education Group in Yunnan, China, providing high school education and tutoring services.",
"Greater China",
"EQT Mid Market Asia III: 2016"
],
[
"Lovable",
"AI software development platform that generates applications from natural language.",
"Sweden",
"EQT Growth: 2025"
],
[
"Luma Vision",
"Development of interventional cardiac imaging and related clinical data platforms.",
"Ireland, Germany",
"LSP HEF 2: 2020"
],
[
"Lumenis",
"Laser, intense pulsed light, and radiofrequency devices for ophthalmology and aesthetics.",
"Israel",
"BPEA Private Equity Fund VII: 2020"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: Lumeon–Medeye
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[354][355][356][357][358][359][360][361][362][363][364][365][366][367][368][369][370][371]
{
"rows": [
[
"Lumeon",
"Healthcare process orchestration and patient care pathway management software.",
"United Kingdom",
"LSP HEF 2: 2018"
],
[
"Lumos Fiber",
"U.S. fiber-to-the-home network; joint venture platform of EQT and T-Mobile.",
"United States",
"EQT Infrastructure VI: 2025"
],
[
"Lundhags",
"Outdoor footwear and apparel, backpacks, and Nordic skating equipment.",
"Sweden",
"EQT Opportunity: 2006"
],
[
"Luxendo",
"Light-sheet microscopy systems.",
"Germany",
"LSP 5: 2015"
],
[
"Mabtech",
"Antibodies, immunoassay reagents, and instruments for life sciences research.",
"Sweden",
"2024"
],
[
"Made of Air",
"Turning wood waste into biochar composites for consumer goods and building products.",
"Germany",
"EQT Foundation Fund: 2021"
],
[
"Madison Energy Infrastructure",
"Development, ownership, and operation of distributed solar and energy storage projects in the United States.",
"United States",
"EQT Infrastructure VI: 2023"
],
[
"Magic Holdings",
"MG facial masks and related skincare products.",
"—",
"BPEA Private Equity Fund V: 2012"
],
[
"Magnific (formerly Freepik)",
"Formerly Freepik, now named Magnific, providing creative assets and generative AI design tools.",
"Spain",
"EQT Mid Market Europe: 2020"
],
[
"Magnit",
"Formerly PRO Unlimited, providing contingent and external workforce management software and services.",
"United States",
"EQT IX: 2021"
],
[
"Magrathea",
"Development of electrolytic magnesium metal production technology using seawater and brine.",
"United States",
"EQT Foundation Fund: 2023"
],
[
"Mambu",
"Cloud core banking software for banks and financial institutions.",
"Netherlands",
"EQT Growth: 2021"
],
[
"Mamezo",
"Mamezou of Japan, providing software engineering, AI, and robotics-related digital services.",
"Japan",
"BPEA EQT Mid-Market Growth: 2026"
],
[
"ManyPets",
"Pet insurance delivered mainly through online services.",
"United Kingdom",
"EQT Growth: 2021"
],
[
"Marvel Fusion",
"Development of laser-driven fusion energy technology.",
"—",
"EQT Ventures III: 2025"
],
[
"MarvelX",
"AI agents for business process automation in insurance and other industries.",
"Netherlands",
"EQT Ventures III: 2025"
],
[
"McNair",
"Data center project serving hyperscale customers in partnership with EdgeConneX.",
"United Kingdom",
"EQT Infrastructure VI: 2024"
],
[
"Medeye",
"Medication verification system using computer vision to check hospital drug administration.",
"Netherlands",
"LSP HEF 1: 2014"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: Medifox–Mongstad Group
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[372][373][374][375][376][377][378][379][380][381][382][383][384][385][386][387][388][389]
{
"rows": [
[
"Medifox",
"Scheduling, care documentation, and billing software for German care providers and therapists; EQT Credit previously provided acquisition financing.",
"Germany",
"EQT Mid-Market Credit, EQT Mid-Market Credit II"
],
[
"Melita",
"Fixed broadband, mobile communications, cable television, and data center services in Malta.",
"Malta",
"EQT Infrastructure IV: 2019"
],
[
"Mendor",
"Finnish blood glucose monitoring medical technology company.",
"Finland",
"LSP 4: 2011"
],
[
"Meridian",
"Instant payment network connecting wallets, merchants, financial institutions, and banking systems.",
"Netherlands",
"EQT Ventures III: 2024"
],
[
"Merus",
"Development of bispecific and trispecific antibodies for cancer treatment.",
"Netherlands",
"LSP 4: 2010"
],
[
"Metalcaucho",
"Design and distribution of rubber, plastic, and metal parts for the automotive aftermarket; EQT previously provided financing.",
"Spain",
"EQT Mid-Market Credit, EQT Mid-Market Credit II"
],
[
"Metall Technologie Holding",
"Industrial metal heat treatment furnaces; EQT previously provided mezzanine acquisition financing.",
"Germany",
"EQT Exp Capital I: 2005"
],
[
"Metlifecare",
"Retirement communities and aged care facilities in New Zealand.",
"New Zealand",
"EQT Infrastructure IV: 2020"
],
[
"Mews",
"Hotel operations, housekeeping, revenue, and guest services management software.",
"Netherlands",
"EQT Growth: 2026"
],
[
"MHC Asia",
"Corporate healthcare benefits, clinic networks, and insurance claims management in Southeast Asia.",
"Singapore",
"2019"
],
[
"Midland Cogeneration Venture",
"Natural gas combined heat and power facility in Michigan, United States.",
"United States",
"EQT Infrastructure I: 2009"
],
[
"Milvus Advanced",
"Research on replacing precious metal catalysts in clean energy equipment with nanomaterials.",
"United Kingdom",
"EQT Foundation Fund: 2025"
],
[
"Min Doktor",
"Swedish digital healthcare and primary care services.",
"Sweden",
"EQT Ventures I: 2016"
],
[
"MinervaX",
"Development of a preventive vaccine against Group B Streptococcus.",
"Denmark",
"LSP 7: 2023"
],
[
"Modern Metal",
"Aluminum alloy die-cast components for automotive, air conditioning, and industrial automation.",
"Greater China",
"EQT Greater China II: 2010"
],
[
"Molecular Attraction",
"Development of biological attractants for mosquito control.",
"Sweden",
"EQT Foundation Fund: 2021"
],
[
"Mollie",
"Merchant payment acceptance and payment processing services in Europe.",
"Netherlands",
"EQT Growth: 2021"
],
[
"Mongstad Group",
"Land, quays, and supporting infrastructure at the Mongstad and Dusavik oil and gas bases in Norway.",
"Norway",
"EQT Infrastructure II: 2015"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: Moonscale–Nexstim
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[390][391][392][393][394][395][396][397][398][399][400][401][402][403][404][405][406][407]
{
"rows": [
[
"Moonscale",
"Synthetic media platform for sales and revenue teams.",
"Germany",
"EQT Ventures III: 2024"
],
[
"Moralis",
"Blockchain data APIs and decentralized application development tools.",
"Sweden",
"EQT Ventures II: 2021"
],
[
"Mosanna Therapeutics",
"Biomedical research and development for unmet medical needs.",
"Switzerland",
"LSP 7: 2024"
],
[
"Movetis",
"Drug development for digestive diseases and chronic constipation.",
"Belgium",
"LSP 3: 2006"
],
[
"Muna Therapeutics",
"Drug development for neurodegenerative diseases and brain function protection.",
"Denmark",
"LSP Dementia Fund: 2021"
],
[
"Munksjö",
"Decor paper, release paper, electrotechnical paper, and other industrial specialty papers.",
"Sweden",
"EQT Exp Capital I, EQT III"
],
[
"Musti Group",
"Nordic retail of pet supplies, food, and related services.",
"Finland",
"EQT Mid Market: 2014"
],
[
"MyCartis (Pronota)",
"Formerly Pronota, biomarker testing and multiplex diagnostics platform.",
"Belgium",
"LSP 3: 2006"
],
[
"Natural Cycles",
"Fertility cycle tracking and digital contraception app.",
"Sweden",
"EQT Ventures I: 2017"
],
[
"Nederman",
"Equipment for source capture and filtration of industrial dust, fumes, and exhaust gases.",
"Sweden",
"EQT Danmark: 1999"
],
[
"Net Japan",
"Recycling and trading of precious metals, diamonds, and jewelry in Japan.",
"—",
"BPEA Private Equity Fund V: 2012"
],
[
"Netlify",
"Platform for building, deploying, and hosting websites and web applications.",
"United States",
"EQT Ventures II: 2020"
],
[
"Neuravi",
"Cerebrovascular thrombectomy medical devices, including EmboTrap.",
"—",
"LSP 5: 2015; LSP HEF 1: 2015"
],
[
"Neurent Medical",
"Development of minimally invasive medical devices for chronic nasal inflammatory diseases.",
"Ireland",
"LSP HEF 2: 2020"
],
[
"Neuros Medical",
"Neurostimulation devices for chronic pain after amputation.",
"United States",
"LSP 7, EQT HE 3: 2025"
],
[
"NewAmsterdam Pharma",
"Drug development for metabolic diseases and lowering LDL cholesterol.",
"Netherlands",
"LSP Dementia Fund: 2021"
],
[
"Nexon Asia Pacific",
"Digital consulting, cybersecurity, cloud, and managed IT services for Australian enterprise and government clients.",
"Australia",
"2019"
],
[
"Nexstim",
"Navigated brain stimulation equipment for neurosurgery and neurological diseases.",
"Finland",
"LSP 3: 2007"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: NitroVolt–Oculis
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[408][409][410][411][412][413][414][415][416][417][418][419][420][421][422][423][424][425][426][427]
{
"rows": [
[
"NitroVolt",
"Development of distributed ammonia synthesis technology using air, water, and renewable electricity.",
"Denmark",
"EQT Foundation Fund: 2024"
],
[
"Niwas Housing Finance",
"Formerly IndoStar Home Finance, affordable housing loan services in India.",
"India",
"BPEA EQT Mid-Market Growth: 2025"
],
[
"Nkarta",
"Development of engineered natural killer cell therapies for cancer treatment.",
"United States",
"LSP 6: 2019"
],
[
"Nobi",
"Smart lamps, fall monitoring, and alarm systems for elderly care.",
"Belgium",
"LSP HEF 2, LSP Dementia Fund: 2022"
],
[
"Noema Pharma",
"Drug development for central nervous system disorders.",
"Switzerland",
"LSP 7: 2024"
],
[
"NORD",
"Danish hazardous waste treatment and incineration-based heat and power generation.",
"Denmark",
"EQT Infrastructure I: 2010"
],
[
"Nord Anglia Education",
"Nord Anglia international school network, providing education from preschool through secondary school.",
"Multinational",
"BPEA Private Equity Fund VIII: 2025"
],
[
"Nordic Aviation Capital",
"Regional aircraft leasing and lease asset management.",
"Ireland",
"EQT VI: 2015"
],
[
"Nordic Ferry Infrastructure",
"Nordic passenger and freight ferry and high-speed passenger vessel operations.",
"Norway, Denmark, Sweden",
"EQT Infrastructure V: 2021"
],
[
"Nordic Info Group",
"Corporate credit and business information services in Denmark and Norway.",
"Denmark",
"EQT Danmark: 1999"
],
[
"Nothing",
"Smartphones, audio products, and AI tools.",
"United Kingdom",
"EQT Ventures III: 2022"
],
[
"Nouscom",
"Development of cancer vaccines and oncolytic virus technology.",
"Switzerland",
"LSP 5: 2015"
],
[
"Noya",
"Direct air capture carbon dioxide technology and carbon removal services.",
"United States",
"EQT Foundation Fund: 2023"
],
[
"Nua Surgical",
"Surgical instruments for obstetric and gynecological procedures such as cesarean sections.",
"Ireland",
"EQT HE 3: 2024"
],
[
"O2 Power",
"Solar, wind, and hybrid renewable energy projects in India.",
"India",
"EQT Infrastructure IV: 2020"
],
[
"Ocea Group",
"Individual water and heat metering equipment and services for French residential buildings.",
"France",
"EQT Active Core Infrastructure I: 2024"
],
[
"OctoPlus",
"Drug delivery technology and pharmaceutical contract development services.",
"Netherlands",
"LSP 3: 2005"
],
[
"Oculis",
"Ophthalmic biomedical research and development.",
"Switzerland",
"LSP 7: 2022"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: Oden Technologies–OxThera
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[428][429][430][431][432][433][434][435][436][437][438][439][440][441][442][443][444][445]
{
"rows": [
[
"Oden Technologies",
"Industrial internet of things and production data analytics software.",
"United States",
"EQT Ventures I: 2015"
],
[
"Odyssey",
"Development of real-time interactive video generation models.",
"United States, United Kingdom",
"EQT Ventures III: 2024"
],
[
"OEM International",
"Technical distribution of industrial components and systems.",
"Sweden",
"EQT X: 2025"
],
[
"Okairos",
"Development of T-cell vaccines for infectious diseases and cancer.",
"Switzerland",
"LSP 3: 2007"
],
[
"Onera Health",
"Sleep diagnostic monitoring and digital health technology.",
"Netherlands",
"EQT HE 3: 2024"
],
[
"Onramper",
"Platform connecting fiat currency payments with crypto asset purchases.",
"Netherlands",
"EQT Ventures III: 2022"
],
[
"Ontinue",
"Managed cyber threat detection and response services, a standalone business that originated from Open Systems.",
"Switzerland",
"EQT Mid Market Europe: 2017"
],
[
"ONWARD",
"Medical technology for restoring motor function after spinal cord injury.",
"Netherlands",
"LSP 5: 2016"
],
[
"Open Systems",
"Secure access service edge networking and managed cybersecurity services.",
"Switzerland",
"EQT Mid Market Europe: 2017"
],
[
"Orphazyme",
"Development of therapies for lysosomal storage and protein misfolding diseases.",
"Denmark",
"LSP 5: 2017"
],
[
"Orrefors Kosta Boda",
"Swedish everyday glassware and art glass products.",
"Sweden",
"EQT I: 1996"
],
[
"Osmose Utilities Services",
"Inspection, maintenance, and restoration of utility and telecom wood poles and steel structures.",
"United States",
"EQT Infrastructure IV: 2019"
],
[
"Oterra",
"Natural coloring ingredients for food and beverages.",
"Denmark",
"EQT IX: 2021"
],
[
"Ottobock Healthcare",
"Prosthetics, orthotics, wheelchairs, and mobility aid medical devices.",
"Germany",
"EQT VII: 2017"
],
[
"Overview Energy",
"Development of technology for transmitting orbital solar power to the ground.",
"United States",
"EQT Foundation Fund: 2024"
],
[
"Owwn",
"Financial app for young consumers.",
"Germany",
"EQT Ventures II: 2021"
],
[
"OX2",
"Development of wind, solar, and energy storage projects in Europe and Australia.",
"Sweden",
"EQT Infrastructure VI: 2024"
],
[
"OxThera",
"Development of therapies for hyperoxaluria.",
"Sweden",
"LSP 5: 2016"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: Packmatic–Perficient
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[446][447][448][449][450][451][452][453][454][455][456][457][458][459][460][461][462][463]
{
"rows": [
[
"Packmatic",
"Packaging product sourcing and supplier matching platform.",
"Germany",
"EQT Ventures III: 2024"
],
[
"PageUp",
"Recruiting, onboarding, talent development, and performance management software.",
"Australia",
"BPEA Private Equity Fund VIII: 2024"
],
[
"Paid",
"Usage- and outcome-based billing, subscription management, and cost analytics software for AI agents.",
"United Kingdom",
"EQT Ventures III: 2024"
],
[
"PaloDEx",
"Dental intraoral and extraoral imaging equipment and image management software.",
"Finland",
"EQT Exp Capital I: 2005"
],
[
"Pantera",
"Production of the actinium-225 isotope needed for targeted radiopharmaceuticals.",
"Belgium",
"LSP 7: 2024"
],
[
"Parcel2Go",
"UK parcel delivery comparison, booking, and e-commerce shipping management platform.",
"United Kingdom",
"EQT Mid Market Europe: 2021"
],
[
"Parexel",
"Clinical trials, drug development, regulatory affairs, and market access services.",
"United States",
"EQT IX: 2021"
],
[
"Parkia",
"Car park operations in Spain and Andorra.",
"Spain",
"EQT Infrastructure I: 2011"
],
[
"Parloa",
"Conversational AI platform for enterprises.",
"Germany",
"EQT Ventures III: 2023"
],
[
"Parques Reunidos",
"Operation of theme parks, water parks, and other leisure attractions.",
"Spain",
"EQT Infrastructure IV: 2019"
],
[
"Patch",
"Carbon credit purchasing platform connecting companies with carbon removal projects.",
"United States",
"EQT Foundation Fund: 2021"
],
[
"Payrails",
"Cross-market payment orchestration and management software.",
"Germany",
"EQT Ventures III: 2023"
],
[
"Peakon",
"Employee engagement survey and HR analytics software.",
"Denmark",
"EQT Ventures I: 2017"
],
[
"Peanut",
"Women’s social platform centered on fertility and motherhood experiences.",
"United Kingdom",
"EQT Ventures II: 2020"
],
[
"Pelago",
"Digital health service providing addiction treatment support through employer benefits.",
"United Kingdom",
"EQT Ventures I: 2018"
],
[
"Peltarion",
"Enterprise AI development platform.",
"Sweden",
"EQT Ventures I: 2016"
],
[
"Peregrine Midstream Partners",
"Ryckman Creek natural gas storage facility and related services in Wyoming, United States.",
"United States",
"EQT Infrastructure I: 2011"
],
[
"Perficient",
"Digital consulting, enterprise software development, and technology services.",
"United States",
"BPEA Private Equity Fund VIII: 2024"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: Perfuze–Prosensa
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[464][465][466][467][468][469][470][471][472][473][474][475][476][477][478][479][480][481][482]
{
"rows": [
[
"Perfuze",
"Development of medical devices for ischemic stroke treatment.",
"Ireland",
"LSP HEF 2: 2022"
],
[
"Perk",
"Business travel booking and expense management platform.",
"Spain",
"EQT Growth: 2025"
],
[
"Perlos",
"Precision plastic and electromechanical parts for the telecommunications and pharmaceutical industries.",
"Finland",
"EQT I: 1996"
],
[
"Permutive",
"Audience data management and analytics software for publishers.",
"United Kingdom",
"EQT Ventures I: 2018"
],
[
"Pfaff-silberblau",
"Transmission equipment such as industrial hoists, material handling, and screw jacks.",
"Germany",
"EQT Opportunity: 2006"
],
[
"Phagenesis",
"Electrical stimulation medical devices for neurogenic dysphagia.",
"United Kingdom",
"EQT HE 3: 2024"
],
[
"PharmaZell",
"Active pharmaceutical ingredient manufacturing, with production facilities in Germany and India.",
"Germany",
"EQT Exp Capital I: 2007"
],
[
"Pharvaris",
"Drug development for rare diseases.",
"Germany",
"LSP 5: 2016"
],
[
"Piab",
"Industrial vacuum automation, handling, and robotic accessories.",
"Sweden",
"EQT VII: 2016"
],
[
"Pioneer",
"Pioneer of Japan, digital entertainment and electronics.",
"Japan",
"BPEA Private Equity Fund VI: 2019; BPEA Private Equity Fund VII: 2019"
],
[
"Plantasjen",
"Nordic retail of gardening, flowers, houseplants, and patio products.",
"Norway",
"EQT III: 2001"
],
[
"Playsome",
"Mobile game development.",
"Finland",
"EQT Ventures II: 2021"
],
[
"Popcore",
"Casual mobile game development.",
"Germany",
"EQT Ventures I: 2019"
],
[
"Press Ganey",
"Patient experience measurement, healthcare performance analytics, and consulting services.",
"United States",
"EQT VII: 2016"
],
[
"Prometric",
"Technology and assessment services for professional certification, education, and occupational examinations.",
"Multinational",
"BPEA Private Equity Fund VI: 2018"
],
[
"PropertyGuru",
"Real estate information and related digital services in Southeast Asia.",
"Singapore",
"BPEA Private Equity Fund VIII: 2024"
],
[
"PropertyMe",
"Property management, trust accounting, rent payment, and customer management software in Australia.",
"Australia",
"BPEA EQT Mid-Market Growth: 2025"
],
[
"Prosensa",
"RNA therapy development for diseases such as Duchenne muscular dystrophy.",
"Netherlands",
"LSP 3, LSP 4: 2007"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: Pruna AI–Rich Healthcare
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[483][484][485][486][487][488][489][490][491][492][493][494][495][496][497][498][499][500]
{
"rows": [
[
"Pruna AI",
"Software for machine learning model inference, compression, and runtime efficiency optimization.",
"Germany",
"EQT Ventures III: 2024"
],
[
"PSM International",
"Fasteners and joining solutions for the automotive, electronics, and manufacturing industries.",
"Greater China",
"EQT Greater China II: 2007"
],
[
"Qarbotech",
"Development of agricultural nanotechnology for improving plant photosynthesis.",
"Malaysia",
"EQT Foundation Fund: 2024"
],
[
"Qevlar AI",
"Artificial intelligence for cybersecurity threat analysis and defense.",
"France",
"EQT Ventures III: 2023"
],
[
"Qinyuan Bakery",
"Qinyuan Bakery chain in China, producing and selling bread, cakes, and seasonal foods.",
"Greater China",
"EQT Greater China II: 2010"
],
[
"Quantios",
"Formed by combining ViewPoint and TrustQuay, providing management software for the trust and corporate services industry.",
"—",
"BPEA EQT Mid-Market Growth: 2023"
],
[
"QurAlis",
"Drug development for amyotrophic lateral sclerosis and other neurodegenerative diseases.",
"United States",
"LSP Dementia Fund: 2022"
],
[
"Radius Global Infrastructure",
"Site interests in communications towers, rooftop sites, data centers, and other digital infrastructure.",
"United States",
"EQT Active Core Infrastructure I: 2023"
],
[
"Rainier Therapeutics",
"Targeted cancer drug development.",
"Netherlands",
"LSP 5: 2016"
],
[
"RBL Bank",
"Corporate and retail banking services in India.",
"India",
"BPEA Private Equity Fund VII: 2020"
],
[
"Recipharm",
"Pharmaceutical contract development and manufacturing, covering oral formulations, sterile fill-finish, and advanced therapies.",
"Sweden",
"EQT IX: 2021"
],
[
"Recover Nordic",
"Nordic building restoration after water and fire damage and industrial environmental cleaning services.",
"Norway",
"EQT VIII: 2020"
],
[
"ReliaQuest",
"Enterprise security operations software integrating threat detection, investigation, and response.",
"United States",
"EQT Growth: 2025"
],
[
"Remember",
"South Korean professional networking, business card management, recruiting, and corporate customer development platform.",
"South Korea",
"BPEA Private Equity Fund VIII: 2025"
],
[
"Rena",
"Waste sorting, plastic recycling, and waste-to-energy incineration in South Korea.",
"South Korea",
"EQT Infrastructure VI: 2024"
],
[
"Reworks",
"Casual game development.",
"Finland",
"EQT Ventures I: 2020"
],
[
"Reworld",
"Formerly Covanta’s U.S. business, waste treatment, resource recovery, and energy recovery services in North America.",
"United States",
"EQT Infrastructure V: 2021"
],
[
"Rich Healthcare",
"Private integrated healthcare services in the Yangtze River Delta of China.",
"—",
"BPEA Private Equity Fund V: 2014"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: RIMES Technologies–Schülke
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[501][502][503][504][505][506][507][508][509][510][511][512][513][514][515][516][517][518]
{
"rows": [
[
"RIMES Technologies",
"Data management and regulatory technology services for financial institutions.",
"United Kingdom",
"EQT Mid Market Europe: 2020"
],
[
"Risk Methods",
"Supply chain risk monitoring and management software.",
"Germany",
"EQT Ventures I: 2016"
],
[
"Roeser",
"Medical supplies distribution, procurement, and logistics services for German hospitals.",
"Germany",
"EQT Expansion Capital II: 2010"
],
[
"Rotation Medical",
"Bioinductive implants for rotator cuff repair.",
"United States",
"LSP HEF 1: 2014"
],
[
"RTI",
"Automated cooking oil delivery, management, and recycling services for foodservice establishments.",
"United States",
"EQT Infrastructure I: 2011"
],
[
"Sabroe Refrigeration",
"Industrial refrigeration and compressor equipment.",
"Denmark",
"EQT I: 1996"
],
[
"SAG",
"Engineering and technical services for electricity, gas, water, and communications networks.",
"Germany",
"EQT V: 2008"
],
[
"Sagility",
"Business process management for health insurers and healthcare providers.",
"India",
"BPEA Private Equity Fund VIII: 2022"
],
[
"SAI360",
"Governance, risk, compliance, and related employee training software.",
"United States",
"BPEA Private Equity Fund VI: 2016"
],
[
"Salcomp",
"Power supplies for mobile phones and other portable devices.",
"Finland",
"EQT II: 1999"
],
[
"Sana Labs",
"Enterprise knowledge search, learning, and AI assistant.",
"Sweden",
"EQT Ventures II: 2021"
],
[
"Sanitec",
"European sanitary ceramics and bathroom products.",
"Finland",
"EQT IV: 2005"
],
[
"Sapiens",
"Development of high-resolution deep brain stimulation technology for neurological diseases.",
"Germany",
"LSP 4: 2011"
],
[
"SAUR",
"Drinking water, wastewater treatment, and related environmental infrastructure services.",
"France",
"EQT Infrastructure IV: 2018; EQT Infrastructure III: 2018"
],
[
"Sausalitos",
"German cocktail bar and casual dining chain.",
"—",
"EQT Expansion Capital II: 2008"
],
[
"Scale Microgrids",
"Development, ownership, and operation of microgrid and distributed energy projects in North America.",
"United States",
"EQT Transition Infrastructure: 2025"
],
[
"Scandic",
"Hotel operations in the Nordic region and other European markets.",
"Sweden",
"EQT V: 2007"
],
[
"Schülke",
"Disinfection, hygiene, and infection prevention products for medical and industrial settings.",
"Germany",
"EQT VIII: 2020"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: Securitas Direct–Sitecore
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[519][520][521][522][523][524][525][526][527][528][529][530][531][532][533][534][535][536][537][538]
{
"rows": [
[
"Securitas Direct",
"Alarm equipment and subscription security monitoring services for homes and small businesses.",
"Sweden",
"EQT V: 2008"
],
[
"Securonix",
"Cloud security information and event management, threat detection, and response software.",
"United States",
"BPEA EQT Mid-Market Growth: 2023"
],
[
"Seeqc",
"Development of digital quantum computing technology.",
"United Kingdom",
"EQT Ventures II: 2020"
],
[
"Segra",
"Enterprise fiber communications, bandwidth, and data center services in the United States.",
"United States",
"EQT Infrastructure III: 2017"
],
[
"Sequana Medical",
"Implantable pump medical devices for fluid overload management.",
"Belgium",
"LSP HEF 1, EQT HE 3: 2024"
],
[
"Service Partner One",
"Office facilities and services management platform.",
"Germany",
"EQT Ventures I: 2016"
],
[
"Seven Seas Water Group",
"Distributed water supply and wastewater treatment facilities in the United States, the Caribbean, and Latin America.",
"United States",
"EQT Infrastructure VI: 2025"
],
[
"SFC KOENIG AG",
"Expansion seals and fluid control technology; EQT previously provided mezzanine financing and held a minority stake.",
"Switzerland",
"EQT Exp Capital II: 2008"
],
[
"SGU",
"St. George’s University in Grenada, providing medical, veterinary, and other higher education.",
"Grenada",
"BPEA Private Equity Fund V: 2014"
],
[
"Shengmu Organic Milk",
"Shengmu Organic Milk of China.",
"—",
"BPEA Private Equity Fund V: 2014"
],
[
"Shinhan",
"Shinhan Financial Group of South Korea, covering banking, securities, life insurance, and investment banking services.",
"South Korea",
"BPEA Private Equity Fund VII: 2020"
],
[
"Shinobi Therapeutics",
"Development of off-the-shelf cell therapies derived from induced pluripotent stem cells.",
"United States",
"LSP 7: 2023"
],
[
"SHL Medical",
"Autoinjectors and other drug delivery systems.",
"Switzerland",
"EQT VIII: 2020; EQT Future: 2023"
],
[
"Sifflet",
"Enterprise data quality monitoring and data system observability software.",
"France",
"EQT Ventures III: 2023"
],
[
"Silexica",
"Software development tools for smart devices and accelerated computing.",
"Germany",
"EQT Ventures I: 2018"
],
[
"Simplify Medical",
"Cervical artificial disc implants.",
"United States",
"LSP 5, LSP HEF 2: 2017"
],
[
"Sirona",
"Dental equipment, digital imaging, and CAD/CAM restoration systems.",
"Germany",
"EQT III: 2003"
],
[
"Sitecore",
"Digital content management, commerce, and personalized customer experience software.",
"Denmark",
"EQT VII: 2016"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: SK Shieldus–Statera
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[539][540][541][542][543][544][545][546][547][548][549][550][551][552][553][554][555][556][557]
{
"rows": [
[
"SK Shieldus",
"Physical security monitoring, emergency response, and cybersecurity services in South Korea.",
"South Korea",
"EQT Infrastructure VI: 2023"
],
[
"Skykon",
"Danish wind power components supplier that filed for bankruptcy in December 2010.",
"—",
"EQT Expansion Capital II: 2009"
],
[
"Skyline Diagnostics",
"Molecular diagnostic products such as leukemia subtype identification.",
"Netherlands",
"LSP 3: 2009"
],
[
"Small Giant Games",
"Mobile game development.",
"Finland",
"EQT Ventures I: 2017"
],
[
"SNIPR Biome",
"Drug development using CRISPR technology to selectively target pathogenic bacteria.",
"Denmark",
"LSP 6: 2019"
],
[
"Solera",
"Software and data services for vehicle claims, repair, sales, and fleet management.",
"—",
"BPEA Private Equity Fund V: 2016"
],
[
"Sonantic",
"AI synthetic voice technology.",
"United Kingdom",
"EQT Ventures I: 2020"
],
[
"South Indian Bank",
"South Indian Bank of India, providing deposits, loans, and other banking services.",
"—",
"BPEA Private Equity Fund V: 2011"
],
[
"SpliceBio",
"Gene therapy development using a protein splicing platform.",
"Spain",
"LSP 7: 2025"
],
[
"Sportfive",
"Sports media and commercial rights marketing; EQT previously provided mezzanine acquisition financing.",
"Germany",
"EQT Exp Capital I: 2004"
],
[
"Sportradar",
"Real-time sports data, odds, and match integrity monitoring services.",
"Switzerland",
"EQT VI, EQT Exp Capital II"
],
[
"Springer SBM",
"Springer Science+Business Media, publishing scientific, technical, and medical journals and books.",
"Luxembourg",
"EQT V: 2010"
],
[
"SPT Labtech",
"Life sciences automated liquid handling, sample preparation and storage instruments, and consumables.",
"United Kingdom",
"EQT IX: 2022"
],
[
"SSP",
"Food and beverage operations at transport hubs such as airports and train stations.",
"United Kingdom",
"EQT IV, EQT Exp Capital I: 2006"
],
[
"Stacks",
"Financial month-end close, reconciliation, and AI-assisted bookkeeping software.",
"Netherlands",
"EQT Ventures III: 2024"
],
[
"Standard AI",
"Computer vision analytics platform for physical retail foot traffic and shopping behavior.",
"United States",
"EQT Ventures II: 2019"
],
[
"Starcloud",
"Development of space data centers and orbital computing infrastructure.",
"United States",
"2026"
],
[
"Statera",
"Battery storage, pumped hydro storage, and flexible generation projects in the United Kingdom.",
"United Kingdom",
"EQT Infrastructure VI: 2024"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: Stenqvist–Syngular Technology
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[558][559][560][561][562][563][564][565][566][567][568][569][570][571][572][573][574][575][576][577]
{
"rows": [
[
"Stenqvist",
"Paper and plastic packaging, shopping bags, and flexible packaging for retail and industrial use.",
"Sweden",
"EQT I, EQT Exp Capital I"
],
[
"StjärnTVnätet",
"Swedish cable television network.",
"Sweden",
"EQT I: 1998"
],
[
"Storable",
"Software, payments, and insurance services for self-storage and marina operators.",
"United States",
"EQT IX: 2021"
],
[
"StormGeo",
"Weather data and operational decision support software for industries such as shipping and energy.",
"Norway",
"EQT Mid Market: 2014"
],
[
"Straive",
"Enterprise data analytics, AI, and digital operations services.",
"Southeast Asia, India",
"BPEA Private Equity Fund VII: 2021"
],
[
"Strauss Innovation",
"German home decor and apparel retail chain.",
"Germany",
"EQT Opportunity: 2008"
],
[
"Strawberry",
"Browser that uses AI agents to operate web pages and automate tasks.",
"United States, Sweden",
"EQT Ventures III: 2025"
],
[
"Struers",
"Equipment and consumables for metallographic sample preparation.",
"Denmark",
"EQT I: 1998"
],
[
"Superlist",
"To-do list and task management software for individuals and teams.",
"Germany",
"EQT Ventures III: 2022"
],
[
"SuperNormal",
"AI meeting notes and tool for generating documents, presentations, and other work products from customer information.",
"Sweden",
"EQT Ventures II: 2020"
],
[
"Supernova",
"Design system management platform.",
"Czech Republic",
"EQT Ventures I: 2021"
],
[
"Supplant",
"Production of food ingredients such as sugars from plant fiber.",
"United Kingdom",
"EQT Ventures I: 2018"
],
[
"SUSE",
"Open-source software for enterprise Linux operating systems, container management, and edge computing.",
"Germany",
"EQT VIII: 2019"
],
[
"Swedegas",
"Swedish high-pressure natural gas transmission network.",
"Sweden",
"EQT Infrastructure I: 2010"
],
[
"swiss smile",
"Swiss dental clinic chain.",
"Switzerland",
"EQT Mid Market: 2013"
],
[
"Symrise",
"Flavors, fragrances, cosmetic ingredients, and aroma chemicals.",
"Germany",
"EQT III: 2002"
],
[
"Synagro",
"Treatment, beneficial reuse, and land application services for wastewater sludge and other residuals in North America.",
"United States",
"EQT Infrastructure II: 2013"
],
[
"Syngular Technology",
"Surgical navigation technology using AI and augmented reality.",
"Hong Kong",
"EQT Foundation Fund: 2025"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: Syntaxin–Tinyclues
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[578][579][580][581][582][583][584][585][586][587][588][589][590][591][592][593][594][595]
{
"rows": [
[
"Syntaxin",
"Development of engineered botulinum toxin-based biologics.",
"United Kingdom",
"LSP 3: 2007"
],
[
"Syntetica",
"Chemical recycling technology for synthetic textile materials such as nylon.",
"France",
"EQT Ventures III: 2024"
],
[
"T-Knife",
"Development of T-cell receptor therapies for cancer.",
"Germany",
"LSP 6: 2021"
],
[
"TAC",
"HVAC controls, building management, and access control and security systems for commercial buildings.",
"Sweden",
"EQT I: 1998"
],
[
"Talentium",
"AI recruiting search and talent matching platform.",
"Sweden",
"EQT Ventures III: 2024"
],
[
"Tampnet",
"Subsea fiber, wireless, and mobile communications networks for offshore oil and gas facilities.",
"Norway",
"EQT Infrastructure II: 2012; EQT Infrastructure: 2012"
],
[
"TBS Energi (fka Toba Bara)",
"Indonesian integrated energy company, formerly Toba Bara, with businesses including power generation, mining, and plantations.",
"—",
"BPEA Private Equity Fund V: 2012"
],
[
"Telus International",
"Digital customer experience, business process, and IT services.",
"Canada",
"BPEA Private Equity Fund VI: 2016"
],
[
"Tenpoint Therapeutics",
"Drug development for presbyopia and other ophthalmic diseases.",
"United States",
"LSP 6: 2021"
],
[
"Terveystalo",
"Finnish primary care, specialist care, occupational health, and diagnostic services.",
"Finland",
"EQT VI: 2013"
],
[
"The CrownX",
"Vietnamese consumer goods and retail platform.",
"Southeast Asia",
"BPEA Private Equity Fund VII: 2021"
],
[
"The Exploration Company",
"Development of reusable orbital spacecraft and space transportation technology.",
"Germany",
"EQT Ventures III: 2023"
],
[
"thinkproject",
"Lifecycle management software for construction and engineering projects.",
"Germany",
"EQT IX: 2021"
],
[
"Thule",
"Roof boxes, trailers, snow chains, and outdoor transport equipment.",
"Sweden",
"EQT II: 1999"
],
[
"TIA Technology",
"Core business software for insurance companies.",
"Denmark",
"EQT Mid Market: 2014"
],
[
"Tigenix (Cellerix)",
"Cell therapy development in areas such as autoimmune diseases.",
"Belgium",
"LSP 3: 2007"
],
[
"Timeless",
"Fractional investment platform for physical assets such as luxury goods.",
"Germany",
"EQT Ventures III: 2021"
],
[
"Tinyclues",
"Deep learning-based predictive marketing and customer relationship management technology.",
"France",
"EQT Ventures I: 2018"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: Tion Renewables–Unmind
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[596][597][598][599][600][601][602][603][604][605][606][607][608][609][610][611][612][613][614]
{
"rows": [
[
"Tion Renewables",
"Ownership and operation of solar, wind, and battery storage assets in Europe.",
"Germany",
"EQT Active Core Infrastructure I: 2023"
],
[
"TitanX",
"Cooling equipment for commercial vehicle powertrains.",
"Sweden",
"EQT Opportunity: 2008"
],
[
"Tognum Group",
"High-power diesel engines for marine, power generation, defense, and industrial use.",
"Germany",
"EQT IV: 2006"
],
[
"Token",
"Open banking payments technology.",
"United States",
"EQT Ventures I: 2017"
],
[
"TOP-TOY",
"Former operator of the Nordic BR and Toys“R”Us toy retail network, which entered bankruptcy in December 2018.",
"Denmark",
"EQT VII: 2016"
],
[
"Touhula",
"Finnish early childhood education and daycare services.",
"Finland",
"EQT Mid Market: 2016"
],
[
"Tradex",
"Self-adhesive functional parts and assembly materials for electronics and other products.",
"Sweden",
"EQT II: 2000"
],
[
"TransIP",
"Domain registration, web hosting, and virtual private server services in the Benelux region.",
"Netherlands",
"EQT Mid Market Europe: 2016"
],
[
"Traplight",
"Mobile game development.",
"Finland",
"EQT Ventures I: 2020"
],
[
"Trescal",
"Calibration of industrial test and measurement equipment and related metrology services.",
"France",
"EQT Infrastructure V: 2023"
],
[
"Trinity Biosystems",
"Development of biomaterials for bone repair and regenerative medicine.",
"United States",
"LSP 3: 2006"
],
[
"TRYT",
"Japanese professional staffing and temporary staffing services.",
"Japan",
"BPEA Private Equity Fund VII: 2018"
],
[
"Tubulis",
"Development of antibody-drug conjugates for solid tumor treatment.",
"Germany",
"LSP 7: 2024"
],
[
"U3 Pharma",
"Development of monoclonal antibodies for cancer treatment.",
"Germany",
"LSP 3: 2006"
],
[
"UDG United Digital Group",
"German digital marketing, user experience design, and technology implementation services.",
"—",
"EQT Expansion Capital II: 2011"
],
[
"Unilode Aviation Solutions",
"Pooling, management, maintenance, and repair of aircraft unit load devices, pallets, and catering trolleys.",
"Switzerland",
"EQT Infrastructure II: 2016"
],
[
"United Talent Agency",
"Entertainment and sports talent representation, as well as brand consulting and marketing services.",
"United States",
"EQT X: 2022"
],
[
"Unmind",
"Employee mental health and digital wellbeing services.",
"United Kingdom",
"EQT Ventures II: 2021"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: Unomaly–ViCentra
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[615][616][617][618][619][620][621][622][623][624][625][626][627][628][629][630][631][632][633]
{
"rows": [
[
"Unomaly",
"Data center log and system anomaly monitoring software.",
"Sweden",
"EQT Ventures I: 2016"
],
[
"Utimaco",
"Data security, digital identity protection, and telecom compliance technology.",
"Germany",
"EQT Mid Market Europe: 2017"
],
[
"Vaasan & Vaasan",
"Bakery products production and distribution in Finland and the Baltic region.",
"Finland",
"EQT II: 1998"
],
[
"Vara",
"AI-assisted software for breast imaging screening.",
"Germany",
"EQT Foundation Fund: 2022"
],
[
"Varjo",
"Professional virtual reality and mixed reality devices and software.",
"Finland",
"EQT Ventures I: 2017"
],
[
"VarmX",
"Development of reversal agents for bleeding associated with oral anticoagulants.",
"Netherlands",
"LSP 6: 2020"
],
[
"VBill",
"VBill of China, merchant acquiring, bank card, and QR code payment services.",
"Greater China",
"EQT Mid Market Asia III: 2019"
],
[
"Vectary",
"In-browser interactive 3D design, product configuration, and augmented reality platform.",
"Slovakia",
"EQT Ventures II: 2020"
],
[
"VectorY",
"Development of therapies for neurodegenerative diseases using viral vectors to deliver antibodies.",
"Netherlands",
"LSP Dementia Fund: 2023"
],
[
"Vectura (Activaero)",
"Drug delivery and medical technology for respiratory diseases.",
"Germany",
"LSP 4: 2011"
],
[
"Ventaleon",
"Development of inhaled therapies for viral lung infections and respiratory diseases.",
"Germany",
"LSP 4: 2012"
],
[
"Veritas Petroleum Services (VPS)",
"Marine fuel testing, bunker quantity surveys, and consulting; EQT Credit previously provided financing.",
"Netherlands",
"EQT Mid-Market Credit, EQT Mid-Market Credit II"
],
[
"Verkor",
"French electric vehicle battery development and manufacturing.",
"France",
"EQT Ventures III: 2021"
],
[
"Vertu",
"Luxury mobile phone brand.",
"United Kingdom",
"EQT VI: 2012"
],
[
"VetPartners",
"Veterinary clinics and animal hospitals in Australia and New Zealand.",
"Australia",
"BPEA Private Equity Fund VIII: 2024"
],
[
"Vev",
"Visual website design tool.",
"Norway",
"EQT Ventures II: 2021"
],
[
"VFS Global",
"Outsourcing of administrative processes in visa, passport, and consular services; originated from an investment in the Kuoni group.",
"Switzerland",
"EQT VII: 2016"
],
[
"ViCentra",
"Insulin pumps for people with diabetes.",
"Netherlands",
"LSP 5, LSP HEF 2, LSP HEF 1: 2016"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: Vico Therapeutics–Wall Street English
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[634][635][636][637][638][639][640][641][642][643][644][645][646][647][648][649][650][651][652]
{
"rows": [
[
"Vico Therapeutics",
"Drug development for central nervous system diseases.",
"Belgium",
"LSP 6: 2019"
],
[
"Videm",
"Development of rapid diagnostic technology for viral and bacterial infections.",
"Sweden",
"EQT Foundation Fund: 2022"
],
[
"Vietnam-USA Society English Centers (“VUS”)",
"English education and tutoring services in Vietnam.",
"Southeast Asia",
"BPEA Private Equity Fund VII: 2019"
],
[
"Vinted",
"Consumer marketplace for secondhand clothing and other goods.",
"Lithuania",
"EQT Growth: 2021"
],
[
"ViridiCO2",
"Catalysts for chemical manufacturing and materials technology using carbon dioxide as a feedstock.",
"United Kingdom",
"EQT Ventures III: 2023"
],
[
"Virtuos",
"Video game development, art, and digital content production.",
"Singapore",
"BPEA Private Equity Fund VII: 2021"
],
[
"Virtusa",
"Digital transformation, software engineering, and enterprise IT services.",
"India",
"BPEA Private Equity Fund VII: 2021"
],
[
"Vistra",
"Fund administration support, company formation, and corporate administrative services; merged with Tricor in 2023.",
"Hong Kong",
"BPEA Private Equity Fund VIII: 2016"
],
[
"Vivasure",
"Polymer implants and delivery systems for minimally invasive vascular closure.",
"Ireland",
"LSP HEF 1: 2016"
],
[
"Vivendy Therapeutics",
"Development of enzyme replacement therapy for mucopolysaccharidosis type VI.",
"Switzerland",
"LSP 3: 2007"
],
[
"Vivoryon Therapeutics",
"Drug development related to Alzheimer’s disease.",
"Germany",
"LSP 4: 2009"
],
[
"Volt",
"Instant account-to-account payment network.",
"United Kingdom",
"EQT Ventures II: 2021"
],
[
"Voltera",
"Operations and energy infrastructure for autonomous vehicle and ride-hailing fleets.",
"United States",
"2022"
],
[
"Vsim",
"Robotics simulation software.",
"United Kingdom",
"EQT Ventures III: 2024"
],
[
"VTI Technologies",
"Micro-electromechanical sensors for automotive, medical, and electronic devices.",
"Finland",
"EQT III: 2002"
],
[
"WA3RM",
"Reuse projects for industrial waste heat, carbon dioxide, and other by-product streams.",
"Sweden",
"EQT Foundation Fund: 2022"
],
[
"Waga Energy",
"Development and operation of energy facilities producing biomethane from landfill gas.",
"—",
"EQT Transition Infrastructure: 2025"
],
[
"Wall Street English",
"Wall Street English, adult English language education.",
"Hong Kong",
"BPEA Private Equity Fund VI: 2018"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: Wandelbots–Yin Rong
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[653][654][655][656][657][658][659][660][661][662][663][664][665][666][667][668][669][670][671]
{
"rows": [
[
"Wandelbots",
"Robot teaching and software development platform.",
"Germany",
"EQT Ventures I: 2018"
],
[
"Warducks",
"Augmented reality and location-based interactive game development.",
"Ireland",
"EQT Ventures I: 2019"
],
[
"WASH",
"Shared laundry equipment and long-term operating services for apartments and universities in North America.",
"United States",
"EQT Infrastructure II: 2015"
],
[
"Watty",
"Energy use monitoring and management technology.",
"Sweden",
"EQT Ventures I: 2016"
],
[
"Waystar",
"Billing, collections, and revenue cycle management software for healthcare providers.",
"United States",
"EQT VIII: 2019"
],
[
"Wellhub",
"Corporate employee fitness, classes, and wellness app benefits platform.",
"United States",
"EQT Growth: 2023"
],
[
"Wildhero",
"Wildhero, an eco-friendly email app from Treecard; Treecard previously offered eco-friendly financial products such as payment cards.",
"United Kingdom",
"EQT Ventures II: 2021"
],
[
"Wolt",
"Delivery platform for restaurant meals, groceries, and other retail goods.",
"Finland",
"EQT Growth, EQT Ventures I: 2016"
],
[
"WorkWave",
"Customer, scheduling, operations, and payments management software for field service businesses.",
"United States",
"EQT IX: 2021; EQT VIII: 2021"
],
[
"World Freight Company",
"Air cargo general sales and service agent network.",
"Hong Kong",
"BPEA Private Equity Fund VI: 2018"
],
[
"WS Audiology",
"Formed by the merger of Sivantos and Widex, developing and selling hearing aids and accessories.",
"Denmark",
"EQT VII, EQT VIII: 2019"
],
[
"WSO2",
"API integration, digital service management, and identity and access management software.",
"United States",
"BPEA Private Equity Fund VIII: 2024"
],
[
"WTS Group",
"Corporate tax and financial advisory services.",
"Germany",
"EQT X: 2025"
],
[
"Xeltis",
"Development of vascular and heart valve implants that are gradually replaced by the body’s own tissue.",
"Netherlands",
"LSP HEF 2, LSP HEF 1: 2014"
],
[
"Xilis",
"Micro-organoid technology for oncology drug research and treatment response assessment.",
"United States",
"LSP 6: 2021"
],
[
"XXL Sport & Villmark",
"Nordic sports and outdoor products retail.",
"Norway",
"EQT V: 2010"
],
[
"XyloCor Therapeutics",
"Gene therapy development for coronary artery disease.",
"United States",
"LSP 6: 2018"
],
[
"Yin Rong",
"Regional fruit juice beverage producer in Xi’an, China.",
"Greater China",
"EQT Greater China II: 2007"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Portfolio Companies and Assets: Ylookup–Zooplus
The following lists portfolio companies and assets across periods; years include follow-on fund investment tranches.[672][673][674][675][676][677][678][679][680]
{
"rows": [
[
"Ylookup",
"AI automation software for tax, audit, and advisory business processes.",
"United Kingdom",
"EQT Ventures III: 2026"
],
[
"Yongda Automobile Services",
"Yongda Automobile of China, providing vehicle sales, after-sales, used car, and related automotive services.",
"—",
"BPEA Private Equity Fund V: 2012"
],
[
"Zayo Group",
"Fiber networks, bandwidth, and communications infrastructure in North America and Europe.",
"United States",
"EQT Infrastructure IV: 2020"
],
[
"Zealand Pharma",
"Development of peptide and small-molecule drugs for obesity, metabolic, and rare diseases.",
"Denmark",
"LSP 3: 2005"
],
[
"Zelestra",
"Development and generation of solar, wind, energy storage, and other renewable energy projects.",
"Spain",
"EQT Infrastructure V: 2021"
],
[
"Zemax",
"Optical and illumination system design and simulation software.",
"United States",
"EQT Mid Market US: 2018"
],
[
"Zeus",
"High-performance polymer tubing, components, and catheter solutions for medical devices.",
"United States",
"EQT X: 2024"
],
[
"Zooplus",
"European online retail of pet food and supplies.",
"Germany",
"EQT IX: 2021"
]
],
"notes": null,
"headers": [
"Company or Asset",
"Main Business",
"Main Market",
"Fund and Investment Year"
],
"version": 1
}Investment and Transaction History: 1997–2007 (1)
Investments and subsequent transactions involving EQT, its predecessors, and the funds it manages are as follows.[681][682][683][684][685][686][687][688][689][690][691][692][693][575][694][151]
{
"rows": [
[
"1997-06-30",
"FlexLink",
"Scandinavian Equity Partners signed an agreement to acquire FlexLink from SKF for SEK 930 million, with SKF retaining 10%; the agreement took effect on August 31 of the same year."
],
[
"1998-03-13",
"StjärnTV",
"Scandinavian Equity Partners, EQT’s predecessor, acquired StjärnTV for SEK 730 million; in July 1999 it signed an agreement to sell its entire stake to UPC."
],
[
"1999-10-01",
"Salcomp",
"EQT Scandinavia II signed an agreement to acquire Salcomp from Nokia, with an initial price of about EUR 140 million plus about EUR 13 million tied to operating performance. In August 2007, Nordstjernan exercised its option to buy EQT’s remaining 22.4% stake, subject to regulatory approval."
],
[
"1999-12-17",
"Nederman",
"EQT Danmark acquired all shares of Nederman from a company backed by Candover; Candover had acquired the engineering businesses that included Nederman from Charter in October of the same year."
],
[
"2001-07-30",
"Struers",
"EQT signed an agreement to sell all shares of Struers to Roper Industries, valued at about DKK 1.2 billion on a cash-free, debt-free basis."
],
[
"2001-12-19",
"Leybold Optics",
"EQT acquired Leybold Optics from Unaxis, with management co-investing, for EUR 166 million, with a possible additional payment upon EQT’s exit."
],
[
"2003-01-28",
"Nordic Info Group",
"On January 28, 2003, EQT completed the sale of Nordic Info Group and its subsidiaries to Experian for about DKK 1.1 billion."
],
[
"2003-04-23",
"Com Hem",
"EQT signed an agreement to acquire Com Hem from TeliaSonera for SEK 2.15 billion; it took over the business in June of the same year."
],
[
"2003-11-10",
"Sirona",
"EQT and management signed an agreement to acquire dental equipment company Sirona from Permira at an enterprise value of EUR 417.5 million, with management holding 15%."
],
[
"2006-11-01",
"Bodilsen",
"EQT Opportunity signed an agreement to buy shares of furniture company Bodilsen for DKK 1 million and committed to inject about DKK 100 million in cash; lenders agreed to write down about DKK 190 million of debt."
],
[
"2007-05-25",
"Symrise",
"EQT III combined Haarmann & Reimer and Dragoco, acquired in 2002, into the flavors and fragrances company Symrise. At the December 2006 listing its stake fell from 52% to 15.9%, and on May 25, 2007, it announced the sale of its remaining shares."
],
[
"2007-07-23",
"Contex",
"EQT invested in scanning and imaging company Contex in 1999, which subsequently acquired Vidar and Z Corporation. On July 23, 2007, EQT and other shareholders signed an agreement to sell it to Ratos at an enterprise value of about $240 million, subject to closing conditions."
]
],
"notes": null,
"headers": [
"Date",
"Company or Asset",
"Investment and Subsequent Transactions"
],
"version": 1
}Investment and Transaction History: 2008–2011 (2)
Investments and subsequent transactions involving EQT, its predecessors, and the funds it manages are as follows.[695][696][697][698][96][699][700][540][701][702][703][704][705][706]
{
"rows": [
[
"2008-04-30",
"Tognum",
"Tognum listed in July 2007 at EUR 24 per share. On April 30, 2008, EQT IV announced the sale of its remaining 22.3% stake to Daimler, completing its exit."
],
[
"2008-06-16",
"Cinterion",
"EQT Expansion Capital II completed a financing investment in the former Siemens Wireless Modules business, supporting an acquisition led by GranvilleBaird; the business operates independently under the name Cinterion Wireless Modules."
],
[
"2008-08-27",
"Duni",
"The holding entity of EQT I and III sold its remaining 7,858,644 shares of Duni, representing 16.72%, completing its exit."
],
[
"2009-06-23",
"Bodilsen",
"On June 23, 2009, Bodilsen’s board filed for bankruptcy with a Danish court, and the company’s operations ceased."
],
[
"2010-07-02",
"Aleris",
"EQT III signed an agreement to sell healthcare company Aleris to Investor AB at an enterprise value of about SEK 4.4 billion, plus a deferred performance payment with a net present value of up to SEK 100 million."
],
[
"2010-08-20",
"Roeser",
"EQT Expansion Capital II invested more than EUR 50 million in Roeser, mainly in a subordinated loan structure, supporting management in acquiring a majority stake."
],
[
"2010-12",
"Skykon",
"EQT Expansion Capital II provided a subordinated loan to wind power components supplier Skykon in 2009. The company suspended payments in October 2010 and filed for bankruptcy in December."
],
[
"2011-02-25",
"Dometic",
"EQT III acquired Dometic from Electrolux in July 2001 and signed an agreement in 2005 to exit at SEK 256 per share. After the company’s 2009 debt restructuring, EQT V proposed a renewed acquisition of about SEK 12 billion in February 2011; these are two separate investments in the same company."
],
[
"2011-03-07",
"CaridianBCT",
"Gambro, jointly controlled by EQT IV and Investor, signed an agreement to sell its blood technology business CaridianBCT to Terumo at an enterprise value of $2.625 billion."
],
[
"2011-03-21",
"Kabel BW",
"EQT IV and V signed an agreement to sell German cable network operator Kabel BW to Liberty Global at an enterprise value of EUR 3.16 billion. EQT bought the company from Blackstone in 2006."
],
[
"2011-06-23",
"Securitas Direct",
"EQT V signed an agreement to sell Securitas Direct to Bain Capital and Hellman & Friedman at a cash enterprise value of about SEK 21 billion, plus performance-linked payments of up to SEK 900 million."
],
[
"2011-10-11",
"VTI Technologies",
"EQT III signed an agreement to sell MEMS sensor company VTI Technologies to Murata at an enterprise value of EUR 195 million. EQT acquired the business from Breed Technologies in June 2002."
]
],
"notes": null,
"headers": [
"Date",
"Company or Asset",
"Investment and Subsequent Transactions"
],
"version": 1
}Investment and Transaction History: 2012–2015 (3)
Investments and subsequent transactions involving EQT, its predecessors, and the funds it manages are as follows.[707][708][709][710][711][712][713][714][715][716][717][718][719][512][308]
{
"rows": [
[
"2012-03-30",
"internetstores",
"EQT Expansion Capital II signed an agreement to invest EUR 30 million, acquiring a minority stake in outdoor e-commerce company internetstores and providing growth capital; in November 2016 it announced the sale of its entire investment to SIGNA Retail."
],
[
"2012-05-17",
"Dako",
"EQT V signed an agreement to sell cancer diagnostics company Dako to Agilent at an enterprise value of about DKK 12.8 billion; the enterprise value at the time of the 2007 investment was DKK 7.25 billion."
],
[
"2012-10-09",
"Tampnet",
"EQT Infrastructure signed an agreement to acquire offshore communications network Tampnet from HitecVision in a transaction valued at about NOK 1.5 billion."
],
[
"2012-10-15",
"KMD",
"EQT V and ATP signed an agreement to sell all shares of KMD to Advent, without disclosing the price. EQT invested in the Danish IT services company in early 2009."
],
[
"2012-12-04",
"Gambro",
"EQT IV and Investor signed an agreement to sell dialysis equipment business Gambro to Baxter at an enterprise value of SEK 26.5 billion. The original group was taken private in 2006 at an enterprise value of SEK 35 billion and later split into dialysis clinics, CaridianBCT, and the equipment business, which were sold separately."
],
[
"2013-03-23",
"itslearning",
"EQT Expansion Capital II signed an agreement to invest about EUR 47 million, equivalent to NOK 350 million, both funding the company’s development and acquiring some shares from existing shareholders."
],
[
"2013-06-19",
"Springer Science+Business Media",
"EQT V and GIC acquired academic publisher Springer in 2010 and in June 2013 signed an agreement to sell it to BC Partners at an enterprise value of about EUR 3.3 billion, including a performance-linked component."
],
[
"2013-08-22",
"Synagro",
"EQT Infrastructure II completed its acquisition of Synagro at an enterprise value of $465 million and reduced about $200 million of debt through a bankruptcy reorganization plan."
],
[
"2013-08-23",
"Hexaware",
"BPEA signed an agreement to acquire 41.8% of Hexaware, about 125 million shares, at INR 126 or 135 per share, with the higher price applying upon reaching a total stake of at least 50%; the initial share consideration was about INR 15.75 billion to 16.87 billion. It also launched an offer for up to 26% of shares at INR 135 per share."
],
[
"2014-11-17",
"Bushu Pharmaceuticals",
"BPEA signed an agreement to acquire all shares of Bushu from funds managed by Tokio Marine Capital at an enterprise valuation of JPY 77.3 billion."
],
[
"2015-02",
"Sanitec",
"Sanitec listed in Stockholm in December 2013; EQT IV continued to sell down in May 2014 and sold its remaining stake when Geberit’s offer was completed in February 2015."
],
[
"2015-03-13",
"ISS",
"ISS began trading in Copenhagen on March 13, 2014, at DKK 160 per share. EQT and funds managed by Goldman Sachs subsequently sold shares in tranches, selling the remaining shares in March 2015 to complete their exit."
]
],
"notes": null,
"headers": [
"Date",
"Company or Asset",
"Investment and Subsequent Transactions"
],
"version": 1
}Investment and Transaction History: 2015–2017 (4)
Investments and subsequent transactions involving EQT, its predecessors, and the funds it manages are as follows.[552][720][721][669][722][314][723][724][725][726][727][728][729][517]
{
"rows": [
[
"2015-05",
"SSP",
"EQT acquired transport hub food and beverage company SSP in a carve-out from Compass in 2006. The company listed in July 2014, and EQT sold its remaining shares in two tranches in January and May 2015, completing its exit."
],
[
"2015-08-06",
"Classic Fine Foods",
"EQT Greater China II sold Classic Fine Foods to Metro at an initial enterprise value of $290 million, plus payments of up to $38 million linked to EBITDA for 2015–2017."
],
[
"2015-09-09",
"XXL Sport & Villmark",
"On September 9, 2015, EQT V announced the sale of its remaining shares in XXL, completing an investment that began in 2010."
],
[
"2015-11-02",
"TOP-TOY",
"EQT VII signed an agreement to invest in Nordic toy retailer TOP-TOY at an enterprise value of DKK 2.325 billion."
],
[
"2016",
"Japan Home Centre",
"EQT Greater China II acquired 40% of Japan Home Centre in 2010; the company listed in Hong Kong in 2013 under the name International Housewares Retail. Through the listing and subsequent sell-downs, EQT sold its last 5% stake in 2016."
],
[
"2016-02-04",
"EEW Energy from Waste",
"EQT Infrastructure II reached an agreement in principle with Beijing Enterprises to sell EEW at an equity price of EUR 1.438 billion; EQT had bought 51% in 2013 and acquired the remaining 49% in 2015."
],
[
"2016-04-01",
"Sitecore",
"EQT VII partnered with the founding team to acquire a controlling stake in Sitecore at an enterprise valuation of about EUR 1 billion; the founders retained a significant stake."
],
[
"2016-05-06",
"TELUS International (later renamed TELUS Digital)",
"BPEA signed an agreement to acquire a 35% stake, corresponding to a company valuation of about $1 billion, with TELUS shareholders retaining 65%."
],
[
"2016-06-20",
"Unomaly",
"EQT Ventures led the EUR 4 million Series A of IT log and anomaly analysis company Unomaly; the EUR 1.9 million seed round the company had previously completed was a separate financing."
],
[
"2016-12-01",
"Automic",
"EQT VI signed an agreement to sell automation software company Automic to CA Technologies at a transaction valuation of EUR 600 million."
],
[
"2016-12-19",
"BSN medical",
"EQT VI signed an agreement to sell BSN medical to SCA at a valuation of EUR 2.74 billion; when EQT signed the acquisition agreement in 2012, the enterprise value was about EUR 1.8 billion."
],
[
"2017",
"Scandic",
"EQT V acquired Scandic from Hilton in 2007 and integrated Rica Hotels during the investment period in 2014; EQT’s website records the exit in 2017."
]
],
"notes": null,
"headers": [
"Date",
"Company or Asset",
"Investment and Subsequent Transactions"
],
"version": 1
}Investment and Transaction History: 2017–2019 (5)
Investments and subsequent transactions involving EQT, its predecessors, and the funds it manages are as follows.[730][731][732][733][734][735][736][737][738][601][739][740][741]
{
"rows": [
[
"2017-05-15",
"Bureau van Dijk",
"EQT VI signed an agreement to sell business information provider Bureau van Dijk to Moody’s at an enterprise value of EUR 3 billion."
],
[
"2017-07-11",
"Certara",
"EQT VII signed an agreement to acquire drug development modeling and software company Certara from Arsenal Capital at an enterprise value of $850 million; Arsenal retained a minority stake."
],
[
"2017-09-18",
"BackWerk",
"EQT Mid Market signed an agreement to sell food franchise brand BackWerk to Valora at an enterprise value of about EUR 190 million."
],
[
"2017-10-27",
"AcadeMedia",
"Marvin, the holding entity of EQT V and co-investors, sold 11,511,385 shares of AcadeMedia at SEK 63 per share, after which it no longer held shares."
],
[
"2018-04-30",
"Piab",
"EQT VII signed an agreement to sell industrial automation company Piab to Patricia Industries at an enterprise value of SEK 6.95 billion."
],
[
"2018-07-02",
"SUSE",
"EQT VIII signed an agreement to acquire open-source enterprise software company SUSE from Micro Focus at an enterprise value of $2.535 billion. The company subsequently became independent in 2019 and listed in 2021."
],
[
"2018-07-09",
"Sportradar",
"EQT VI signed an agreement to sell a 35% stake in Sportradar to CPP Investments and TCV at a transaction valuation of EUR 2.1 billion. EQT Expansion Capital II first invested in 2012, and EQT VI took over in 2014."
],
[
"2018-12-21",
"Small Giant Games",
"EQT Ventures signed an agreement to sell its stake to Zynga in a transaction implying a company valuation of $700 million. EQT had previously led the $5.7 million Series A in March 2017 and the $41 million financing in January 2018."
],
[
"2018-12-28",
"TOP-TOY",
"TOP-TOY applied for reconstruction on November 30, 2018, and the reconstruction plan was approved on December 21; on December 28, the board filed for bankruptcy, and the company entered bankruptcy under a court-appointed trustee."
],
[
"2019-01-23",
"UDG United Digital Group",
"EQT Expansion Capital II signed an agreement to sell digital marketing group UDG to PIA, part of Equistone; UDG originated from the 2011 combination of nine German digital agencies and separately sold its media and performance marketing businesses to Omnicom in 2018."
],
[
"2019-06-11",
"IP-Only",
"The EQT Mid Market funds signed an agreement to sell IP-Only to EQT Infrastructure IV at an enterprise value of SEK 18.25 billion, plus performance payments of up to SEK 1 billion."
],
[
"2019-06-11",
"Press Ganey",
"EQT VII signed an agreement to sell healthcare experience and analytics company Press Ganey to investors including Leonard Green and Ares. EQT took the company private in 2016; the 2019 exit announcement did not disclose the consideration."
]
],
"notes": null,
"headers": [
"Date",
"Company or Asset",
"Investment and Subsequent Transactions"
],
"version": 1
}Investment and Transaction History: 2019–2020 (6)
Investments and subsequent transactions involving EQT, its predecessors, and the funds it manages are as follows.[742][743][744][745][746][747][137][748][749][750][751][752][753][754][755][756]
{
"rows": [
[
"2019-06-20",
"AutoStore",
"EQT VII completed its acquisition of warehouse robotics company AutoStore in January 2017; in June 2019 it signed an agreement to sell a controlling stake to THL Partners while reinvesting and retaining about 10%. Neither the purchase nor the sale announcement disclosed the transaction amount."
],
[
"2019-09-12",
"Parques Reunidos",
"Piolin BidCo, backed by EQT Infrastructure IV, Alba, and GBL, announced the offer results, with a combined stake of 86.40%. The cash price per share was adjusted from EUR 14 to EUR 13.753 for dividends paid."
],
[
"2019-11-29",
"LBX Pharmacy",
"EQT Greater China II announced the sale of its remaining 24.78% stake in LBX Pharmacy at RMB 55 per share. EQT jointly controlled the company with its founders from 2008, and the company listed in Shanghai in 2015."
],
[
"2019-12-05",
"itslearning",
"Sanoma completed its acquisition of learning management system company itslearning on December 5, 2019, and EQT Expansion Capital II exited; the transaction price was not disclosed."
],
[
"2020-02-10",
"Deutsche Glasfaser",
"EQT Infrastructure IV and OMERS signed an agreement to acquire Deutsche Glasfaser and merge it with inexio, with planned stakes of 51% and 49%, respectively. The two proposed investing more than EUR 7 billion over the coming years to expand the fiber network; that amount is an expansion investment plan."
],
[
"2020-02-12",
"Clinical Innovations",
"LABORIE completed its acquisition of obstetric and neonatal medical device company Clinical Innovations on February 12, 2020, at a published enterprise value of $525 million."
],
[
"2020-03-09",
"Zayo",
"EQT Infrastructure IV and Digital Colony completed the take-private of Zayo on March 9, 2020. The total transaction value was $14.3 billion, with original shareholders receiving $35 in cash per share."
],
[
"2020-07-14",
"IFS",
"EQT VIII and IX and TA Associates signed an agreement to acquire IFS from EQT VII in a transaction valued at more than EUR 3 billion. This transaction involved different funds under the same manager; EQT’s investment relationship with IFS began in 2015."
],
[
"2020-09-26",
"Oterra",
"EQT IX signed an agreement to acquire Chr. Hansen’s natural colors business for EUR 800 million. The business later operated under the name Oterra."
],
[
"2020-11-03",
"Metlifecare",
"Asia Pacific Village Group, backed by EQT, acquired all shares of Metlifecare on November 3, 2020, and the company was delisted that day. The final scheme of NZD 6 per share replaced the original 2019 agreement of NZD 7 per share and resolved related litigation."
],
[
"2020-11-18",
"HusCompagniet",
"The HusCompagniet IPO was priced at DKK 117 per share. In May 2021, the EQT VI holding entity signed an agreement to sell 5 million shares at DKK 118 per share, and in August it sold another 3,842,268 shares at DKK 116.40 per share."
],
[
"2020-12-06",
"Apleona",
"EQT VII signed an agreement to sell facility management company Apleona to PAI Partners in a transaction valued at about EUR 1.6 billion. Part of the proceeds was allocated to original seller Bilfinger under a prior arrangement, with the announcement expecting Bilfinger to receive EUR 450 million to 470 million."
]
],
"notes": null,
"headers": [
"Date",
"Company or Asset",
"Investment and Subsequent Transactions"
],
"version": 1
}Investment and Transaction History: 2020–2021 (7)
Investments and subsequent transactions involving EQT, its predecessors, and the funds it manages are as follows.[757][758][759][760][761][762][763][764][765][766][767][768][769]
{
"rows": [
[
"2020-12-15",
"Certara",
"Certara’s IPO was completed on December 15, 2020, at $23 per share. EQT VII sold about 14.2 million shares, with net proceeds after underwriting discounts of about $306 million, and held about 49% after completion."
],
[
"2021-01-19",
"Schülke",
"Schülke signed an agreement to sell its personal care business to Ashland for EUR 262.5 million in cash, retaining its medical infection prevention business."
],
[
"2021-02-09",
"IVC Evidensia",
"IVC Evidensia announced an expanded shareholder partnership with total new investment of EUR 3.5 billion and an enterprise value of about EUR 12.3 billion; EQT increased its investment, Silver Lake joined, and Nestlé increased its minority stake. EQT invested in Evidensia in 2014 and in IVC in December 2016, and the two merged in May 2017."
],
[
"2021-02-10",
"CYE",
"EQT Mid Market Europe signed an agreement to invest about $100 million in Israeli cybersecurity company CYE; founder Reuven Aronashvili retained a significant stake and continued to lead the company."
],
[
"2021-02-11",
"Virtusa",
"BPEA completed the take-private of IT services company Virtusa on February 11, 2021; the acquisition agreement was at $51.35 per share, with a total value of about $2 billion. CPP Investments’ $300 million commitment corresponded to a stake of about 24%."
],
[
"2021-02-24",
"Innovyze",
"EQT Mid Market US signed an agreement to sell water infrastructure software company Innovyze to Autodesk at an enterprise value of $1 billion."
],
[
"2021-03-01",
"Dorner",
"EQT Mid Market US signed an agreement to sell precision conveyor company Dorner to Columbus McKinnon at an enterprise value of $485 million."
],
[
"2021-03-03",
"Lumenis",
"BPEA signed an agreement to sell Lumenis’s surgical business to Boston Scientific for $1.07 billion, subject to closing adjustments; the aesthetics and ophthalmology businesses remained held by BPEA."
],
[
"2021-03-22",
"Epidemic Sound",
"Epidemic Sound completed a financing of about $540 million at a valuation of $1.4 billion. Of this, EQT Growth and Blackstone Growth together invested $450 million, with AMF, Alecta, and TIN participating in a subsequent portion."
],
[
"2021-05-10",
"StormGeo",
"EQT Mid Market signed an agreement to sell weather decision software company StormGeo to Alfa Laval for NOK 3.63 billion."
],
[
"2021-05-12",
"Vinted",
"EQT Growth, through EQT AB’s balance sheet, led Vinted’s EUR 250 million Series F at a pre-money valuation of EUR 3.5 billion."
],
[
"2021-05-18",
"The CrownX",
"A consortium led by Alibaba and BPEA signed an agreement to acquire a 5.5% stake in Vietnamese consumer retail platform The CrownX for $400 million in cash, corresponding to a pre-money equity valuation of $6.9 billion."
]
],
"notes": null,
"headers": [
"Date",
"Company or Asset",
"Investment and Subsequent Transactions"
],
"version": 1
}Investment and Transaction History: 2021–2022 (8)
Investments and subsequent transactions involving EQT, its predecessors, and the funds it manages are as follows.[770][771][772][773][774][775][776][777][778][779][780][781][278][782][783][784][785][786]
{
"rows": [
[
"2021-06-08",
"Anticimex",
"EQT announced the first investment of its long-hold strategy, moving Anticimex from EQT VI into a new investment structure at an enterprise value of SEK 60 billion; participants included MSAB, GIC, AMF, Interogo, and Alecta."
],
[
"2021-06-22",
"Mollie",
"EQT Growth, through EQT AB’s balance sheet, participated in payment provider Mollie’s $800 million Series C at a valuation of $6.5 billion."
],
[
"2021-07-01",
"Fertin Pharma",
"EQT Mid Market Europe signed an agreement to sell oral delivery technology company Fertin Pharma to Philip Morris International at an enterprise value of DKK 5.1 billion."
],
[
"2021-07-08",
"Igenomix",
"EQT VIII signed an agreement to sell reproductive genetic testing company Igenomix to Vitrolife at an enterprise value of EUR 1.25 billion, with a payment structure including cash and shares issued to EQT and other shareholders."
],
[
"2021-07-21",
"First Student and First Transit",
"EQT Infrastructure V acquired the North American school bus and public transit businesses from FirstGroup; the April 2021 agreement announced a combined transaction value of $4.6 billion, and the deal was completed on July 21. The combined price cannot be allocated separately to the acquisition cost of each business."
],
[
"2021-08-30",
"Aldevron",
"Danaher completed its acquisition of Aldevron on August 30, 2021, at an enterprise value of $9.6 billion. EQT VIII co-invested in the biomanufacturing company in 2019 with TA Associates, the founders, and management."
],
[
"2021-11-03",
"Fenix Marine Services",
"EQT Infrastructure III signed an agreement to sell Port of Los Angeles terminal operator Fenix Marine Services to CMA CGM at an enterprise value of $2.3 billion."
],
[
"2021-11-15",
"Parexel",
"EQT IX and Goldman Sachs Asset Management completed the acquisition of clinical research services company Parexel from Pamplona on November 15, 2021, at an enterprise value of $8.5 billion."
],
[
"2021-11-19",
"Icon Group",
"EQT Infrastructure V announced the acquisition of Australian cancer care company Icon Group. The investment covers services including radiotherapy, medical oncology, pharmaceutical compounding, and hospital pharmacy."
],
[
"2021-11-25",
"Solarpack (later renamed Zelestra)",
"EQT Infrastructure V announced the offer results on November 25, 2021, with an acceptance rate of 96.04% at EUR 26.50 per share. The original major shareholders committed to reinvest, retaining about 8% after settlement of the squeeze-out of the remaining shares."
],
[
"2021-11-30",
"Covanta (later renamed Reworld)",
"EQT Infrastructure V completed the $5.3 billion acquisition on November 30, 2021, taking Covanta private. The company’s North American waste services business was subsequently renamed Reworld."
],
[
"2022-01-17",
"zooplus",
"Zorro Bidco, backed by H&F and EQT IX, announced the results of the second-stage delisting offer: as of January 12, 2022, the two-stage offers had together obtained about 97% of the share capital. The final offer price was EUR 480 per share."
]
],
"notes": null,
"headers": [
"Date",
"Company or Asset",
"Investment and Subsequent Transactions"
],
"version": 1
}Investment and Transaction History: 2022–2023 (9)
Investments and subsequent transactions involving EQT, its predecessors, and the funds it manages are as follows.[787][416][788][789][790][791][792][793][794][795][796][797][226][798]
{
"rows": [
[
"2022-06-01",
"Nordic Aviation Capital",
"Nordic Aviation Capital completed its Chapter 11 restructuring on June 1, 2022, cutting nearly $4.1 billion of debt and receiving about $537 million in new capital support. EQT’s website lists its investment, which began in 2015, as exited in 2021."
],
[
"2022-06-07",
"Envirotainer",
"EQT X and Mubadala signed an agreement to acquire pharmaceutical temperature-controlled transport equipment company Envirotainer from Cinven and Novo Holdings at an enterprise value of about EUR 2.8 billion."
],
[
"2022-06-10",
"Ariceum Therapeutics",
"EQT Life Sciences and HealthCap co-founded radiopharmaceutical company Ariceum and co-led its EUR 25 million Series A, with Pureos Bioventures participating."
],
[
"2022-06-22",
"SPT Labtech",
"EQT IX signed an agreement to acquire laboratory automation equipment company SPT Labtech from Battery Ventures for GBP 650 million."
],
[
"2022-07-29",
"Levande",
"EQT completed the acquisition of Stockland’s retirement living business on July 29, 2022. Stockland’s annual report lists a final price of about AUD 934 million after adjustments for operating working capital and inventory, down from AUD 987 million at the time of the agreement."
],
[
"2022-10-14",
"GlobalConnect",
"EQT Infrastructure III and IV signed an agreement to sell a minority stake in GlobalConnect to Mubadala, with EQT remaining the largest shareholder after closing. The Nordic data communications platform was formed by combining several network businesses invested in since 2017."
],
[
"2022-12-16",
"Billtrust",
"EQT X completed the take-private of Billtrust on December 16, 2022; original shareholders received $9.50 in cash per share, and the stock ceased trading on Nasdaq."
],
[
"2023-02-15",
"VBill",
"In 2019, EQT signed an agreement to subscribe for 10% of VBill’s new shares, with the entire company’s equity valued at up to RMB 5.88 billion depending on audited 2018 net profit. In February 2023, it announced a full exit through exercising a put option and a company buyback."
],
[
"2023-03-01",
"Radius Global Infrastructure",
"EQT Active Core signed an agreement to participate in the take-private of Radius at $15 in cash per share, at an enterprise value of about $3 billion."
],
[
"2023-03-03",
"SK Shieldus",
"EQT Infrastructure VI signed an agreement to acquire a controlling stake in SK Shieldus from SK Square and Macquarie, with an agreed structure of EQT holding 68% and SK Square retaining 32%; the announcement did not disclose the total consideration."
],
[
"2023-03-06",
"First Transit",
"Transdev completed its acquisition of First Transit on March 6, 2023; First Student, previously acquired together with it, remains a separate investment."
],
[
"2023-03-09",
"QurAlis",
"EQT Life Sciences, through the LSP Dementia Fund, co-led QurAlis’s $88 million Series B with Sanofi Ventures and Droia Ventures, for the development of drugs for neurodegenerative diseases."
]
],
"notes": null,
"headers": [
"Date",
"Company or Asset",
"Investment and Subsequent Transactions"
],
"version": 1
}Investment and Transaction History: 2023–2024 (10)
Investments and subsequent transactions involving EQT, its predecessors, and the funds it manages are as follows.[799][800][801][802][803][804][805][806][630][807][808][809][810][811]
{
"rows": [
[
"2023-03-14",
"Tinyclues",
"Splio announced its acquisition of customer marketing prediction software company Tinyclues on March 14, 2023."
],
[
"2023-03-23",
"IntegrityNext",
"EQT Growth invested EUR 100 million in supply chain sustainability software company IntegrityNext, becoming its first institutional investor."
],
[
"2023-03-24",
"Tion Renewables",
"EQT Active Core signed an agreement to directly and indirectly acquire 82.1% of Tion Renewables, at a base valuation of EUR 150 million for the entire share capital, about EUR 31.61 per share, with additional payments linked to the performance of certain new energy projects."
],
[
"2023-04-25",
"IMG Academy",
"BPEA VIII signed an agreement to acquire sports education institution IMG Academy from Endeavor at an enterprise value of $1.25 billion and established an education partnership with Nord Anglia Education."
],
[
"2023-06-20",
"Credila Financial Services",
"A consortium led by BPEA VIII and ChrysCapital signed an agreement to acquire about 90% of HDFC Credila, priced on a pre-money valuation of INR 103.5 billion for the entire company; it also planned to inject INR 20 billion of new capital."
],
[
"2023-07-28",
"Vistra and Tricor",
"BPEA VIII completed the merger of Vistra and Tricor on July 28, 2023, with a combined enterprise value of $6.5 billion and businesses covering fund administration and corporate services."
],
[
"2023-08-24",
"Coforge",
"BPEA VII sold its remaining 26.6% stake in Coforge through a block trade for $924 million. BPEA and co-investors bought 70.1% of the shares in May 2019."
],
[
"2023-10-11",
"VetPartners",
"BPEA VIII announced the acquisition of Australian and New Zealand veterinary services network VetPartners; the investment tranche recorded on EQT’s website is 2024."
],
[
"2023-11-13",
"SUSE",
"SUSE shareholders approved a merger by absorption into Marcel New Lux IV; the surviving entity was renamed SUSE, and the company was delisted from the Frankfurt Stock Exchange on November 13, 2023."
],
[
"2023-12-18",
"Zeus",
"EQT X signed an agreement to acquire medical polymer tubing and components company Zeus from the Tourville family. The announcement planned closing in the first quarter of 2024 and did not disclose the price."
],
[
"2024-01-03",
"LimaCorporate",
"Enovis completed its acquisition of orthopedic implant company LimaCorporate. The closing documents list cash of about EUR 726.8 million, including partial debt repayment, transfer taxes, and notary fees, plus 1,942,686 Enovis shares with an agreed reference value of EUR 100 million; these items cannot collectively be called EQT’s cash proceeds."
],
[
"2024-01-16",
"Dechra Pharmaceuticals",
"An acquisition vehicle backed by EQT X and Luxinva completed the take-private of Dechra, with shareholders accepting a price of GBP 38.75 per share."
]
],
"notes": null,
"headers": [
"Date",
"Company or Asset",
"Investment and Subsequent Transactions"
],
"version": 1
}Investment and Transaction History: 2024–2024 (11)
Investments and subsequent transactions involving EQT, its predecessors, and the funds it manages are as follows.[812][813][814][815][816][817][818][819][820][821][822][823][824][825][826]
{
"rows": [
[
"2024-02-28",
"CMS Info Systems",
"BPEA VI sold its remaining 26.7% stake in CMS Info Systems through a $187 million block trade."
],
[
"2024-03-13",
"Ottobock",
"EQT VII signed an agreement to sell the 20% stake in Ottobock it acquired in 2017 to the Näder family; the announcement expected closing in the first half of 2024 and did not disclose the price."
],
[
"2024-03-25",
"Cardior",
"Novo Nordisk signed an agreement to acquire Cardior for up to EUR 1.025 billion, including an upfront payment and development and commercial milestone payments; EQT Life Sciences is one of the selling investors."
],
[
"2024-04-02",
"Avetta",
"EQT X signed an agreement to acquire supply chain risk management software company Avetta from WCAS; the parties did not disclose the price."
],
[
"2024-06-28",
"idealista",
"EQT IX invested in idealista at a valuation of EUR 1.3 billion in 2020 and in June 2024 signed an agreement to transfer a controlling stake to Cinven at a valuation of EUR 2.9 billion; the agreement provides for Cinven to hold 70% and EQT to retain 18%."
],
[
"2024-07-15",
"Amolyt Pharma",
"AstraZeneca completed its acquisition of Amolyt Pharma on July 15, 2024: an $800 million upfront payment at closing plus a $250 million regulatory milestone payment, for a maximum of $1.05 billion. EQT Life Sciences invested in the company through LSP 6."
],
[
"2024-07-16",
"Asceneuron",
"EQT Life Sciences’ LSP Dementia Fund participated in Asceneuron’s $100 million Series C, led by Novo Holdings, for small-molecule drug development for neurodegenerative diseases."
],
[
"2024-07-25",
"Fiberklaar",
"EQT Infrastructure V signed an agreement to sell a majority stake in Fiberklaar to co-shareholder Proximus for EUR 246 million."
],
[
"2024-08-14",
"AMCS",
"EQT signed an agreement to invest in resource management and sustainability software company AMCS, acquiring a majority stake. The announcement listed the investment partnership of EQT X and EQT Future and did not disclose the price."
],
[
"2024-09-24",
"EdgeConneX",
"EQT Infrastructure IV and V signed an agreement to sell a minority stake in data center company EdgeConneX to Sixth Street, with EQT remaining the largest shareholder after the transaction. EQT has invested in the company since 2020."
],
[
"2024-09-26",
"Qarbotech",
"EQT Foundation invested EUR 100,000 in agricultural technology company Qarbotech as part of a $1.5 million seed round."
],
[
"2024-10-02",
"Perficient",
"BPEA VIII completed its acquisition of digital consultancy Perficient on October 2, 2024, and the company stopped trading on Nasdaq the same day. The May acquisition agreement was at $76 per share, with an enterprise value of about $3 billion."
]
],
"notes": null,
"headers": [
"Date",
"Company or Asset",
"Investment and Subsequent Transactions"
],
"version": 1
}Investment and Transaction History: 2024–2025 (12)
Investments and subsequent transactions involving EQT, its predecessors, and the funds it manages are as follows.[784][827][828][829][830][831][832][833][834][835][836][837][838][839][840]
{
"rows": [
[
"2024-10-02",
"Reworld",
"EQT Infrastructure V signed an agreement to bring in GIC through a capital increase and a secondary share transfer, giving GIC a 25% stake; EQT remained the largest shareholder after closing."
],
[
"2024-10-08",
"OX2",
"EQT Infrastructure VI announced the results of its SEK 60 per share offer, controlling 269,282,357 shares after the extended acceptance period, about 98.81% of OX2’s share capital and voting rights."
],
[
"2024-10-24",
"Keywords Studios",
"An investor group comprising EQT, CPP Investments, and Temasek announced the completion of its acquisition of games technology services provider Keywords Studios, whose shares ceased trading on AIM and were delisted; EQT invested through BPEA VIII."
],
[
"2024-11-13",
"NitroVolt",
"EQT Foundation participated in green ammonia production technology company NitroVolt’s EUR 3.5 million seed round, for on-farm demonstration units and technology expansion."
],
[
"2024-11-18",
"ATB Therapeutics",
"EQT Life Sciences and MRL Ventures Fund co-led ATB Therapeutics’ EUR 54 million Series A, supporting its antibody platform and drug development."
],
[
"2024-12-02",
"Calisen",
"EQT and GIC signed an agreement to acquire a majority stake in UK smart meter company Calisen, subject to regulatory and other conditions."
],
[
"2024-12-11",
"Noema Pharma",
"EQT Life Sciences led a Series B extension for Noema Pharma, bringing the round’s cumulative total to CHF 130 million; this figure includes funds previously raised."
],
[
"2024-12-13",
"PropertyGuru",
"BPEA VIII completed the take-private of PropertyGuru on December 13, 2024, at $6.70 in cash per share, with an equity value of about $1.1 billion, and the company left the New York Stock Exchange."
],
[
"2025",
"O2 Power",
"JSW Neo Energy completed its acquisition of the Indian renewable energy platform co-founded by EQT Infrastructure and Temasek in 2020. The buyer announced an enterprise valuation of about INR 124.68 billion after agreed adjustments; 4.7 gigawatts is the platform capacity including projects under construction and in development."
],
[
"2025-03-18",
"Dellner Couplers",
"EQT VIII signed an agreement to sell train coupling systems company Dellner Couplers to Wabtec at a valuation of about EUR 890 million."
],
[
"2025-03-20",
"Nord Anglia Education",
"A consortium including EQT, Neuberger Berman, and CPP Investments completed the acquisition at an enterprise valuation of $14.5 billion. BPEA’s investment relationship with the company began in 2008, with CPP Investments brought in in 2017; the 2025 transaction included new fund investment and reinvestment by existing shareholders."
],
[
"2025-04-01",
"Lumos Fiber",
"T-Mobile and EQT Infrastructure VI completed the acquisition of Lumos from EQT Infrastructure III on April 1, 2025. T-Mobile’s 2025 annual report lists an actual investment of $932 million for a 50% interest in the joint venture and 97,000 fiber customers; it also planned to invest about $500 million more in 2027–2028."
]
],
"notes": null,
"headers": [
"Date",
"Company or Asset",
"Investment and Subsequent Transactions"
],
"version": 1
}Investment and Transaction History: 2025–2025 (13)
Investments and subsequent transactions involving EQT, its predecessors, and the funds it manages are as follows.[750][841][842][843][844][845][846][847][848][849][850][851][852][853]
{
"rows": [
[
"2025-04-09",
"IFS",
"A new minority stake transaction in IFS valued the company at more than EUR 15 billion. Hg planned to increase its holding to joint control with EQT, an ADIA subsidiary and CPP Investments joined, and TA Associates continued to hold a minority stake; the agreement was then still subject to regulatory approval."
],
[
"2025-05-29",
"Acumatica",
"EQT signed an agreement to sell cloud ERP software company Acumatica to Vista Equity Partners; EQT’s investment relationship with the company began in 2019."
],
[
"2025-06-11",
"SpliceBio",
"EQT Life Sciences and Sanofi Ventures co-led SpliceBio’s $135 million Series B, funding its protein splicing platform and genetic medicine development."
],
[
"2025-07-09",
"Neuros Medical",
"EQT Life Sciences’ LSP 7 and its Health Economics strategy co-led Neuros Medical’s $56 million Series D, supporting the commercialization of its neurostimulation medical device."
],
[
"2025-07-24",
"Fortnox",
"EQT X and First Kraft made the acquisition through Omega II; on July 9, 2025, the company disclosed that the acquirers controlled about 97.3% of the shares and had initiated compulsory redemption of the remaining shares. Nasdaq approved July 24 as the last trading day."
],
[
"2025-08-11",
"Remember",
"BPEA VIII signed an agreement to acquire a controlling stake in South Korean HR platform Remember from shareholders including Ark & Partners, with an announced transaction value of about KRW 500 billion, equivalent to $400 million."
],
[
"2025-08-27",
"Karo Healthcare",
"KKR completed its acquisition of Karo Healthcare on August 27, 2025, and EQT VIII exited. The April signing announcement by the two parties did not disclose the price."
],
[
"2025-09-02",
"Cyted Health",
"EQT Life Sciences led Cyted Health’s $44 million Series B funding package, co-led with Advent Life Sciences and British Business Bank; the total includes non-dilutive funding related to a partnership with HCA Healthcare."
],
[
"2025-09-12",
"Waystar",
"EQT VIII sold about 7.8 million shares in a public offering for proceeds of about $304.5 million, retaining about 24.9 million shares after the transaction; all sellers together sold about 18 million shares for proceeds of about $705.8 million. The company issued no new shares and received no sale proceeds."
],
[
"2025-10-06",
"Harvey",
"EQT Growth invested EUR 50 million in legal AI company Harvey as part of a Series E extension; the amount is EQT’s investment."
],
[
"2025-10-20",
"Syngular Technology",
"EQT Foundation invested EUR 100,000 in surgical navigation technology company Syngular Technology through a SAFE."
],
[
"2025-10-22",
"Electra Therapeutics",
"EQT Life Sciences and Nextech co-led Electra Therapeutics’ $183 million Series C to advance antibody drug development."
]
],
"notes": null,
"headers": [
"Date",
"Company or Asset",
"Investment and Subsequent Transactions"
],
"version": 1
}Investment and Transaction History: 2025–2026 (14)
Investments and subsequent transactions involving EQT, its predecessors, and the funds it manages are as follows.[854][855][856][857][858][859][860][861][862][863][864][865][866][867][868][869]
{
"rows": [
[
"2025-10-31",
"TELUS Digital",
"TELUS completed the take-private on October 31, 2025, acquiring the remaining minority shares for cash or stock consideration of $4.50 per share. EQT’s September agreement announcement expected closing proceeds for its remaining shares of about $215 million; the total transaction amount of about $539 million announced by TELUS covers all acquired minority shareholders."
],
[
"2025-11-07",
"Douzone Bizon",
"EQT signed an agreement to acquire 37.6% of South Korean enterprise software company Douzone Bizon, with 23.2% from the founder and 14.4% from Shinhan Value-up. The agreement amount was about KRW 1.3 trillion, equivalent to $930 million, subject to closing conditions."
],
[
"2025-11-20",
"Milvus Advanced",
"EQT Foundation invested EUR 200,000 in nanomaterials company Milvus Advanced, participating in a GBP 5 million seed round led by Hoxton Ventures."
],
[
"2025-12-01",
"Pioneer",
"CarUX completed its acquisition of car audio and navigation company Pioneer on December 1, 2025; EQT signed the sale agreement in June of the same year, with an announced transaction amount of about $1.1 billion."
],
[
"2025-12-11",
"Kodiak Gas Services",
"EQT Infrastructure announced on December 11, 2025, that it had fully exited natural gas compression services company Kodiak, through a process including the 2023 listing and subsequent share sales."
],
[
"2025-12-12",
"Merus",
"Genmab completed the initial tender offer for Merus, with about 94.2% of outstanding common shares tendered, paying $97 in cash per share; the total value of the acquisition agreement was about $8 billion. A subsequent offering period continued to accept the remaining shares. EQT Life Sciences has invested in Merus since 2010."
],
[
"2025-12-15",
"ImCheck Therapeutics",
"Ipsen completed its acquisition of ImCheck Therapeutics on December 15, 2025; the agreement provided for a EUR 350 million upfront payment plus milestone payments tied to regulatory and commercial goals. EQT Life Sciences is one of the selling shareholders."
],
[
"2025-12-15",
"Waga Energy",
"EQT completed its controlling acquisition on September 18, 2025. On December 15 it announced the offer results: as of the close on December 12, directly held and deemed-held shares together represented 85.88% of the capital and 85.82% of the voting rights. The price was EUR 21.55 per share, plus a contingent payment of up to EUR 2.15 depending on the monetization of U.S. tax credits."
],
[
"2026-01-12",
"Vivasure Medical",
"EQT Life Sciences announced the exit of its stake in Vivasure Medical through Haemonetics’ acquisition; the entire acquisition involved an upfront payment of EUR 100 million plus contingent payments of up to EUR 85 million."
],
[
"2026-01-23",
"Mamezo",
"EQT, in partnership with ITOCHU, launched a tender offer for Japanese software engineering company Mamezo at JPY 3,551 per share, with an announced transaction size of about $371 million."
],
[
"2026-02-12",
"Urbaser",
"EQT Infrastructure VI and Blackstone’s infrastructure fund signed an agreement to acquire environmental services provider Urbaser from Platinum Equity, with each planning to hold 50%; the transaction remained subject to closing conditions."
],
[
"2026-02-26",
"Azelis",
"EQT VIII completed its exit by selling about 24 million shares. Total seller proceeds were about EUR 190 million, of which about EUR 173 million was attributable to EQT VIII."
]
],
"notes": null,
"headers": [
"Date",
"Company or Asset",
"Investment and Subsequent Transactions"
],
"version": 1
}Investment and Transaction History: 2026–2026 (15)
Investments and subsequent transactions involving EQT, its predecessors, and the funds it manages are as follows.[870][871][872][873][874][875][876][877][878][879][880][881][882][883][884]
{
"rows": [
[
"2026-03-02",
"AES",
"A consortium of GIP, EQT Infrastructure VI, CalPERS, and QIA signed an agreement to acquire AES at $15 per share. The equity value was about $10.7 billion and the enterprise value about $33.4 billion, with the announcement expecting closing in late 2026 or early 2027."
],
[
"2026-03-13",
"Galderma",
"EQT VIII completed its final sell-down; total seller proceeds for about 34 million shares were about CHF 4.9 billion, of which about CHF 1.3 billion was attributable to EQT VIII. EQT announced that since the 2019 investment, its funds and co-investors had received cumulative proceeds of about CHF 21 billion, or about $26 billion."
],
[
"2026-03-23",
"Fujitec",
"On July 30, 2025, EQT announced a plan for a take-private tender offer of about $2.7 billion, after which it would hold 85% and the founding family would retain 15%. Japan Exchange records show the company was delisted on March 23, 2026, following the tender offer and a share consolidation."
],
[
"2026-05-01",
"Arium Networks and Zayo",
"Crown Castle completed the sale of its fiber business segments: Arium Networks, backed by EQT Active Core, acquired the small cell business, and Zayo acquired the fiber network business, in two transactions of about $4.25 billion each, totaling $8.5 billion."
],
[
"2026-05-07",
"Americold",
"EQT and Americold signed an agreement to form a cold storage joint venture comprising 12 facilities with a total asset value of more than $1.3 billion. EQT planned to hold 70% and Americold to retain 30%; the announcement expected closing in the third quarter."
],
[
"2026-05-15",
"Enity",
"EQT VII completed the sale of its remaining 11,818,670 shares and exited Enity. Seller proceeds were about SEK 768 million, of which about SEK 605 million was attributable to EQT VII."
],
[
"2026-05-21",
"Tubulis",
"Gilead completed its acquisition of Tubulis on May 21, 2026; the agreement provided for a $3.15 billion upfront cash payment and up to $1.85 billion in milestone payments. The maximum of $5 billion is the cap on the total acquisition consideration."
],
[
"2026-06-18",
"Beijer Ref",
"EQT IX’s final sale of about 30.7 million B shares settled on June 18, 2026, completing its exit. Seller proceeds were about EUR 370 million, of which about EUR 275 million was attributable to EQT IX."
],
[
"2026-06-24",
"RQ Bio",
"EQT Life Sciences participated in RQ Bio’s $115 million Series A, led by Frazier Life Sciences, with funds used for antiviral antibody development."
],
[
"2026-07-06",
"Orikan",
"EQT Mid-Market Growth signed an agreement to acquire parking enforcement and compliance technology company Orikan; the transaction remained subject to closing conditions."
],
[
"2026-07-07",
"TachoSil",
"EQT X signed an agreement to acquire the TachoSil biosurgery business from Corza Medical, with the announcement expecting completion in the fourth quarter of 2026."
],
[
"2026-07-09",
"Copia Power",
"EQT Infrastructure VII signed an agreement to acquire power and AI infrastructure platform Copia Power from Carlyle, expected to close at the end of 2026. The 2.6 gigawatts listed in the announcement are operating or under-construction energy assets, and the 9 gigawatts are a data center development pipeline."
]
],
"notes": null,
"headers": [
"Date",
"Company or Asset",
"Investment and Subsequent Transactions"
],
"version": 1
}Investment and Transaction History: 2026–2026 (16)
Investments and subsequent transactions involving EQT, its predecessors, and the funds it manages are as follows.[885][886][887][888][889][890][891][892][893]
{
"rows": [
[
"2026-07-29",
"Quantios",
"EQT signed an agreement to sell trust and corporate services software provider Quantios to Vista Equity Partners, with the announcement expecting closing in the third quarter of 2026."
],
[
"2026-07-30",
"European logistics properties",
"EQT signed an agreement to acquire 14 logistics assets from Logicor for EUR 532 million; at the time of the announcement, the eight in the United Kingdom had been completed, while four in Germany and two in France were still pending closing."
],
[
"2026-08-05",
"ICEYE",
"The Scaleup Europe Fund managed by EQT co-led ICEYE’s EUR 1 billion Series F transaction, including EUR 450 million of new equity financing, at a valuation of more than EUR 10 billion. The company’s announcement stated that the transaction remained subject to regulatory approval and closing conditions."
],
[
"2026-08-11",
"Vaderis Therapeutics",
"EQT Life Sciences participated in Vaderis’s $152 million Series B, with EQT investing $17.5 million; Goldman Sachs Life Sciences and TCGX co-led the round."
],
[
"2026-08-13",
"Kakaku.com",
"The EQT consortium raised its tender offer price for Kakaku.com from JPY 3,450 to JPY 3,570 per share and extended the offer deadline to August 27."
],
[
"2026-08-17",
"U.S. Midwest logistics properties",
"EQT completed the sale of 20 properties across six Midwestern markets, totaling about 4.4 million square feet."
],
[
"2026-08-19",
"Melbourne Storm",
"EQT announced a transaction to acquire a majority interest in the Melbourne Storm rugby league club; until completion the club remains held by its existing owners, and the transaction requires approval from the Australian Rugby League Commission."
],
[
"2026-08-27",
"U.S. Southeast logistics properties",
"EQT completed the sale of 46 logistics buildings in the southeastern United States, totaling about 10.5 million square feet, to an affiliate of LBA Realty."
],
[
"2026-09-04",
"McGill and Partners",
"EQT signed an agreement to acquire a majority stake in insurance and reinsurance broker McGill and Partners from Warburg Pincus, with an announced amount of $2 billion; management will retain equity, and completion is expected in the first half of 2027."
]
],
"notes": null,
"headers": [
"Date",
"Company or Asset",
"Investment and Subsequent Transactions"
],
"version": 1
}Sources
- EQT — From Nordic to Global (opens in a new window)
- EQT与Exeter合并协议 (opens in a new window)
- EQT：2021年半年度报告 (opens in a new window)
- EQT完成收购LSP (opens in a new window)
- EQT combines with BPEA to capture growth opportunities in Asia (opens in a new window)
- Per Franzén获任EQT首席执行官 (opens in a new window)
- EQT：2026年半年度报告 (opens in a new window)
- EQT：完成与Coller Capital合并 (opens in a new window)
- EQT推出亚太常青策略 (opens in a new window)
- Announcing a $300M tender at a $22B valuation (opens in a new window)
- EQT：机构与投资策略 (opens in a new window)
- 1X：投资及业务介绍 (opens in a new window)
- 3Shape：投资及业务介绍 (opens in a new window)
- AcadeMedia：投资及业务介绍 (opens in a new window)
- Acerta Analytics：投资及业务介绍 (opens in a new window)
- Aceve：投资及业务介绍 (opens in a new window)
- ActoGeniX (Intrexon)：投资及业务介绍 (opens in a new window)
- Acumatica：投资及业务介绍 (opens in a new window)
- Acuon Capital：投资及业务介绍 (opens in a new window)
- Adamo：投资及业务介绍 (opens in a new window)
- ADR-Haanpää：投资及业务介绍 (opens in a new window)
- Adven：投资及业务介绍 (opens in a new window)
- Aelin Therapeutics：投资及业务介绍 (opens in a new window)
- Aerska：投资及业务介绍 (opens in a new window)
- Affimed：投资及业务介绍 (opens in a new window)
- Agomab Therapeutics：投资及业务介绍 (opens in a new window)
- AGS Health：投资及业务介绍 (opens in a new window)
- AIG Hospitals：投资及业务介绍 (opens in a new window)
- Airkit：投资及业务介绍 (opens in a new window)
- Aldevron：投资及业务介绍 (opens in a new window)
- Aleris：投资及业务介绍 (opens in a new window)
- Altus Intervention：投资及业务介绍 (opens in a new window)
- Am-Pharma：投资及业务介绍 (opens in a new window)
- Ambow Education：投资及业务介绍 (opens in a new window)
- AMCS：投资及业务介绍 (opens in a new window)
- Amolyt Pharma：投资及业务介绍 (opens in a new window)
- Anticimex：投资及业务介绍 (opens in a new window)
- AnyDesk：投资及业务介绍 (opens in a new window)
- Anyfin：投资及业务介绍 (opens in a new window)
- Anyfin：业务及沿革补充 (opens in a new window)
- APAC HR Tech：投资及业务介绍 (opens in a new window)
- Apleona：投资及业务介绍 (opens in a new window)
- Arcwood Environmental：投资及业务介绍 (opens in a new window)
- Ardoq：投资及业务介绍 (opens in a new window)
- Argenx：投资及业务介绍 (opens in a new window)
- Argil：投资及业务介绍 (opens in a new window)
- Argil：业务及沿革补充 (opens in a new window)
- Ariceum Therapeutics：投资及业务介绍 (opens in a new window)
- Arium Networks：投资及业务介绍 (opens in a new window)
- Arlanda Express：投资及业务介绍 (opens in a new window)
- Artios Pharma：投资及业务介绍 (opens in a new window)
- Arvelle Therapeutics：投资及业务介绍 (opens in a new window)
- Asceneuron：投资及业务介绍 (opens in a new window)
- AstronauTx：投资及业务介绍 (opens in a new window)
- Atain (formely IGT Solutions) ：投资及业务介绍 (opens in a new window)
- Atalanta Therapeutics：投资及业务介绍 (opens in a new window)
- ATB Therapeutics：投资及业务介绍 (opens in a new window)
- Atlantic Therapeutics：投资及业务介绍 (opens in a new window)
- Atos Medical：投资及业务介绍 (opens in a new window)
- Atricom and Le Büro：投资及业务介绍 (opens in a new window)
- Atricom and Le Büro：业务及沿革补充 (opens in a new window)
- Automic：投资及业务介绍 (opens in a new window)
- AutoStore：投资及业务介绍 (opens in a new window)
- Avenso：投资及业务介绍 (opens in a new window)
- Avetta：投资及业务介绍 (opens in a new window)
- AviadoBio：投资及业务介绍 (opens in a new window)
- Avidicure：投资及业务介绍 (opens in a new window)
- Azelis：投资及业务介绍 (opens in a new window)
- BackWerk：投资及业务介绍 (opens in a new window)
- Baffin Bay Networks：投资及业务介绍 (opens in a new window)
- Baller League：投资及业务介绍 (opens in a new window)
- Ballingslöv：投资及业务介绍 (opens in a new window)
- Banking Circle：投资及业务介绍 (opens in a new window)
- BBS Automation：投资及业务介绍 (opens in a new window)
- Beamery：投资及业务介绍 (opens in a new window)
- Beat81：投资及业务介绍 (opens in a new window)
- Beijer Ref：投资及业务介绍 (opens in a new window)
- Believe：投资及业务介绍 (opens in a new window)
- Benesse：投资及业务介绍 (opens in a new window)
- Beside：投资及业务介绍 (opens in a new window)
- Bespak：投资及业务介绍 (opens in a new window)
- Bewator：投资及业务介绍 (opens in a new window)
- BHS：投资及业务介绍 (opens in a new window)
- Billtrust：投资及业务介绍 (opens in a new window)
- Binx Health：投资及业务介绍 (opens in a new window)
- BioArctic：投资及业务介绍 (opens in a new window)
- Biographica：投资及业务介绍 (opens in a new window)
- Biolevate：投资及业务介绍 (opens in a new window)
- Biovian：投资及业务介绍 (opens in a new window)
- Blizoo：投资及业务介绍 (opens in a new window)
- BLOOM FRESH International：投资及业务介绍 (opens in a new window)
- Bluebook：投资及业务介绍 (opens in a new window)
- Bluebook：业务及沿革补充 (opens in a new window)
- BluumBio：投资及业务介绍 (opens in a new window)
- BMEye：投资及业务介绍 (opens in a new window)
- Bodilsen：投资及业务介绍 (opens in a new window)
- Broadnet：投资及业务介绍 (opens in a new window)
- Brukens Thermotreat：投资及业务介绍 (opens in a new window)
- BSN medical：投资及业务介绍 (opens in a new window)
- BTX Group：投资及业务介绍 (opens in a new window)
- Buena：投资及业务介绍 (opens in a new window)
- Buena：业务及沿革补充 (opens in a new window)
- Bureau van Dijk：投资及业务介绍 (opens in a new window)
- Bushu Pharmaceuticals：投资及业务介绍 (opens in a new window)
- Calisen：投资及业务介绍 (opens in a new window)
- Calldesk：投资及业务介绍 (opens in a new window)
- Camion：投资及业务介绍 (opens in a new window)
- Candela：投资及业务介绍 (opens in a new window)
- Candyking：投资及业务介绍 (opens in a new window)
- Cardiac Dimensions：投资及业务介绍 (opens in a new window)
- Cardior：投资及业务介绍 (opens in a new window)
- CareNet：投资及业务介绍 (opens in a new window)
- CaridianBCT：投资及业务介绍 (opens in a new window)
- Carl Zeiss Vision：投资及业务介绍 (opens in a new window)
- Cast & Crew：投资及业务介绍 (opens in a new window)
- Cath Kidston：投资及业务介绍 (opens in a new window)
- CBR：投资及业务介绍 (opens in a new window)
- Celladon：投资及业务介绍 (opens in a new window)
- Cemvision：投资及业务介绍 (opens in a new window)
- Cerba Healthcare：投资及业务介绍 (opens in a new window)
- Certara：投资及业务介绍 (opens in a new window)
- CFB Group：投资及业务介绍 (opens in a new window)
- CFC：投资及业务介绍 (opens in a new window)
- Charleston：投资及业务介绍 (opens in a new window)
- Charly：投资及业务介绍 (opens in a new window)
- China Shine：投资及业务介绍 (opens in a new window)
- Cimbria：投资及业务介绍 (opens in a new window)
- Cinterion：投资及业务介绍 (opens in a new window)
- Cirba Solutions：投资及业务介绍 (opens in a new window)
- Citius Tech：投资及业务介绍 (opens in a new window)
- Clarifeye：投资及业务介绍 (opens in a new window)
- Clarivate Analytics：投资及业务介绍 (opens in a new window)
- Classic Fine Foods：投资及业务介绍 (opens in a new window)
- Cleo：投资及业务介绍 (opens in a new window)
- ClexBio：投资及业务介绍 (opens in a new window)
- Clinical Innovations：投资及业务介绍 (opens in a new window)
- Clinical Innovations：业务及沿革补充 (opens in a new window)
- CluePoints：投资及业务介绍 (opens in a new window)
- CMS Info Systems：投资及业务介绍 (opens in a new window)
- Coches.net：投资及业务介绍 (opens in a new window)
- Codacy：投资及业务介绍 (opens in a new window)
- Codemao：投资及业务介绍 (opens in a new window)
- Coforge：投资及业务介绍 (opens in a new window)
- Colisee：投资及业务介绍 (opens in a new window)
- Com Hem：投资及业务介绍 (opens in a new window)
- Compass Education：投资及业务介绍 (opens in a new window)
- Concert Bio：投资及业务介绍 (opens in a new window)
- Constellation Cold Logistics：投资及业务介绍 (opens in a new window)
- Contanda：投资及业务介绍 (opens in a new window)
- Contex Holding：投资及业务介绍 (opens in a new window)
- Contex Holding：业务及沿革补充 (opens in a new window)
- Coromatic：投资及业务介绍 (opens in a new window)
- Credila Financial Services：投资及业务介绍 (opens in a new window)
- Cue：投资及业务介绍 (opens in a new window)
- Cue：业务及沿革补充 (opens in a new window)
- Curaeos：投资及业务介绍 (opens in a new window)
- Curetis：投资及业务介绍 (opens in a new window)
- Curetis：业务及沿革补充 (opens in a new window)
- CYE：投资及业务介绍 (opens in a new window)
- Cypress Creek Energy：投资及业务介绍 (opens in a new window)
- Cyted Health：投资及业务介绍 (opens in a new window)
- Cytora：投资及业务介绍 (opens in a new window)
- Dahl International：投资及业务介绍 (opens in a new window)
- DAKO：投资及业务介绍 (opens in a new window)
- Data Intensity：投资及业务介绍 (opens in a new window)
- DataFlow：投资及业务介绍 (opens in a new window)
- Dechra Pharmaceuticals：投资及业务介绍 (opens in a new window)
- Dellner Couplers：投资及业务介绍 (opens in a new window)
- DELTA Fiber：投资及业务介绍 (opens in a new window)
- Depict.AI：投资及业务介绍 (opens in a new window)
- Depict | AI merchandising for e-commerce brands (opens in a new window)
- Desotec：投资及业务介绍 (opens in a new window)
- Deutsche Glasfaser：投资及业务介绍 (opens in a new window)
- Direct ChassisLink：投资及业务介绍 (opens in a new window)
- DNA Script：投资及业务介绍 (opens in a new window)
- Dometic：投资及业务介绍 (opens in a new window)
- Dorner：投资及业务介绍 (opens in a new window)
- DOTS Technology：投资及业务介绍 (opens in a new window)
- DOTS Technology：业务及沿革补充 (opens in a new window)
- dottxt：投资及业务介绍 (opens in a new window)
- Ducky：投资及业务介绍 (opens in a new window)
- Duni：投资及业务介绍 (opens in a new window)
- Dunlop：投资及业务介绍 (opens in a new window)
- Dwelly：投资及业务介绍 (opens in a new window)
- E.I.S. Aircraft：投资及业务介绍 (opens in a new window)
- Eagle Railcar Services：投资及业务介绍 (opens in a new window)
- EC-Council：投资及业务介绍 (opens in a new window)
- Econ Healthcare：投资及业务介绍 (opens in a new window)
- ecoplanet：投资及业务介绍 (opens in a new window)
- EdgeConneX：投资及业务介绍 (opens in a new window)
- Educo Platform：投资及业务介绍 (opens in a new window)
- EEW Energy from Waste：投资及业务介绍 (opens in a new window)
- Egle Therapeutics：投资及业务介绍 (opens in a new window)
- Einride：投资及业务介绍 (opens in a new window)
- Eldon Holding：投资及业务介绍 (opens in a new window)
- Electra Therapeutics：投资及业务介绍 (opens in a new window)
- ELEVATE：投资及业务介绍 (opens in a new window)
- Ellab：投资及业务介绍 (opens in a new window)
- Eloxx Pharma：投资及业务介绍 (opens in a new window)
- Encyclis：投资及业务介绍 (opens in a new window)
- Endgame：投资及业务介绍 (opens in a new window)
- Endgame：业务及沿革补充 (opens in a new window)
- Endotronix：投资及业务介绍 (opens in a new window)
- Enity Group：投资及业务介绍 (opens in a new window)
- Envirotainer：投资及业务介绍 (opens in a new window)
- Epidemic Sound：投资及业务介绍 (opens in a new window)
- eTheRNA：投资及业务介绍 (opens in a new window)
- Eton：投资及业务介绍 (opens in a new window)
- Euclid Vision：投资及业务介绍 (opens in a new window)
- Europa Biosite：投资及业务介绍 (opens in a new window)
- Evidia：投资及业务介绍 (opens in a new window)
- Evommune：投资及业务介绍 (opens in a new window)
- evroc：投资及业务介绍 (opens in a new window)
- EX-Fusion：投资及业务介绍 (opens in a new window)
- Exciva：投资及业务介绍 (opens in a new window)
- Eyesense：投资及业务介绍 (opens in a new window)
- Facile：投资及业务介绍 (opens in a new window)
- Fenix Marine Services：投资及业务介绍 (opens in a new window)
- Fertifa：投资及业务介绍 (opens in a new window)
- Fertin Pharma：投资及业务介绍 (opens in a new window)
- Fiberklaar：投资及业务介绍 (opens in a new window)
- Filament：投资及业务介绍 (opens in a new window)
- Findus：投资及业务介绍 (opens in a new window)
- Finn-Power：投资及业务介绍 (opens in a new window)
- First Student：投资及业务介绍 (opens in a new window)
- First Transit：投资及业务介绍 (opens in a new window)
- FlexLink：投资及业务介绍 (opens in a new window)
- Flix：投资及业务介绍 (opens in a new window)
- Flow Engineering：投资及业务介绍 (opens in a new window)
- Flowcardia：投资及业务介绍 (opens in a new window)
- Fly.io：投资及业务介绍 (opens in a new window)
- Flying Tiger：投资及业务介绍 (opens in a new window)
- Formo：投资及业务介绍 (opens in a new window)
- Forsta：投资及业务介绍 (opens in a new window)
- Fortnox：投资及业务介绍 (opens in a new window)
- FoRx Therapeutics：投资及业务介绍 (opens in a new window)
- Frontify：投资及业务介绍 (opens in a new window)
- Fujitec：投资及业务介绍 (opens in a new window)
- Fundamental VR：投资及业务介绍 (opens in a new window)
- Færch Plast：投资及业务介绍 (opens in a new window)
- Gala TV：投资及业务介绍 (opens in a new window)
- Galderma：投资及业务介绍 (opens in a new window)
- Gambro：投资及业务介绍 (opens in a new window)
- GeBBS Healthcare Solutions：投资及业务介绍 (opens in a new window)
- Generative Engineering：投资及业务介绍 (opens in a new window)
- GETEC：投资及业务介绍 (opens in a new window)
- Giant Interactive：投资及业务介绍 (opens in a new window)
- Ginko：投资及业务介绍 (opens in a new window)
- Global Indian Schools：投资及业务介绍 (opens in a new window)
- GlobalConnect：投资及业务介绍 (opens in a new window)
- GotPhoto：投资及业务介绍 (opens in a new window)
- GPA Global：投资及业务介绍 (opens in a new window)
- Granngården：投资及业务介绍 (opens in a new window)
- Griffin：投资及业务介绍 (opens in a new window)
- Guardian Shanghai Hygiene Service Ltd.：投资及业务介绍 (opens in a new window)
- HackerOne：投资及业务介绍 (opens in a new window)
- Handshake：投资及业务介绍 (opens in a new window)
- Harvey：投资及业务介绍 (opens in a new window)
- HCP Global：投资及业务介绍 (opens in a new window)
- Headspin：投资及业务介绍 (opens in a new window)
- Headspin：业务及沿革补充 (opens in a new window)
- Heart Aerospace：投资及业务介绍 (opens in a new window)
- Hector Rail：投资及业务介绍 (opens in a new window)
- HemoCue：投资及业务介绍 (opens in a new window)
- Hexaware：投资及业务介绍 (opens in a new window)
- HMI Group：投资及业务介绍 (opens in a new window)
- Holidu：投资及业务介绍 (opens in a new window)
- Horizon Robotics：投资及业务介绍 (opens in a new window)
- HotSpot Therapeutics：投资及业务介绍 (opens in a new window)
- HRBrain：投资及业务介绍 (opens in a new window)
- HTL-Strefa：投资及业务介绍 (opens in a new window)
- Hubs：投资及业务介绍 (opens in a new window)
- Hume.AI：投资及业务介绍 (opens in a new window)
- HusCompagniet：投资及业务介绍 (opens in a new window)
- Hutchmed：投资及业务介绍 (opens in a new window)
- HyTest：投资及业务介绍 (opens in a new window)
- I-MED：投资及业务介绍 (opens in a new window)
- Icon Group：投资及业务介绍 (opens in a new window)
- IDEA：投资及业务介绍 (opens in a new window)
- Idealista：投资及业务介绍 (opens in a new window)
- IFS：投资及业务介绍 (opens in a new window)
- Igenomix：投资及业务介绍 (opens in a new window)
- ILA Vietnam：投资及业务介绍 (opens in a new window)
- Illuminoss：投资及业务介绍 (opens in a new window)
- ImCheck：投资及业务介绍 (opens in a new window)
- Imcyse：投资及业务介绍 (opens in a new window)
- IMG Academy：投资及业务介绍 (opens in a new window)
- Immunic：投资及业务介绍 (opens in a new window)
- Impro Precision：投资及业务介绍 (opens in a new window)
- In.Corp Global：投资及业务介绍 (opens in a new window)
- Indesso：投资及业务介绍 (opens in a new window)
- Indira IVF：投资及业务介绍 (opens in a new window)
- Indium：投资及业务介绍 (opens in a new window)
- Ineffable Intelligence：投资及业务介绍 (opens in a new window)
- Infinit：投资及业务介绍 (opens in a new window)
- InfoJobs：投资及业务介绍 (opens in a new window)
- Innovative Molecules：投资及业务介绍 (opens in a new window)
- Innovyze：投资及业务介绍 (opens in a new window)
- Insempra：投资及业务介绍 (opens in a new window)
- Insempra：业务及沿革补充 (opens in a new window)
- Instabee：投资及业务介绍 (opens in a new window)
- InstaVolt：投资及业务介绍 (opens in a new window)
- IntegrityNext：投资及业务介绍 (opens in a new window)
- International Health Insurance：投资及业务介绍 (opens in a new window)
- internetstores：投资及业务介绍 (opens in a new window)
- IP-Only：投资及业务介绍 (opens in a new window)
- IslaLink：投资及业务介绍 (opens in a new window)
- ISS：投资及业务介绍 (opens in a new window)
- iStar Medical：投资及业务介绍 (opens in a new window)
- itslearning：投资及业务介绍 (opens in a new window)
- IVC Evidensia：投资及业务介绍 (opens in a new window)
- Iver：投资及业务介绍 (opens in a new window)
- Jakarta Eye Center：投资及业务介绍 (opens in a new window)
- Japan Home Centre：投资及业务介绍 (opens in a new window)
- JD Health：投资及业务介绍 (opens in a new window)
- Jerini：投资及业务介绍 (opens in a new window)
- Ju:niz Energy：投资及业务介绍 (opens in a new window)
- Juni：投资及业务介绍 (opens in a new window)
- Kabel Baden-Württemberg：投资及业务介绍 (opens in a new window)
- Kaiber：投资及业务介绍 (opens in a new window)
- Kangda Holdings：投资及业务介绍 (opens in a new window)
- Kangda Holdings：业务及沿革补充 (opens in a new window)
- Karo Healthcare：投资及业务介绍 (opens in a new window)
- Keywords Studios：投资及业务介绍 (opens in a new window)
- kfzteile24：投资及业务介绍 (opens in a new window)
- Kinaset：投资及业务介绍 (opens in a new window)
- Kive：投资及业务介绍 (opens in a new window)
- KMD：投资及业务介绍 (opens in a new window)
- Knoetic：投资及业务介绍 (opens in a new window)
- Knoetic：业务及沿革补充 (opens in a new window)
- Kodiak Gas Services：投资及业务介绍 (opens in a new window)
- Koole Terminals：投资及业务介绍 (opens in a new window)
- Kota：投资及业务介绍 (opens in a new window)
- Kuros：投资及业务介绍 (opens in a new window)
- Kyobo Life Insurance：投资及业务介绍 (opens in a new window)
- Kühnle, Kopp & Kausch：投资及业务介绍 (opens in a new window)
- Lafarge：投资及业务介绍 (opens in a new window)
- Lafarge：业务及沿革补充 (opens in a new window)
- Lazer Logistics：投资及业务介绍 (opens in a new window)
- LBX Pharmacy：投资及业务介绍 (opens in a new window)
- Lenus：投资及业务介绍 (opens in a new window)
- Let's Do This：投资及业务介绍 (opens in a new window)
- Levande：投资及业务介绍 (opens in a new window)
- Leybold Optics：投资及业务介绍 (opens in a new window)
- LimaCorporate：投资及业务介绍 (opens in a new window)
- Linearity：投资及业务介绍 (opens in a new window)
- Living Carbon：投资及业务介绍 (opens in a new window)
- Logen：投资及业务介绍 (opens in a new window)
- Long-spring Education Group：投资及业务介绍 (opens in a new window)
- Lovable：投资及业务介绍 (opens in a new window)
- Luma Vision：投资及业务介绍 (opens in a new window)
- Luma Vision：业务及沿革补充 (opens in a new window)
- Lumenis：投资及业务介绍 (opens in a new window)
- Lumeon：投资及业务介绍 (opens in a new window)
- Lumos Fiber：投资及业务介绍 (opens in a new window)
- Lundhags：投资及业务介绍 (opens in a new window)
- Luxendo：投资及业务介绍 (opens in a new window)
- Mabtech：投资及业务介绍 (opens in a new window)
- Made of Air：投资及业务介绍 (opens in a new window)
- Madison Energy Infrastructure：投资及业务介绍 (opens in a new window)
- Magic Holdings：投资及业务介绍 (opens in a new window)
- Magnific (formerly Freepik)：投资及业务介绍 (opens in a new window)
- Magnit：投资及业务介绍 (opens in a new window)
- Magrathea：投资及业务介绍 (opens in a new window)
- Mambu：投资及业务介绍 (opens in a new window)
- Mamezo：投资及业务介绍 (opens in a new window)
- ManyPets：投资及业务介绍 (opens in a new window)
- Marvel Fusion：投资及业务介绍 (opens in a new window)
- MarvelX：投资及业务介绍 (opens in a new window)
- McNair：投资及业务介绍 (opens in a new window)
- Medeye：投资及业务介绍 (opens in a new window)
- Medifox：投资及业务介绍 (opens in a new window)
- Melita：投资及业务介绍 (opens in a new window)
- Mendor：投资及业务介绍 (opens in a new window)
- Meridian：投资及业务介绍 (opens in a new window)
- Merus：投资及业务介绍 (opens in a new window)
- Metalcaucho：投资及业务介绍 (opens in a new window)
- Metall Technologie Holding：投资及业务介绍 (opens in a new window)
- Metlifecare：投资及业务介绍 (opens in a new window)
- Mews：投资及业务介绍 (opens in a new window)
- MHC Asia：投资及业务介绍 (opens in a new window)
- Midland Cogeneration Venture：投资及业务介绍 (opens in a new window)
- Milvus Advanced：投资及业务介绍 (opens in a new window)
- Min Doktor：投资及业务介绍 (opens in a new window)
- MinervaX：投资及业务介绍 (opens in a new window)
- Modern Metal：投资及业务介绍 (opens in a new window)
- Molecular Attraction：投资及业务介绍 (opens in a new window)
- Mollie：投资及业务介绍 (opens in a new window)
- Mongstad Group：投资及业务介绍 (opens in a new window)
- Moonscale：投资及业务介绍 (opens in a new window)
- Moralis：投资及业务介绍 (opens in a new window)
- Mosanna Therapeutics：投资及业务介绍 (opens in a new window)
- Movetis：投资及业务介绍 (opens in a new window)
- Muna Therapeutics：投资及业务介绍 (opens in a new window)
- Munksjö：投资及业务介绍 (opens in a new window)
- Musti Group：投资及业务介绍 (opens in a new window)
- MyCartis (Pronota)：投资及业务介绍 (opens in a new window)
- Natural Cycles：投资及业务介绍 (opens in a new window)
- Nederman：投资及业务介绍 (opens in a new window)
- Net Japan：投资及业务介绍 (opens in a new window)
- Netlify：投资及业务介绍 (opens in a new window)
- Neuravi：投资及业务介绍 (opens in a new window)
- Neurent Medical：投资及业务介绍 (opens in a new window)
- Neuros Medical：投资及业务介绍 (opens in a new window)
- NewAmsterdam Pharma：投资及业务介绍 (opens in a new window)
- Nexon Asia Pacific：投资及业务介绍 (opens in a new window)
- Nexstim：投资及业务介绍 (opens in a new window)
- NitroVolt：投资及业务介绍 (opens in a new window)
- Niwas Housing Finance：投资及业务介绍 (opens in a new window)
- Nkarta：投资及业务介绍 (opens in a new window)
- Nobi：投资及业务介绍 (opens in a new window)
- Nobi：业务及沿革补充 (opens in a new window)
- Noema Pharma：投资及业务介绍 (opens in a new window)
- NORD：投资及业务介绍 (opens in a new window)
- Nord Anglia Education：投资及业务介绍 (opens in a new window)
- Nordic Aviation Capital：投资及业务介绍 (opens in a new window)
- Nordic Ferry Infrastructure：投资及业务介绍 (opens in a new window)
- Nordic Info Group：投资及业务介绍 (opens in a new window)
- Nothing：投资及业务介绍 (opens in a new window)
- Nothing：业务及沿革补充 (opens in a new window)
- Nouscom：投资及业务介绍 (opens in a new window)
- Noya：投资及业务介绍 (opens in a new window)
- Nua Surgical：投资及业务介绍 (opens in a new window)
- O2 Power：投资及业务介绍 (opens in a new window)
- Ocea Group：投资及业务介绍 (opens in a new window)
- OctoPlus：投资及业务介绍 (opens in a new window)
- Oculis：投资及业务介绍 (opens in a new window)
- Oden Technologies：投资及业务介绍 (opens in a new window)
- Odyssey：投资及业务介绍 (opens in a new window)
- OEM International：投资及业务介绍 (opens in a new window)
- Okairos：投资及业务介绍 (opens in a new window)
- Onera Health：投资及业务介绍 (opens in a new window)
- Onramper：投资及业务介绍 (opens in a new window)
- Ontinue：投资及业务介绍 (opens in a new window)
- ONWARD：投资及业务介绍 (opens in a new window)
- Open Systems：投资及业务介绍 (opens in a new window)
- Orphazyme：投资及业务介绍 (opens in a new window)
- Orrefors Kosta Boda：投资及业务介绍 (opens in a new window)
- Osmose Utilities Services：投资及业务介绍 (opens in a new window)
- Oterra：投资及业务介绍 (opens in a new window)
- Ottobock Healthcare：投资及业务介绍 (opens in a new window)
- Overview Energy：投资及业务介绍 (opens in a new window)
- Owwn：投资及业务介绍 (opens in a new window)
- OX2：投资及业务介绍 (opens in a new window)
- OxThera：投资及业务介绍 (opens in a new window)
- Packmatic：投资及业务介绍 (opens in a new window)
- PageUp：投资及业务介绍 (opens in a new window)
- Paid：投资及业务介绍 (opens in a new window)
- PaloDEx：投资及业务介绍 (opens in a new window)
- Pantera：投资及业务介绍 (opens in a new window)
- Parcel2Go：投资及业务介绍 (opens in a new window)
- Parexel：投资及业务介绍 (opens in a new window)
- Parkia：投资及业务介绍 (opens in a new window)
- Parloa：投资及业务介绍 (opens in a new window)
- Parques Reunidos：投资及业务介绍 (opens in a new window)
- Patch：投资及业务介绍 (opens in a new window)
- Payrails：投资及业务介绍 (opens in a new window)
- Peakon：投资及业务介绍 (opens in a new window)
- Peanut：投资及业务介绍 (opens in a new window)
- Pelago：投资及业务介绍 (opens in a new window)
- Peltarion：投资及业务介绍 (opens in a new window)
- Peregrine Midstream Partners：投资及业务介绍 (opens in a new window)
- Perficient：投资及业务介绍 (opens in a new window)
- Perfuze：投资及业务介绍 (opens in a new window)
- Perk：投资及业务介绍 (opens in a new window)
- Perlos：投资及业务介绍 (opens in a new window)
- Permutive：投资及业务介绍 (opens in a new window)
- Pfaff-silberblau：投资及业务介绍 (opens in a new window)
- Phagenesis：投资及业务介绍 (opens in a new window)
- PharmaZell：投资及业务介绍 (opens in a new window)
- Pharvaris：投资及业务介绍 (opens in a new window)
- Piab：投资及业务介绍 (opens in a new window)
- Pioneer：投资及业务介绍 (opens in a new window)
- Plantasjen：投资及业务介绍 (opens in a new window)
- Playsome：投资及业务介绍 (opens in a new window)
- Popcore：投资及业务介绍 (opens in a new window)
- Press Ganey：投资及业务介绍 (opens in a new window)
- Prometric：投资及业务介绍 (opens in a new window)
- PropertyGuru：投资及业务介绍 (opens in a new window)
- PropertyMe：投资及业务介绍 (opens in a new window)
- PropertyMe：业务及沿革补充 (opens in a new window)
- Prosensa：投资及业务介绍 (opens in a new window)
- Pruna AI：投资及业务介绍 (opens in a new window)
- PSM International：投资及业务介绍 (opens in a new window)
- Qarbotech：投资及业务介绍 (opens in a new window)
- Qevlar AI：投资及业务介绍 (opens in a new window)
- Qinyuan Bakery：投资及业务介绍 (opens in a new window)
- Quantios：投资及业务介绍 (opens in a new window)
- QurAlis：投资及业务介绍 (opens in a new window)
- Radius Global Infrastructure：投资及业务介绍 (opens in a new window)
- Rainier Therapeutics：投资及业务介绍 (opens in a new window)
- RBL Bank：投资及业务介绍 (opens in a new window)
- Recipharm：投资及业务介绍 (opens in a new window)
- Recover Nordic：投资及业务介绍 (opens in a new window)
- ReliaQuest：投资及业务介绍 (opens in a new window)
- Remember：投资及业务介绍 (opens in a new window)
- Rena：投资及业务介绍 (opens in a new window)
- Reworks：投资及业务介绍 (opens in a new window)
- Reworld：投资及业务介绍 (opens in a new window)
- Rich Healthcare：投资及业务介绍 (opens in a new window)
- RIMES Technologies：投资及业务介绍 (opens in a new window)
- Risk Methods：投资及业务介绍 (opens in a new window)
- Roeser：投资及业务介绍 (opens in a new window)
- Rotation Medical：投资及业务介绍 (opens in a new window)
- RTI：投资及业务介绍 (opens in a new window)
- Sabroe Refrigeration：投资及业务介绍 (opens in a new window)
- SAG：投资及业务介绍 (opens in a new window)
- Sagility：投资及业务介绍 (opens in a new window)
- SAI360：投资及业务介绍 (opens in a new window)
- Salcomp：投资及业务介绍 (opens in a new window)
- Sana Labs：投资及业务介绍 (opens in a new window)
- Sanitec：投资及业务介绍 (opens in a new window)
- Sapiens：投资及业务介绍 (opens in a new window)
- SAUR：投资及业务介绍 (opens in a new window)
- Sausalitos：投资及业务介绍 (opens in a new window)
- Scale Microgrids：投资及业务介绍 (opens in a new window)
- Scandic：投资及业务介绍 (opens in a new window)
- Schülke：投资及业务介绍 (opens in a new window)
- Securitas Direct：投资及业务介绍 (opens in a new window)
- Securonix：投资及业务介绍 (opens in a new window)
- Securonix：业务及沿革补充 (opens in a new window)
- Seeqc：投资及业务介绍 (opens in a new window)
- Segra：投资及业务介绍 (opens in a new window)
- Sequana Medical：投资及业务介绍 (opens in a new window)
- Service Partner One：投资及业务介绍 (opens in a new window)
- Seven Seas Water Group：投资及业务介绍 (opens in a new window)
- SFC KOENIG AG：投资及业务介绍 (opens in a new window)
- SGU：投资及业务介绍 (opens in a new window)
- SGU：业务及沿革补充 (opens in a new window)
- Shengmu Organic Milk：投资及业务介绍 (opens in a new window)
- Shinhan：投资及业务介绍 (opens in a new window)
- Shinobi Therapeutics：投资及业务介绍 (opens in a new window)
- SHL Medical：投资及业务介绍 (opens in a new window)
- Sifflet：投资及业务介绍 (opens in a new window)
- Silexica：投资及业务介绍 (opens in a new window)
- Simplify Medical：投资及业务介绍 (opens in a new window)
- Sirona：投资及业务介绍 (opens in a new window)
- Sitecore：投资及业务介绍 (opens in a new window)
- SK Shieldus：投资及业务介绍 (opens in a new window)
- Skykon：投资及业务介绍 (opens in a new window)
- Skyline Diagnostics：投资及业务介绍 (opens in a new window)
- Small Giant Games：投资及业务介绍 (opens in a new window)
- SNIPR Biome：投资及业务介绍 (opens in a new window)
- Solera：BPEA Fund V investment (opens in a new window)
- Sonantic：投资及业务介绍 (opens in a new window)
- South Indian Bank：投资及业务介绍 (opens in a new window)
- SpliceBio：投资及业务介绍 (opens in a new window)
- Sportfive：投资及业务介绍 (opens in a new window)
- Sportradar：投资及业务介绍 (opens in a new window)
- Springer SBM：投资及业务介绍 (opens in a new window)
- SPT Labtech：投资及业务介绍 (opens in a new window)
- SSP：投资及业务介绍 (opens in a new window)
- Stacks：投资及业务介绍 (opens in a new window)
- Standard AI：投资及业务介绍 (opens in a new window)
- Standard AI：业务及沿革补充 (opens in a new window)
- Starcloud：投资及业务介绍 (opens in a new window)
- Statera：投资及业务介绍 (opens in a new window)
- Stenqvist：投资及业务介绍 (opens in a new window)
- StjärnTVnätet：投资及业务介绍 (opens in a new window)
- Storable：投资及业务介绍 (opens in a new window)
- StormGeo：投资及业务介绍 (opens in a new window)
- Straive：投资及业务介绍 (opens in a new window)
- Strauss Innovation：投资及业务介绍 (opens in a new window)
- Strawberry：投资及业务介绍 (opens in a new window)
- Struers：投资及业务介绍 (opens in a new window)
- Superlist：投资及业务介绍 (opens in a new window)
- SuperNormal：投资及业务介绍 (opens in a new window)
- SuperNormal：业务及沿革补充 (opens in a new window)
- Supernova：投资及业务介绍 (opens in a new window)
- Supplant：投资及业务介绍 (opens in a new window)
- SUSE：投资及业务介绍 (opens in a new window)
- Swedegas：投资及业务介绍 (opens in a new window)
- swiss smile：投资及业务介绍 (opens in a new window)
- Symrise：投资及业务介绍 (opens in a new window)
- Symrise：业务及沿革补充 (opens in a new window)
- Synagro：投资及业务介绍 (opens in a new window)
- Syngular Technology：投资及业务介绍 (opens in a new window)
- Syntaxin：投资及业务介绍 (opens in a new window)
- Syntetica：投资及业务介绍 (opens in a new window)
- T-Knife：投资及业务介绍 (opens in a new window)
- TAC：投资及业务介绍 (opens in a new window)
- Talentium：投资及业务介绍 (opens in a new window)
- Tampnet：投资及业务介绍 (opens in a new window)
- TBS Energi (fka Toba Bara)：投资及业务介绍 (opens in a new window)
- Telus International：投资及业务介绍 (opens in a new window)
- Tenpoint Therapeutics：投资及业务介绍 (opens in a new window)
- Terveystalo：投资及业务介绍 (opens in a new window)
- The CrownX：投资及业务介绍 (opens in a new window)
- The Exploration Company：投资及业务介绍 (opens in a new window)
- thinkproject：投资及业务介绍 (opens in a new window)
- Thule：投资及业务介绍 (opens in a new window)
- TIA Technology：投资及业务介绍 (opens in a new window)
- Tigenix (Cellerix)：投资及业务介绍 (opens in a new window)
- Timeless：投资及业务介绍 (opens in a new window)
- Tinyclues：投资及业务介绍 (opens in a new window)
- Tion Renewables：投资及业务介绍 (opens in a new window)
- TitanX：投资及业务介绍 (opens in a new window)
- Tognum Group：投资及业务介绍 (opens in a new window)
- Token：投资及业务介绍 (opens in a new window)
- TOP-TOY：投资及业务介绍 (opens in a new window)
- TOP-TOY：业务及沿革补充 (opens in a new window)
- Touhula：投资及业务介绍 (opens in a new window)
- Tradex：投资及业务介绍 (opens in a new window)
- TransIP：投资及业务介绍 (opens in a new window)
- Traplight：投资及业务介绍 (opens in a new window)
- Trescal：投资及业务介绍 (opens in a new window)
- Trinity Biosystems：投资及业务介绍 (opens in a new window)
- TRYT：投资及业务介绍 (opens in a new window)
- Tubulis：投资及业务介绍 (opens in a new window)
- U3 Pharma：投资及业务介绍 (opens in a new window)
- UDG United Digital Group：投资及业务介绍 (opens in a new window)
- Unilode Aviation Solutions：投资及业务介绍 (opens in a new window)
- United Talent Agency：投资及业务介绍 (opens in a new window)
- Unmind：投资及业务介绍 (opens in a new window)
- Unomaly：投资及业务介绍 (opens in a new window)
- Utimaco：投资及业务介绍 (opens in a new window)
- Vaasan & Vaasan：投资及业务介绍 (opens in a new window)
- Vara：投资及业务介绍 (opens in a new window)
- Varjo：投资及业务介绍 (opens in a new window)
- VarmX：投资及业务介绍 (opens in a new window)
- VBill：投资及业务介绍 (opens in a new window)
- Vectary：投资及业务介绍 (opens in a new window)
- Vectary：业务及沿革补充 (opens in a new window)
- VectorY：投资及业务介绍 (opens in a new window)
- Vectura (Activaero)：投资及业务介绍 (opens in a new window)
- Ventaleon：投资及业务介绍 (opens in a new window)
- Veritas Petroleum Services (VPS)：投资及业务介绍 (opens in a new window)
- Verkor：投资及业务介绍 (opens in a new window)
- Vertu：投资及业务介绍 (opens in a new window)
- VetPartners：投资及业务介绍 (opens in a new window)
- Vev：投资及业务介绍 (opens in a new window)
- VFS Global：投资及业务介绍 (opens in a new window)
- ViCentra：投资及业务介绍 (opens in a new window)
- Vico Therapeutics：投资及业务介绍 (opens in a new window)
- Videm：投资及业务介绍 (opens in a new window)
- Vietnam-USA Society English Centers (“VUS”)：投资及业务介绍 (opens in a new window)
- Vinted：投资及业务介绍 (opens in a new window)
- ViridiCO2：投资及业务介绍 (opens in a new window)
- ViridiCO2：业务及沿革补充 (opens in a new window)
- Virtuos：投资及业务介绍 (opens in a new window)
- Virtusa：投资及业务介绍 (opens in a new window)
- Vistra：投资及业务介绍 (opens in a new window)
- Vivasure：投资及业务介绍 (opens in a new window)
- Vivendy Therapeutics：投资及业务介绍 (opens in a new window)
- Vivoryon Therapeutics：投资及业务介绍 (opens in a new window)
- Volt：投资及业务介绍 (opens in a new window)
- Voltera：投资及业务介绍 (opens in a new window)
- Vsim：投资及业务介绍 (opens in a new window)
- VTI Technologies：投资及业务介绍 (opens in a new window)
- WA3RM：投资及业务介绍 (opens in a new window)
- Waga Energy：投资及业务介绍 (opens in a new window)
- Wall Street English：投资及业务介绍 (opens in a new window)
- Wandelbots：投资及业务介绍 (opens in a new window)
- Warducks：投资及业务介绍 (opens in a new window)
- WASH：投资及业务介绍 (opens in a new window)
- Watty：投资及业务介绍 (opens in a new window)
- Waystar：投资及业务介绍 (opens in a new window)
- Wellhub：投资及业务介绍 (opens in a new window)
- Wildhero：投资及业务介绍 (opens in a new window)
- Wildhero：业务及沿革补充 (opens in a new window)
- Wolt：投资及业务介绍 (opens in a new window)
- WorkWave：投资及业务介绍 (opens in a new window)
- World Freight Company：投资及业务介绍 (opens in a new window)
- WS Audiology：投资及业务介绍 (opens in a new window)
- WSO2：投资及业务介绍 (opens in a new window)
- WTS Group：投资及业务介绍 (opens in a new window)
- Xeltis：投资及业务介绍 (opens in a new window)
- Xilis：投资及业务介绍 (opens in a new window)
- XXL Sport & Villmark：投资及业务介绍 (opens in a new window)
- XyloCor Therapeutics：投资及业务介绍 (opens in a new window)
- Yin Rong：投资及业务介绍 (opens in a new window)
- Ylookup：投资及业务介绍 (opens in a new window)
- Yongda Automobile Services：投资及业务介绍 (opens in a new window)
- Zayo Group：投资及业务介绍 (opens in a new window)
- Zealand Pharma：投资及业务介绍 (opens in a new window)
- Zealand Pharma：业务及沿革补充 (opens in a new window)
- Zelestra：投资及业务介绍 (opens in a new window)
- Zemax：投资及业务介绍 (opens in a new window)
- Zeus：投资及业务介绍 (opens in a new window)
- Zooplus：投资及业务介绍 (opens in a new window)
- Confirmation - Sale of FlexLink Systems (opens in a new window)
- Scandinavian Equity Partners acquires StjärnTV (opens in a new window)
- EQT Scandinavia to sell StjärnTV to UPC (opens in a new window)
- EQT Scandinavia II Fund Acquires Salcomp (opens in a new window)
- EQT sells its remaining shares in Salcomp (opens in a new window)
- EQT acquires Nederman from Candover (opens in a new window)
- EQT sells Struers to Roper Industries (opens in a new window)
- EQT acquires Leybold Optics GmbH from Unaxis (opens in a new window)
- EQT finalises sale of Nordic Info Group A/S to Experian (opens in a new window)
- EQT acquires Com Hem from TeliaSonera (opens in a new window)
- EQT sells Com Hem (opens in a new window)
- EQT acquires the dental market leader Sirona from the Permira Fund (opens in a new window)
- EQT’s new special situations fund – EQT Opportunity Fund – to acquire the Danish furniture manufacturer Bodilsen (opens in a new window)
- EQT and management offers to acquire Contex A/S on Copenhagen Stock Exchange (opens in a new window)
- Tognum IPO offer price set at EUR 24.00 (opens in a new window)
- EQT sells remaining shares in Tognum to Daimler (opens in a new window)
- EQT Expansion Capital II is financing the acquisition of Siemens Wireless Modules by an equity consortium led by GranvilleBaird (opens in a new window)
- EQT divests final stake in Duni (opens in a new window)
- EQT III sells Aleris (opens in a new window)
- EQT Expansion Capital II invests in Roeser Group (opens in a new window)
- EQT sells Dometic to funds advised by BC Partners (opens in a new window)
- EQT V submits offer to acquire Dometic Group (opens in a new window)
- Agreement signed to divest CaridianBCT (opens in a new window)
- EQT agrees to sell Kabel BW to Liberty Global Inc. (opens in a new window)
- EQT V sells Securitas Direct to Bain Capital and Hellman & Friedman (opens in a new window)
- EQT III sells VTI Technologies to Murata Manufacturing (opens in a new window)
- EQT Expansion Capital II invests in online bike and outdoor retailer internetstores AG (opens in a new window)
- EQT Expansion Capital sells its entire investment in internetstores (opens in a new window)
- EQT to acquire Dako (opens in a new window)
- EQT V agrees to sell Dako to Agilent Technologies (opens in a new window)
- EQT Infrastructure Funds to acquire offshore high capacity communication operator Tampnet (opens in a new window)
- EQT V and ATP to sell KMD to Advent International (opens in a new window)
- EQT and Investor to sell Gambro to Baxter (opens in a new window)
- EQT Expansion Capital II invests in itslearning AS (opens in a new window)
- EQT V and GIC agree to acquire Springer Science+Business Media from Candover and Cinven (opens in a new window)
- EQT V and GIC agree to sell Springer Science+Business Media to BC Partners (opens in a new window)
- EQT Infrastructure II acquires Synagro Technologies, the leading organic residuals management provider in the US (opens in a new window)
- Hexaware Announces Agreement for Baring Private Equity Asia to acquire a 41.8% stake in Hexaware from Promoter Entities, led by Atul Nishar, and General Atlantic (opens in a new window)
- Baring Asia to Acquire Bushu Pharmaceuticals from Tokyo Marine Capital (opens in a new window)
- EQT GREATER CHINA II SELLS CLASSIC FINE FOODS GROUP TO METRO GROUP (opens in a new window)
- Sale of remaining shares in XXL ASA (opens in a new window)
- EQT VII invests in TOP-TOY (opens in a new window)
- EQT Infrastructure II sells EEW Energy from Waste to Beijing Enterprises Holding (opens in a new window)
- EQT VII enters into partnership with founder group to acquire Sitecore, the global leading provider of customer experience management software (opens in a new window)
- Baring Private Equity Asia To Acquire 35 Per Cent Stake In TELUS International (opens in a new window)
- EQT Ventures invests in Unomaly (opens in a new window)
- EQT VI sells Automic to CA Technologies (opens in a new window)
- EQT VI to acquire BSN medical (opens in a new window)
- EQT VI to sell BSN medical to SCA (opens in a new window)
- EQT VI to sell Bureau van Dijk to Moody’s Corporation (opens in a new window)
- EQT VII acquires health technology company Certara for USD 850 million (opens in a new window)
- EQT Mid Market to sell food franchise concept BackWerk to Valora Group (opens in a new window)
- Sale of shares in AcadeMedia AB (publ) (opens in a new window)
- EQT to sell global industrial automation company Piab (opens in a new window)
- EQT to acquire leading open source software provider SUSE (opens in a new window)
- SUSE：交易公告 (opens in a new window)
- EQT to sell its stake in Sportradar to consortium of CPPIB and TCV (opens in a new window)
- First exit by EQT Ventures - sells stake in Small Giant Games at USD 700 million valuation (opens in a new window)
- EQT Expansion Capital to sell UDG to PIA (opens in a new window)
- EQT Mid Market sells IP-Only to EQT Infrastructure (opens in a new window)
- EQT to sell Press Ganey (opens in a new window)
- EQT VII to Acquire AutoStore (opens in a new window)
- EQT to sell AutoStore (opens in a new window)
- EQT, through Piolin BidCo, successfully completes voluntary tender offer for Parques Reunidos (opens in a new window)
- EQT sells remaining stake in LBX Pharmacy (opens in a new window)
- EQT sells itslearning to Sanoma (opens in a new window)
- EQT and OMERS acquire Deutsche Glasfaser, a leading provider of fiber-optic internet access in Germany (opens in a new window)
- Zayo：交易公告 (opens in a new window)
- EQT funds to acquire global enterprise software provider IFS and bring in TA Associates as minority partner (opens in a new window)
- EQT, Hg and TA-owned IFS valued at EUR 15 billion in minority stake sale, following investment from Hg, ADIA and CPP Investments (opens in a new window)
- Oterra：交易公告 (opens in a new window)
- Metlifecare：交易公告 (opens in a new window)
- HusCompagniet, the leading asset-light housebuilder in Denmark, prices IPO on Nasdaq Copenhagen (opens in a new window)
- Sale of 5,000,000 existing shares in HusCompagniet A/S (opens in a new window)
- Sale of 3,842,268 existing shares in HusCompagniet A/S (opens in a new window)
- EQT to sell Apleona, Europe’s leading facility management services provider, to PAI Partners (opens in a new window)
- EQT VII portfolio company Certara closes Initial Public Offering (opens in a new window)
- schülke sells its Personal Care Business and completes strategic repositioning to a pureplay healthcare company in infection prevention solutions (opens in a new window)
- IVC Evidensia：交易公告 (opens in a new window)
- EQT Private Equity invests in CYE, an Israel-based global cybersecurity leader (opens in a new window)
- CPP INVESTMENTS JOINS BPEA IN VIRTUSA TRANSACTION WITH $300 MILLION COMMITMENT (opens in a new window)
- Baring Private Equity Asia Completes Acquisition of Virtusa (opens in a new window)
- EQT Private Equity to sell Innovyze (opens in a new window)
- EQT Private Equity to sell Dorner to Columbus McKinnon for an Enterprise Value of USD 485m (opens in a new window)
- BARING PRIVATE EQUITY ASIA ANNOUNCES AGREEMENT TO SELL LUMENIS’ SURGICAL BUSINESS TO BOSTON SCIENTIFIC FOR USD1.07 BILLION (opens in a new window)
- EQT Private Equity broadens investor base in Epidemic Sound – brings in AMF, Alecta and TIN (opens in a new window)
- EQT Private Equity to sell StormGeo to Alfa Laval (opens in a new window)
- EQT Growth leads investment in Vinted, Europe’s largest online C2C platform dedicated to second-hand fashion (opens in a new window)
- BARING PRIVATE EQUITY ASIA AND ALIBABA ENTER PARTNERSHIP WITH THE CROWNX: LEADS USD400MM INVESTMENT (opens in a new window)
- EQT introduces longer-hold investment strategy – announces first investment in Anticimex (opens in a new window)
- EQT Growth invests in Mollie, one of the largest payment service providers in Europe (opens in a new window)
- EQT Private Equity to sell Fertin Pharma to Philip Morris International (opens in a new window)
- EQT Private Equity to sell Igenomix to Vitrolife for an enterprise value of EUR 1.25 billion (opens in a new window)
- EQT Infrastructure to acquire First Student and First Transit, the market leading providers of essential North American transportation services, for USD 4.6bn (opens in a new window)
- First Student 与 First Transit：交易公告 (opens in a new window)
- EQT Private Equity to sell Aldevron to Danaher Corporation for enterprise value of USD 9.6 billion (opens in a new window)
- Aldevron：交易公告 (opens in a new window)
- EQT Infrastructure to sell Fenix Marine Services to CMA CGM for an enterprise value of USD 2.3 billion (opens in a new window)
- EQT Private Equity and Goldman Sachs Asset Management to acquire Parexel, a leading global clinical research organization, for USD 8.5 billion (opens in a new window)
- Parexel：交易公告 (opens in a new window)
- EQT Infrastructure to acquire Icon Group, Australia’s largest integrated cancer care provider (opens in a new window)
- EQT Infrastructure successfully completes the voluntary tender offer for Solarpack (opens in a new window)
- Covanta and EQT Infrastructure to create the leading sustainable waste solutions provider, driving compelling value for all stakeholders (opens in a new window)
- EQT Broadens Reworld™ Investor Base, Welcoming GIC as Strategic Investor (opens in a new window)
- Hellman & Friedman partners with EQT Private Equity for an improved voluntary tender offer by Zorro Bidco for zooplus AG at increased and final offer price of EUR 480 per share (opens in a new window)
- Zorro Bidco holds a total of 97 percent in zooplus after completion of the public delisting tender offer – zooplus shares delisted from Frankfurt Stock Exchange among others (opens in a new window)
- Nordic Aviation Capital：交易公告 (opens in a new window)
- EQT Private Equity and Mubadala to acquire Envirotainer, the leading global provider of mission-critical biopharma transport services (opens in a new window)
- EQT Life Sciences announces launch and series A Financing Round of portfolio company Ariceum Therapeutics (opens in a new window)
- EQT Private Equity to acquire SPT Labtech, a fast-growing laboratory automation player focused on low-volume liquid handling technology for GBP 650 million from Battery Ventures (opens in a new window)
- Levande：交易公告 (opens in a new window)
- EQT Infrastructure broadens investor base in GlobalConnect (opens in a new window)
- Billtrust：交易公告 (opens in a new window)
- EQT to invest in VBill, a leading third-party payment service provider in China (opens in a new window)
- EQT exits VBill, an independent third-party payment service provider and merchant acquirer in China (opens in a new window)
- EQT Active Core Infrastructure announces first investment to acquire Radius Global Infrastructure (opens in a new window)
- EQT Value-Add Infrastructure to acquire SK Shieldus, a leading South Korean integrated security operator (opens in a new window)
- EQT Life Sciences Co-leads $88 Million Series B Financing in QurAlis (opens in a new window)
- Tinyclues：交易公告 (opens in a new window)
- EQT Growth invests EUR 100 million in IntegrityNext, a sustainability software platform dedicated to making supply chains more transparent and compliant (opens in a new window)
- EQT Active Core Infrastructure to acquire Tion Renewables, a renewable energy producer based in Germany (opens in a new window)
- BPEA EQT, in partnership with Nord Anglia Education, to acquire IMG Academy, a world leading sports education brand (opens in a new window)
- BPEA EQT-led consortium to acquire HDFC Credila (opens in a new window)
- BPEA EQT completes the merger of Vistra and Tricor, creating a global fund and corporate services platform (opens in a new window)
- BPEA EQT exits Coforge, a multinational Digital IT Solutions & Technology Consulting Services provider (opens in a new window)
- EQT to acquire VetPartners, the leading provider of veterinary and animal health services in Australia and New Zealand (opens in a new window)
- SUSE：交易公告 (opens in a new window)
- EQT Private Equity to acquire Zeus, a global leader in advanced polymer components used in life-saving medical procedures (opens in a new window)
- EQT Private Equity to sell LimaCorporate, one of the global leaders in joint replacement solutions (opens in a new window)
- LimaCorporate：交易公告 (opens in a new window)
- Dechra Pharmaceuticals：交易公告 (opens in a new window)
- EQT Private Capital Asia exits CMS (opens in a new window)
- EQT Private Equity to sell its 20% stake in Ottobock, the global leader in wearable human bionics (opens in a new window)
- EQT Life Sciences’ portfolio company Cardior Pharmaceuticals to be acquired by Novo Nordisk (opens in a new window)
- EQT Private Equity to Acquire Avetta from WCAS (opens in a new window)
- EQT acquires idealista – the leading online real estate classifieds platform in Southern Europe (opens in a new window)
- EQT to sell majority stake in real estate platform idealista in EUR 2.9 billion transaction (opens in a new window)
- EQT Life Sciences portfolio company Amolyt Pharma to be acquired by AstraZeneca for up to USD 1.05 billion (opens in a new window)
- Amolyt Pharma：交易公告 (opens in a new window)
- EQT Life Sciences invests in Asceneuron, a neurodegeneration therapeutics company, as part of USD 100 million Series C financing round (opens in a new window)
- EQT to sell its stake in fiber-to-the-home network Fiberklaar (opens in a new window)
- EQT Private Equity to acquire a majority stake in AMCS, a global leader in performance and sustainability software to resource-intensive industries (opens in a new window)
- EQT Welcomes Sixth Street as Strategic Investor in EdgeConneX (opens in a new window)
- EQT Foundation invests in agritech company, Qarbotech (opens in a new window)
- EQT to acquire Perficient (opens in a new window)
- EQT Completes Acquisition of Perficient (opens in a new window)
- EQT to successfully acquire OX2, one of Europe’s leading renewable energy developers (opens in a new window)
- EQT, together with CPP Investments and Temasek and Keywords Studios, announce acquisition completion (opens in a new window)
- EQT Foundation invests in NitroVolt, revolutionizing green ammonia production (opens in a new window)
- EQT Life Sciences leads €54 Million Series A Financing of ATB Therapeutics (opens in a new window)
- EQT and GIC to acquire majority stake in Calisen, a leading independent smart metering company in the UK (opens in a new window)
- EQT Life Sciences Leads Series B Extension in Noema Pharma, Raising Total Series B Financing to CHF 130 million (opens in a new window)
- EQT Completes Acquisition of PropertyGuru (opens in a new window)
- EQT to Exit Indian Renewable Energy Platform O2 Power (opens in a new window)
- O2 Power：交易公告 (opens in a new window)
- EQT to sell Dellner Couplers to Wabtec (opens in a new window)
- Neuberger Berman Private Markets, EQT and CPP Investments Form Consortium to Acquire Leading International Schools Organization Nord Anglia Education (opens in a new window)
- EQT Consortium Completes Acquisition of Nord Anglia Education (opens in a new window)
- T-Mobile and EQT Announce Joint Venture to Acquire Lumos and Build Out the Un-carrier’s First Fiber Footprint (opens in a new window)
- T-Mobile US, Inc. Form 10-K for the fiscal year ended December 31, 2025 (opens in a new window)
- EQT to sell Acumatica to Vista Equity Partners, following transformational growth journey (opens in a new window)
- EQT Life Sciences Co-Leads USD 135 Million Series B Financing in SpliceBio (opens in a new window)
- EQT Life Sciences leads USD 56 million Series D financing in Neuros Medical to commercialize FDA-approved treatment for post-amputation pain (opens in a new window)
- Fortnox：交易公告 (opens in a new window)
- Fortnox：交易公告 (opens in a new window)
- EQT to acquire South Korea’s leading AI-enabled HR Tech Platform, Remember (opens in a new window)
- EQT to sell Karo Healthcare, a Leading Pan-European Consumer health Platform, to KKR (opens in a new window)
- Karo Healthcare：交易公告 (opens in a new window)
- EQT Life Sciences Leads USD 44 Million Series B Financing in Cyted Health to Accelerate US Expansion (opens in a new window)
- EQT completes public offering of common stock of Waystar Holding Corp. (opens in a new window)
- Harvey Announces €50 million Investment from EQT Growth, Tapping EQT’s Global Platform to Accelerate International Expansion (opens in a new window)
- EQT Foundation invests in surgical tech company, Syngular Technology (opens in a new window)
- EQT Life Sciences Co-Leads USD 183 Million Series C Financing in Electra Therapeutics (opens in a new window)
- EQT to Exit Remaining Stake in TELUS Digital, a Global AI-Driven Customer Experience and Digital Solutions Leader, in Connection with TELUS Corporation’s Proposed Acquisition of TELUS Digital (opens in a new window)
- TELUS Completes Privatization of TELUS Digital (opens in a new window)
- EQT to invest USD 930 million in Douzone Bizon, a leading provider of ERP and software solutions in South Korea (opens in a new window)
- EQT Foundation invests in Milvus Advanced to enable greener, cheaper catalysts for the energy transition (opens in a new window)
- EQT to sell Pioneer Corporation, a leading Japanese provider of in-car sound and multimedia products and solutions, to CarUX for USD 1.1 billion (opens in a new window)
- Pioneer：交易公告 (opens in a new window)
- EQT exits remaining stake in Kodiak Gas Services, a leading provider of natural gas contract compression services in the United States (opens in a new window)
- EQT Life Sciences portfolio company Merus to be acquired by Genmab in an all-cash USD 8.0 billion transaction (opens in a new window)
- Merus：交易公告 (opens in a new window)
- EQT Life Sciences’ ImCheck Therapeutics to be acquired by Ipsen in a transaction valued at up to EUR 1 billion (opens in a new window)
- ImCheck Therapeutics：交易公告 (opens in a new window)
- EQT completes tender offer on Waga Energy (opens in a new window)
- EQT Life Sciences to exit Vivasure Medical via sale to Haemonetics (opens in a new window)
- EQT to Launch USD 371 million Tender Offer for MAMEZO (opens in a new window)
- EQT and Blackstone Infrastructure to acquire Urbaser, a leading waste management infrastructure platform (opens in a new window)
- EQT exits remaining stake in Azelis Group (opens in a new window)
- Consortium Led by Global Infrastructure Partners and EQT Agrees to Acquire AES (opens in a new window)
- EQT exits Galderma Group AG in full via largest sponsor-backed block trade ever (opens in a new window)
- EQT Announces USD2.7 billion Tender Offer to Privatize Fujitec (opens in a new window)
- Fujitec：交易公告 (opens in a new window)
- EQT to acquire Crown Castle’s Small Cells Solutions business (opens in a new window)
- Arium Networks 与 Zayo：交易公告 (opens in a new window)
- Americold Realty Trust, Inc. and EQT Announce a $1.3 Billion North American Cold Storage Joint Venture (opens in a new window)
- EQT exits remaining stake in Enity Holding AB (publ) (opens in a new window)
- EQT Life Sciences to exit minority stake in Tubulis via sale to Gilead Sciences for up to USD 5.0 billion (opens in a new window)
- Tubulis：交易公告 (opens in a new window)
- EQT exits remaining stake in Beijer Ref (opens in a new window)
- EQT Life Sciences participates in RQ Bio’s USD 115 million Series A financing (opens in a new window)
- Orikan：交易公告 (opens in a new window)
- TachoSil：交易公告 (opens in a new window)
- Copia Power：交易公告 (opens in a new window)
- Quantios：交易公告 (opens in a new window)
- 欧洲物流物业：交易公告 (opens in a new window)
- ICEYE：Scaleup Europe Fund参与F轮 (opens in a new window)
- Vaderis Therapeutics：交易公告 (opens in a new window)
- Kakaku.com：交易公告 (opens in a new window)
- 美国中西部物流物业：交易公告 (opens in a new window)
- Melbourne Storm：交易公告 (opens in a new window)
- 美国东南部物流物业：交易公告 (opens in a new window)
- McGill and Partners：交易公告 (opens in a new window)